0001520138-22-000250.txt : 20220603 0001520138-22-000250.hdr.sgml : 20220603 20220603152357 ACCESSION NUMBER: 0001520138-22-000250 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 44 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kallo Inc. CENTRAL INDEX KEY: 0001389034 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-MISCELLANEOUS RETAIL [5900] IRS NUMBER: 980542529 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53183 FILM NUMBER: 22994114 BUSINESS ADDRESS: STREET 1: 255 DUNCAN MILLS ROAD STREET 2: SUITE 504 CITY: TORONTO STATE: A6 ZIP: M3B 3H9 BUSINESS PHONE: (416) 246-9997 MAIL ADDRESS: STREET 1: 255 DUNCAN MILLS ROAD STREET 2: SUITE 504 CITY: TORONTO STATE: A6 ZIP: M3B 3H9 FORMER COMPANY: FORMER CONFORMED NAME: Diamond Technologies Inc. DATE OF NAME CHANGE: 20091203 FORMER COMPANY: FORMER CONFORMED NAME: Printing Components Inc. DATE OF NAME CHANGE: 20070206 10-K 1 kalo-20211231_10k.htm 10-K
0001389034 false FY --12-31 2021 false 2022-12-31 0001389034 2021-01-01 2021-12-31 0001389034 2022-01-31 0001389034 2022-04-21 0001389034 2021-12-31 0001389034 2020-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2021-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2020-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2021-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2020-12-31 0001389034 2020-01-01 2020-12-31 0001389034 us-gaap:PreferredStockMember 2019-12-31 0001389034 us-gaap:CommonStockMember 2019-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2019-12-31 0001389034 us-gaap:RetainedEarningsMember 2019-12-31 0001389034 2019-12-31 0001389034 us-gaap:PreferredStockMember 2020-12-31 0001389034 us-gaap:CommonStockMember 2020-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2020-12-31 0001389034 us-gaap:RetainedEarningsMember 2020-12-31 0001389034 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001389034 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2020-01-01 2020-12-31 0001389034 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001389034 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001389034 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2021-01-01 2021-12-31 0001389034 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001389034 us-gaap:PreferredStockMember 2021-12-31 0001389034 us-gaap:CommonStockMember 2021-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2021-12-31 0001389034 us-gaap:RetainedEarningsMember 2021-12-31 0001389034 2017-04-07 0001389034 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember srt:DirectorMember 2021-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember srt:DirectorMember 2021-01-01 2021-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember srt:DirectorMember 2021-12-31 0001389034 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember srt:DirectorMember 2021-01-01 2021-12-31 0001389034 srt:DirectorMember 2020-10-01 2020-12-31 0001389034 srt:DirectorMember 2020-07-01 2020-09-30 0001389034 srt:DirectorMember 2019-01-01 2019-12-31 0001389034 srt:DirectorMember 2021-12-31 0001389034 srt:DirectorMember 2020-12-31 0001389034 kalo:FEPharmacyMember 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities1Member 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities1Member 2020-12-31 0001389034 kalo:ConvertibleDebtSecurities2Member 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities2Member 2020-12-31 0001389034 kalo:ShortTermDebt1Member 2021-12-31 0001389034 kalo:ShortTermDebt1Member 2020-12-31 0001389034 kalo:ShortTermDebt3Member 2021-12-31 0001389034 kalo:ShortTermDebt3Member 2020-12-31 0001389034 kalo:ShortTermDebt2Member 2021-12-31 0001389034 kalo:ShortTermDebt2Member 2020-12-31 0001389034 us-gaap:JudicialRulingMember 2017-04-20 2017-04-21 0001389034 us-gaap:JudicialRulingMember 2016-10-23 2016-10-24 0001389034 us-gaap:PendingLitigationMember 2017-10-05 2017-10-06 0001389034 us-gaap:PendingLitigationMember 2021-01-01 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-K

 

xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021

 

Commission file number 000-53183

KALLO INC.

(Exact name of registrant as specified in its charter)

 

Nevada 98-0542529

(State or other jurisdiction of

incorporation or organization)

 (I.R.S. Employer Identification No.)

 

255 Duncan Mill Road, Suite 504, Toronto, Ontario, Canada M3B 3H9

(Address of Principal Executive Offices) (Zip Code)

 

(416) 246-9997

(Issuer’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act: Securities registered pursuant to section 12(g) of the Act:

None

(Title of Class)

Common Stock

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes o No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes x No o

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o Accelerated filer o
Non-accelerated Filer o Smaller reporting company x
    Emerging growth company o

(Do not check if a smaller reporting company)

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No o

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of January 31, 2022: $10,226,975

 

The registrant had 6,356,429,586 shares of common stock outstanding as of April 21, 2022.

 

 

 

 

As used herein, the term “we,” “us,” “our,” and the “Company” refers to Kallo, Inc. a Nevada corporation.

 

FORWARD-LOOKING STATEMENTS

 

THIS FORM 10-K CONTAINS “FORWARD-LOOKING STATEMENTS”. FORWARD-LOOKING STATEMENTS ARE STATEMENTS CONCERNING ESTIMATES, PLANS, OBJECTIVES, GOALS, STRATEGIES, EXPECTATIONS, INTENTIONS, PROJECTIONS, DEVELOPMENTS, FUTURE EVENTS, PERFORMANCE OR PRODUCTS, UNDERLYING (EXPRESSED OR IMPLIED) ASUMPTIONS AND OTHER STATEMENTS THAT ARE OTHER THAN HISTORICAL FACTS. IN GENERAL FORWARD-LOOKING STATEMENTS CAN BE IDENTIFIED BY THE USE OF FORWARD-LOOKING WORDS SUCH AS “ESTIMATED,” “BELIEVES,” “EXPECTS,” “MAY,” “WILL,” “SHOULD,” OR “ANTICIPATES,” OR THE NEGATIVE OF THESE WORDS OR OTHER VARIATIONS OF THESE WORDS OR COMPARABLE WORDS, OR BY DISCUSSIONS OF PLANS OR STRATEGY THAT INVOLVE RISKS AND UNCERTAINTIES. MANAGEMENT WISHES TO CAUTION THE READER THAT THESE FORWARD-LOOKING STATEMENTS, INCLUDING, BUT NOT LIMITED TO, STATEMENTS REGARDING THE COMPANY AND ITS PLANS OR INTENTIONS, ESTIMATES, GOALS, COMPETITIVE TRENDS AND OTHER MATTERS THAT ARE NOT HISTORICAL FACTS ARE ONLY PREDICTIONS. NO ASSURANCES CAN BE GIVEN THAT SUCH PREDICTIONS WILL PROVE CORRECT OR THAT THE ANTICIPATED FUTURE RESULTS WILL BE ACHIEVED. ACTUAL EVENTS OR RESULTS MAY DIFFER MATERIALLY EITHER BECAUSE ONE OR MORE PREDICTIONS PROVE TO BE ERRONEOUS OR AS A RESULT OF OTHER RISKS FACING THE COMPANY. FORWARD-LOOKING STATEMENTS SHOULD BE READ IN LIGHT OF THE CAUTIONARY STATEMENTS AND IMPORTANT FACTORS DESCRIBED IN THIS FORM 10-K, INCLUDING, BUT NOT LIMITED TO “THE FACTORS THAT MAY AFFECT FUTURE RESULTS” SHOWN AS ITEM 1A AND IN MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. THE RISKS INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS ASSOCIATED WITH AN EARLY-STAGE COMPANY HAS LIMITED ASSETS AND OPERATIONS, THE COMPARATIVELY LIMITED FINANCIAL RESOURCES OF THE COMPANY, THE LOSSES THAT THE COMPANY INCURS EACH YEAR, THE COMPANY IS INSOLVENT AND ITS TOTAL LIABILITIES EXCEED ITS TOTAL ASSETS, THE INTENSE COMPETITION THE COMPANY FACES FROM OTHER ESTABLISHED COMPETITORS, AND THE LEGAL UNCERTAINTIES THAT DIRECTLY AND INDIRECTLY IMPACT DEVELOPMENT-STAGE COMPANIES. ANY ONE OR MORE OF THESE OR OTHER RISKS COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THE FUTURE RESULTS INDICATED, EXPRESSED, OR IMPLIED IN SUCH FORWARD-LOOKING STATEMENTS. WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENT TO REFLECT EVENTS, CIRCUMSTANCES, OR NEW INFORMATION AFTER THE DATE OF THIS FORM 10-K OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED OR OTHER SUBSEQUENT EVENTS. MAKE NO MISTAKE: WE ARE INSOLVENT AND OUR COMMON STOCK SHOULD ONLY BE ACQUIRED BY PERSONS WHO CAN AFFORD THE TOTAL LOSS OF THEIR INVESMENT SINCE OUR COMMON STOCK MUST BE CONSIDERED A “HIGH RISK” SECURITY.

 

 

TABLE OF CONTENTS

 

    Page
  PART I  
     
Item 1. Business. 1
Item 1A. Risk Factors. 8
Item 1B. Unresolved Staff Comments. 11
Item 2. Properties. 11
Item 3. Legal Proceedings. 11
Item 4. Mine Safety Disclosures. 11
     
  PART II  
     
Item 5. Market for Our Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 12
Item 6. Selected Financial Data. 13
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 13
Item 7A. Quantitative and Qualitative Disclosures about Market Risk. 26
Item 8. Financial Statements and Supplementary Data. 27
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 45
Item 9A. Controls and Procedures. 45
Item 9B. Other Information. 45
     
  PART III  
     
Item 10. Directors, Executive Officers and Corporate Governance. 46
Item 11. Executive Compensation. 50
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 52
Item 13. Certain Relationships and Related Transactions, and Director Independence. 53
Item 14. Principal Accountant Fees and Services. 53
     
  PART IV  
     
Item 15. Exhibits and Financial Statement Schedules. 54
     
Signatures 57

 

PART I

 

ITEM 1. BUSINESS.

 

As used herein, the term “we,” “our,” “us,” and the “Company” refers to Kallo, Inc., a Nevada corporation unless otherwise noted.

 

We were incorporated in the state of Nevada on December 12, 2006 as Printing Components Inc. and then changed our name to Diamond Technologies Inc. and then to our current name of Kallo Inc. On December 11, 2009, we merged with Kallo Technologies Inc. (formerly known as Rophe Medical Technologies Inc.), an Ontario corporation and its shareholders (collectively “Rophe”) wherein we acquired all of the issued and outstanding shares of common stock of Rophe in exchange for 3,000,000 common shares and $1,200,000.

 

Upon acquiring Rophe, the focus of our business was to develop medical information technology software. It has since expanded to the delivery and support of what we believe may offer an end-to-end healthcare solution for developing countries and rural communities with the goal on improving all aspects of health care delivery. We have incurred over $8,000,000 in losses in 2021 and we cannot be certain that we will avoid additional losses at that level or higher.

 

Business Overview

 

We are a small company with limited financial and managerial resources and we offer what we believe may be an end-to-end health care solution that is called the Kallo Integrated Delivery System (KIDS). Our KIDS product currently consists of the following three (3) components:

 

  1. Care Platforms

 

  a. These include the care facility platforms – MobileCareTM and RuralCareTM described in more detail in the MD&A section, Dialysis care and brick and mortar hospitals as well as the emergency medical services care both land and air transportation.

 

  2. Digital Technology

 

  a. This component of the business includes the Electronic Medical Records (EMR), Picture Archiving and Communication System (PACS), eLearning system, eGovernance solutions as well as our Tele-health solution that supports the Global and Regional response centers for real time support of medical emergencies.

 

  3. Education & Training

 

  a. This component includes the education and training for all aspects of healthcare management – clinical including clinical informatics, engineering including bio-medical, information and communications technology and health administration.

 

Each of these components are currently included in the full KIDS solution but can also be used as individual components to enhance an existing health care infrastructure.

 

Our Copyrighted Technologies:

 

While we believe that our technologies are protected under Canadian and International copyrights and are authored by and owned by John Cecil., we have not obtained any evaluation of the extent of our copyright or other intellectual property right claims by any independent third party and we have no present plans to obtain any such evaluation at this time. And in that context, we believe that Kallo Inc. has the rights to the products referred in this section, of which items B, C, and D (listed below) are under development and we anticipate that they will likely require further development work. There can be no assurance that we will not later discover that the extent of our copyright claims are limited and/or that we may be subject to claims of infringement asserted by other persons. In that event we may be exposed to significant and protracted litigation with likely consequential and serious financial losses resulting thereby.

-1-

  A. M.C. Telehealth – Mobile Clinic Telehealth System – Developed and launched in November 2011.

 

  B. EMR Integration Engine – Electronic Medical Record Integration Engine - Under development.

 

  C. C&ID-IMS – Communicable and Infectious Disease Information Management System - Under Development

 

  D. CCG Technology – Clinical-Care Globalization technology – Under Development

 

The following is a summary of the information:

 

Number  Date of Filing  Place of Filing  Duration
1072203  November 3, 2009  Canada  Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year
1072204  November 3, 2009  Canada  Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year
1072205  November 3, 2009  Canada  Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year
1072543  November 17, 2009  Canada  Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year

 

Our Products in Development

 

Our product portfolio currently includes three earlier stage products listed below, all of which highlight what we believe could demonstrate the broad applicability of our proprietary technologies that may offer potential future product opportunities for us if market conditions allow. In that event and if we have sufficient financial resources, we plan to evaluate partnership opportunities for further development and commercialization of these products.

 

  1. Our copyrighted technology “EMR Integration Engine” that demonstrate what we believe may be the future direction for integrated solutions as well as current efforts that illustrate interoperability within the continuum of care. EMR Integration Engine is software, which connects all the other applications in or outside a hospital/clinic with the EMR system. This enables the doctor/nurse to seamlessly access information in other healthcare applications without moving from one computer to the next.

 

  2.

C&ID-IMS is an Internet-based solution for monitoring and managing Communicable and Infectious Disease information. Our target markets are Health Organizations and Ministries of Health, hospitals and Center for Disease Control (CDC) & the World Health Organization (WHO) members around the globe.

 

While we believe that our technologies are protected under Canadian and International copyrights and are authored by and owned by John Cecil. However, we have not obtained any third-party independent evaluation of the extent of our copyright or other intellectual property right claims by any independent third-party and we have no present plans to obtain any such evaluation. And in that context, we believe that Kallo Inc. has the rights to the products referred in this section, of which items B, C, and D (listed below) are under development and we anticipate that they will likely require further development work. There can be no assurance that we will not later discover that the extent of our copyright claims are limited and/or that we may be subject to claims of infringement asserted by other persons. In that event, our plans and strategies may be seriously compromised with the result that we may suffer serious long-term financial losses thereby.

-2-

  3. CCG is, what we believe, may be our clinical-care globalization technology. We believe that this product may, if market and competitive conditions allow, offer us an opportunity to respond to the growing “medical tourism phenomenon” - patients going to low-cost countries for elective medical procedures.  Based on our own internal and limited assessment undertaken without any independent third -party evaluation, we believe that this may be a fast-growing worldwide industry segment that may be actively promoted by certain countries. In that sense, it may be that CCG may be used by both the destination and home country of a patient to maintain complete and accurate records of the treatment history, avoiding errors due to incomplete patient data and lessening the burden and expense of corrective action on the home country when medical tourists return home. But we also know that any such growth in this segment will likely be subject to then current laws and regulations in addition to other factors over which we have no control.

 

  4. MC-Telehealth (Mobile Clinic with Telehealth system) is our planned mobile clinic long distance or Telehealth technology. We believe that our product, if properly installed and used, may allow the remote transmission of standardized formats of data for laboratory information, diagnostic imaging, diagnosis and clinical notes.

 

  5. KIDS (Kallo Integrated Delivery System), a Technology & process framework defines and describes the component parts of the various products and services that Kallo is delivering to its clients, including the human resources component, and how these parts interact and relate to one another. The framework also recognizes the need for collaboration with local care facilities, services and providers to support continuity of care and facilitate patient transport between facilities.

 

  6.

KIDS (Kallo Integrated Delivery System) Global Tele-Health Ecosystems. The Tele-health Program encompasses the broad variety of Technologies and administrative processes needed to deliver virtual medical care, health promotion/prevention and other patient education to KIDS patients. If properly installed and managed, we believe that our tele-health program may serve to facilitate synchronous and asynchronous interactions where patients or care providers are in different locations. The KIDS system includes scheduling, information delivery and care management services that we believe may offer opportunities to enhance the delivery of healthcare services if the system is properly installed and managed.

 

Overall, we have conducted only a limited amount of internal evaluation of our technology and our planned business operations. That is, we have not engaged or secured any independent third-party evaluation of our technology, our copyright claims, and our planned business operations and even our business model. In that respect there is a clear risk that we may later discover that our limited internal management assessments are materially inaccurate and in one or more respects we have made inaccurate assumptions regarding the willingness of the marketplace to adopt, accept or utilize all of our technology and/or the business model that we have adopted. We may also discover that our copyright claims are invalid and conflict with superior claims asserted by other persons with the result we are exposed to conflicting claims with resulting liability thereby. To the extent that our assumptions and/or our business model is materially inaccurate or fails to address the needs of the healthcare marketplace, we will likely incur significant and protracted financial losses thereby.

 

   

The following are “Forward-Looking Statements” that are subject to the qualifications set forth at the beginning of this Form 10-K and subject to the Risk Factors set forth herein.

-3-

Target Market

 

Based on our current internal management assessments undertaken without the benefit of any independent third-party review or evaluation, we believe that our primary target market for the Kallo Integrated Delivery System (KIDS) may be one or more selected markets in certain developing countries where health care services are limited and where we may be able to enter into what we hope may be commercially feasible contractual arrangements without undue and unacceptable risks and challenges. To that end and in anticipation that we may be successful in these efforts, we have established several sales and marketing partnership agreements under “Business Associate” section either representing Kallo independently or as an organization. While we are currently in various stages of our sales cycle with more than 10 countries, we cannot assure you that we will be successful in these efforts or, if we are successful, that we can implement and undertake our business plans without incurring significant and protracted losses and negative cash flow. Yet, we have incurred over $8,000,000 in losses in 2021 and we cannot be certain that we will avoid additional losses at that level or higher.

 

Additionally, with the components of our KIDS solution, we are targeting markets where, if our financial resources and market conditions allow, we believe we may be able to offer complimentary services to existing health care infrastructures. These markets currently include the following:

 

  ● Communicable & Infectious disease Information Management System – supporting World Health Organization (WHO) and Center for Disease Control (CDC); $200B market

 

  ● Electronic Medical Records integration engine for Health Information Access Layer – focused on clinics, hospitals, IDC & IHC; $100B market

 

  ● Clinical Care Globalization – focused on medical tourism; $40B market

 

  ●

Mobile Medical Clinics – focused on disaster recovery management and rural community health services for wide range of services, HIV monitoring, chemotherapy, acute care, dialysis, etc; $30B market

 

However, we are acutely aware that market conditions are ever-changing and we can not assure you that we can undertake these efforts, or if we do, that we can do so without incurring significant and protracted losses and negative cash flow.

 

Intellectual Property and Research and Development

 

If market conditions and our financial resources allow, we anticipate that we likely will continue our efforts in research and development through collaborations with medical faculties in Canada and the United States on an ongoing basis where our company stands to benefit from the technology ownership of the treatment or diagnostic systems developed for commercial use.

 

Since 2016, we decreased our expenses relating to research and development but we anticipate that we will, if market conditions and our financial resources allow, continue our research and development work on the Mobile Clinic and Telehealth system, which we anticipate will may1 be in demand in the future if our internal management assessments are accurate and market conditions do not become unfavorable.

 

Competition

 

We are a small company with limited financial and managerial resources. We compete with many larger, well-established entities in various sectors; mobile clinic and temporary medical facility manufacturers, health care equipment resellers, EMR developers, health care education providers, EMS contracted services, etc. Our competitors tend to be focused on a component of our health care solution, but they do have established histories in their particular area of expertise affording them a resource advantage. We are effectively in the start-up phase of operations and as a result, we have little or no impact upon our competition. We believe that, if market conditions and our financial resources allow, we may be able to offer a fully integrated solution. In the opportunities that we have been engaged in, we have not encountered a competitor that offers the full end to end solution that we are offering in the marketplace.

-4-

Management’s View of the Market Trend

 

The Intelligence Unit of The Economist published a report in 2017 recognizing that access to healthcare is a key topic of debate worldwide and that countries are facing a range of healthcare challenges.

 

In 2016, they developed the Global Access to Healthcare Index to measure how healthcare systems across 60 countries are working to address their most pressing healthcare needs.

 

As shown in Chart 1 below, the index is based on a set of accessibility and healthcare-system measures. The accessibility domain measures access to specific kinds of care and the healthcare systems domain measures access to effective and relevant healthcare services such as policy, institutions, and infrastructure.

 

(IMAGE)

 

One of the primary findings of this report is that much more needs to be done to develop and extend coverage, the geographical reach of infrastructure, equity of access, and efficiency to improve the sustainability of health systems.

 

Specifically, the key findings of the report are as follows:

 

1.Political will and a social compact are prerequisites for both access and sustainable health systems.

 

2.Public investment underpins good access and demonstrates the commitment of governments to ensuring the health of their populations.

 

3.Universal coverage does not mean universal access, but extending universal health coverage (UHC) can be a crucial part of improving access.

 

4.Access to data is fundamental.

 

5.A well-trained and integrated workforce is the backbone of a sustainable healthcare system.

 

6.Good primary care is a vital building block for good access.

 

As might be expected, the index reveals that developed countries are performing much better in all areas compared with developing countries. For example, Chart 8 below identifies the lowest performing countries in the area of equity of access to healthcare.

-5-

(IMAGE)

 

The report also recognizes that many developing countries have shown significant improvements in their efforts to meet the UN’s Millennium Development Goals (MDGs), and the countries that have signed up to the Sustainable Development Goals (SDGs) have agreed to aim for a 40% reduction in premature deaths by 2030. As part of the SDGs, countries have pledged to reduce child and maternal deaths and mortality from tuberculosis, HIV and malaria by two-thirds, and deaths from non-communicable diseases (NCDs) and other causes by one-third. Yet it is increasingly clear that insufficient investment in healthcare, particularly in the developing world, has led to disparities in health outcomes globally.

 

Over the last couple of decades, we have noted that there have been growing multilateral efforts to encourage countries to increase the amount of money they spend on healthcare. The WHO has recommended that countries spend a minimum of 5% of GDP on health in order to be taken seriously on provision of access. Meanwhile, in the Abuja Declaration of 2001 the heads of state of African Union countries pledged to set a target of allocating at least 15% of their budgets to improving healthcare. Over a decade later, however, many of them were still making insufficient progress.

 

The extensive work that Kallo has done over the past 10 years studying the health challenges faced by many African countries has led to the design of our comprehensive healthcare delivery solution which addresses all of the key findings of this report.

 

With respect to the importance of political will, Kallo’s approach of working closely with the government, providing a national healthcare system tailored to the specific needs of the country and Kallo’s commitment to providing ongoing support helps to engender the political will that developing countries need to achieve success.

 

With respect to the importance of public investment in healthcare, Kallo is helping to address this need by providing innovative financing options which allow developing countries to make the needed healthcare investments without creating undue negative economic impact.

 

With respect to the issue of universal health coverage, the report states that there is an important distinction to be made between the ability to access healthcare services and its successful delivery to a wide population. Further, the report states that a right to healthcare may be guaranteed in law, but not actually available in reality, especially in remote and underdeveloped regions. Kallo’s KIDS solution specifically recognizes the importance of extending universal health coverage through the innovative use of a variety of care platforms that can reach the unreached while using technology to ensure that the access to healthcare services is available to all the citizens of a country.

 

With respect to access to data, we believe that our KIDS solution includes state-of-the-art integrated electronic medical records and hospital information systems to gather and process the data that is critical to allowing governance structures to effectively oversee the entire healthcare system. However, we have not evaluated our technology relative to the technology offered by others. We may discover that far better technology is offered by other established providers who offer better technology and at a price level that is a perceived “greater-value” to the purchaser.

-6-

With respect to the importance of a well-trained and integrated workforce, we have recognized the importance of providing education and training to local healthcare practitioners by establishing Kallo University which collaborates with teaching institutions and hospitals in Canada to provide a wide range of these services.

 

We believe that in today’s market, offering high quality primary care is critically important. And although we have not conducted or received any independent research, we have taken steps to ensure that our KIDS solution specifically focuses on providing primary care through all of its care platforms as well as providing specialized care as required.

 

Through all of our study of the healthcare challenges facing developing countries and as confirmed by the key findings of this Economist Intelligence Unit report, we believe that our comprehensive KIDS solution and our approach to working directly with the governments of developing countries likely provides the greatest opportunity for achieving success in significantly improving access to world class healthcare services for all.

 

Government Regulation and Compliance

 

The healthcare regulations and standards vary widely in the geographic areas that we are focused in, with the primary concerns around patient health, safety, and privacy. With rapid advances in clinical and technology changes, the increased scrutiny by governments, the media and consumers has created continual monitoring and increased regulation on drug and patient safety specifically.

 

Within the global market that we serve, North America has some of the most stringent regulations and standards for medical technology and pharmaceutical approvals. As such, we have partnered with a number of major biomedical devices/equipment suppliers to ensure the highest standards of equipment. If we are successful, we intend to utilize only the highest standards of product regardless of the market that we are serving.

 

Employees

 

As of March 31, 2022, we have four full time employees.

 

Warranties

 

We do not provide warranties in connection with our products or services. Our third party products are supplied with the manufacturer’s warranty and we offer additional coverage with a service agreement.

 

Insurance

 

We currently do not have insurance but, if our financial resources allow, we plan to obtain general liability and other insurance as appropriate.

 

Executive Offices

 

Our administrative office is located at 255 Duncan Mill Road, Suite 504, Toronto, Ontario, Canada, M3B 3H9, our telephone number is (416) 246-9997. Our registered agent for services of process is the Corporation Trust Company of Nevada, located at 6100 Neil Road, Suite 500, Reno, Nevada 89511. Our fiscal year end is December 31st.

-7-

  ITEM 1A. RISK FACTORS.

 

Our Common Stock is subject to a number of substantial risks, including those described below. No attempt has been made to rank these risks in the order of their likelihood or potential harm. In addition to those general risks enumerated elsewhere in the document, any purchaser of the Company’s common stock should also consider the following risk factors:

 

Risks Related to the Ownership of the Company’s Stock

 

1. No Revenues from Operations & Continuing Losses; Risk of Loss & Insolvency. During the past two fiscal years we have not generated and revenues and there can be no assurances that we will be successful in generating revenues in the future. In that respect we face all of the risks inherent in an early-stage business. We have incurred losses and there can be no assurance that we will ever achieve profitability and positive cash flow. While we believe that our business strategies are sound, there can be no assurance that our business will generate profits and positive cash flow or if we generate profits and positive cash flow, that it can be sustained. Investors should be aware that they may lose all or substantially all of their investment. We are also insolvent since our Total Liabilities exceed our Total Assets. In that connection, we incurred over $8,000,000 in losses in 2021 and we cannot be certain that we will avoid additional losses at that level or higher in future years.

 

2. Limited Corporate Officers & Employees. We have only three corporate officers, one of which is part-time and an aggregate of four employees, including our three officers. As a result, we may not be able to evaluate ever-changing market, technology and competitive trends effectively and we are likely to incur losses thereby.

 

3. Conduct and Decisions while in the “Zone of Insolvency.” We believe that we are in the “Zone of Insolvency.” Under the corporate common law of many jurisdictions, a Board of Directors of a corporation that is in the “Zone of Insolvency” generally owe a duty of care to the holders of its debt instruments and other creditors to take steps to avoid or minimize the losses that such persons would otherwise incur. While we believe that we have acted with due regard to our duty of care to our stockholders and to our creditors, we cannot assure you that we have always acted with the requisite level to discharge our duties to each of the foregoing. In that event, holders of our Common Stock and holders of our Preferred Stock will likely suffer additional losses thereby.

 

4. Auditor’s Opinion: Going Concern & Insolvency. Our independent auditors have expressed substantial doubt about the Company’s ability to continue as a going concern since: (a) our Total Current Liabilities exceed our Total Current Assets; (b) our Total Liabilities exceed our Total Assets; and (c) we are an early-stage company and there exists only a limited history of operations. Since our Total Liabilities exceed our Total Assets, we are insolvent and anyone who acquires our Common Stock should be prepared to lose their entire investment. We incurred losses of over $8 million in our fiscal year ending December 31, 2021 and we cannot assure you that we will not incur losses at or exceeding that level in the future.

 

5. Absence of any Financial Resources; Need for Additional Financing. Our financial resources are minimal and we are insolvent (since we have limited assets and over $6.5 million in liabilities). We need to obtain additional financing from the sale of our Common Stock, Debt, or some combination thereof in order to undertake further business plans. Our ability to operate as a going concern is contingent upon our receipt of additional financing through private placements or by loans. We anticipate that we will require significant additional funds in the future if we are successful in marketing our products and services. There can be no assurance that if additional funds are required they will be available, or, if available, that they can be obtained on terms satisfactory to our Board of Directors. In the event the Company elects to issue stock to raise additional capital, any rights or privileges attached to such stock may either (i) dilute the percentage of ownership of the already issued common shares or (ii) dilute the value of such shares; or (iii) both. No rights or privileges have been assigned to the stock and any such rights and privileges will be at the total discretion of the Board of Directors of the Company. There can be no guarantee that we will be able to obtain additional financing, or if we are successful, that we will be able to do so on terms that are reasonable in light of current market conditions. Further, we have not received any commitment from any person to provide any additional financing and we cannot assure that any such commitment is forthcoming.

 

6. Limited and Sporadic Trading Market for Common Stock. Our Common Stock trades on the OTC Market on a limited and sporadic basis and there can be no assurance that a liquid trading market for our Common Stock will develop and, if it does develop, that it can be sustained. Currently we do not have a sponsoring registered broker-dealer serving as our market-maker. Since the Securities and Exchange Commission amended Rule 15c2-11 effective September 28, 2021, our lack of a market-maker may result in a cessation of our listing and trading of our Common Stock on the U.S. OTC Market. In that event, holders of our Common Stock may lose an ability to offer and/or sell our Common Stock on the OTC Market with the result that our Common Stock will not be tradable in any market and the value of our Common Stock will dramatically and significantly decline. In that event holders of our Common Stock will likely lose their entire investment.

-8-

7. Lack of Revenues and Development Stage Company. We have no history of generating Sales Revenues and we cannot assure that we will generate any Sales Revenues at ant time in the future or, if we do, that we can achieve Sales Revenues at a level that will allow us to also achieve and maintain profitability and positive cash flow. We face all of the risks inherent in a new business. There is no information at this time upon which to base an assumption that our plans will either materialize or prove successful. Our present business plans and strategies have been developed by our corporate officers and they have been evaluated by any independent third party. plans have not been determined. There can be no assurance that any of our business plans and strategies will generate sales revenues that will result in any profits or positive cash flow. Investors should be aware that they may lose all or substantially all of their investment.

 

8. Lack of Dividends & No Likelihood of Dividends. We have not paid dividends and do not contemplate paying dividends in the foreseeable future. We have no cash assets and we have an accumulated deficit.

 

9. Competition. We are an insignificant participant among firms which offer health care products and services. There are many well-established health care product and service companies which have significantly greater financial and managerial resources, technical expertise and experience than the Company. In view of our limited financial and managerial resources, we will likely be at a significant competitive disadvantage vis-a-vis our competitors.

 

10. No Ability to Control & Matter of Voting Rights Held by our President. Any person who acquires our Common Stock will have no real ability to influence or control the Company or otherwise have any ability to elect any person to our Board of Directors. Our officers, directors, and certain other persons currently control the Company and there is no likelihood that any person who acquires our Common Stock will have any real ability to influence or control the Company in any meaningful way. Further and at present, our President, John Cecil, is the owner and holder of 5,000,000 shares of our Series B Preferred Stock with each share having one thousand (1,000) votes per share with the right to vote with our Common Stockholders at any meeting of or action taken by the holders of our Common Stock. As a result, Mr. Cecil has the clear ability to control the Company via the exercise of his voting rights provided by the Series B Preferred Stock and all of the holders of our Common Stock effectively have no real ability to exercise any influence upon the affairs of the Company. In addition, Mr. Cecil is the owner and holder of 70,000,000 shares of the Company’s Series A Preferred Stock with each Series A Preferred share having one hundred (100) votes per share. As a result of the foregoing, any holder or group of holders of our Common Stock will have no reasonable ability to influence or control the Company’s policies, affairs, or strategies.

 

11. Negative Equity & “Zone of Insolvency”. Our Total Liabilities exceed our Total Assets. Since we have limited cash assets and given our accumulated deficit, we are in the “Zone of Insolvency” which can result in the interests of our Common Stockholders becoming subject to the interests of our creditors. As a result, we are insolvent, and we cannot assure you that we will be able to become solvent at any time in the future.

 

12. Possible Rule 144 Stock Sales. Many of our shares of our outstanding Common Stock are “restricted securities” and may be sold only in compliance with Rule 144 adopted under the Securities Act of 1933, as amended or other applicable exemptions from registration. Any person who acquires our common stock in any private placement should carefully review Rule 144 since any potential public resale may be limited and current broker-dealer and clearing firm requirements may make any re-sale of our common stock difficult at best.

 

13. Absence of Underwriter Commitment. Based on our current plans, we anticipate that we will likely need to raise significant additional capital to meet our current and anticipated financial needs, we have not received any commitment from any registered broker-dealer or underwriter to assist us in raising needed capital. As a result, we face a clear risk that we will not have sufficient cash resources to meet our current financial obligations and otherwise implement our business plans. In that event, we may not be able to implement our plans and we will not be able to achieve profitability and positive cash flow or, if we do, that we can sustain either or both of them for any period of time.

-9-

14. Ten Day Stop Trading Order Imposed by SEC in March 2021. As set forth in greater detail elsewhere in this Annual Report, in March of 2021, the U.S. Securities and Exchange Commission (the “SEC”) imposed a Ten Day Stop Trading Order on the trading of our Common Stock (the ‘Order”). While the Order has expired, we cannot assure you that the SEC or any other securities regulator has not undertaken or will undertake further investigative action or other action that may further disrupt our affairs and cause significant financial injury to us. It is not uncommon that such “follow-on” actions to be taken by one or more securities regulators after the SEC takes action as set forth in the Order. IN that event, we may incur significant and prolonged costs and expenses and resulting financial losses and resulting permanent damage to our reputation.

 

15. Risks of Low-Priced Stocks. In the past, the Company’s common stock had only limited and sporadic trading in the so-called “pink sheets,” and before that, on the “Electronic Bulletin Board.” As a result and due to the absence of a market, a shareholder may find it more difficult to dispose of, or to obtain accurate quotations as to the price of, the Company’s securities. In the absence of a security being quoted on NASDAQ, or the Company having $2,000,000 in net tangible assets, trading in the Common Stock is covered by Rule 3a51-1 promulgated under the Securities Exchange Act of 1934 for non-NASDAQ and non-exchange listed securities. Under such rule, broker/dealers who recommend such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or an annual income exceeding $200,000 or $300,000 jointly with their spouse) must make a special written suitability determination for the purchaser and receive the purchaser’s written agreement to a transaction prior to sale.

 

In general, securities are also exempt from this rule if the market price is at least $5.00 per share, or for warrants, if the warrants have an exercise price of at least $5.00 per share. The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosure related to the market for penny stocks and for trades in any stock defined as a penny stock. The Commission has recently adopted regulations under such Act which define a penny stock to be any NASDAQ or non-NASDAQ equity security that has a market price or exercise price of less than $5.00 per share and allow for the enforcement against violators of the proposed rules.

 

In addition, unless exempt, the rules require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule prepared by the Commission explaining important concepts involving the penny stock market, the nature of such market, terms used in such market, the broker/dealer’s duties to the customer, a toll-free telephone number for inquiries about the broker/dealer’s disciplinary history, and the customer’s rights and remedies in case of fraud or abuse in the sale.

 

Disclosure also must be made about commissions payable to both the broker/dealer and the registered representative, current quotations for the securities, and if the broker/dealer is the sole market-maker, the broker/dealer must disclose this fact and its control over the market.

 

Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. While many NASDAQ stocks are covered by the proposed definition of penny stock, transactions in NASDAQ stock are exempt from all but the sole market-maker provision for (i) issuers who have $2,000,000 in tangible assets ($5,000,000 if the issuer has not been in continuous operation for three years), (ii) transactions in which the customer is an institutional accredited investor and (iii) transactions that are not recommended by the broker/dealer. In addition, transactions in a NASDAQ security directly with the NASDAQ market-maker for such securities, are subject only to the sole market-maker disclosure, and the disclosure with regard to commissions to be paid to the broker/dealer and the registered representatives.

 

Finally, all NASDAQ securities are exempt if NASDAQ raised its requirements for continued listing so that any issuer with less than $2,000,000 in net tangible assets or stockholder’s equity would be subject to delisting. These criteria are more stringent than the proposed increased in NASDAQ’s maintenance requirements.

 

Our securities are subject to the above rules on penny stocks and the market liquidity for our securities could be severely affected by limiting the ability of broker/dealers to sell our securities.

-10-

  ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

None.

 

  ITEM 2. PROPERTIES.

 

The executive offices of Kallo Inc. are located at 255 Duncan Mill Road, Suite 504, Toronto, Ontario, Canada, M3B 3H9, our telephone number is (416) 246-9997. This location is the office of one of our directors, who has graciously agreed to provide us use of this address and a meeting room, when needed, without charge.

 

  ITEM 3. LEGAL PROCEEDINGS.

 

On April 21, 2017, an ex-employee of Kallo obtained a judgement ordering Kallo to pay Canadian $ 135,959 for unpaid wages and expenses relating to services performed in 2016. The full amount has been accrued for in the financial statements of Kallo.

 

On October 24, 2016, a consultant obtained a judgement ordering Kallo to pay Canadian $34,924 for unpaid fees. The full amount has been accrued for in the financial statements of Kallo.

 

On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. An amount of Canadian $134,960 has been accrued for in the financial statements of Kallo.

 

There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. An amount of Canadian $24,016 has been accrued for in the financial statements of Kallo. Negotiations are in process for the settlement of this debt for a lump sum.

 

While we believe that we may be successful in resolving these claims, we cannot assure that the outcome will not have a material adverse effect upon us.

 

  ITEM 4. MINE SAFETY DISCLOSURES.

 

None.

-11-

PART II

 

  ITEM 5. MARKET FOR OUR COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Our shares are traded on OTC Markets under the symbol “KALO”. A summary of trading by quarter for 2021 and 2020 is as follows:

 

Fiscal Year
2021		  High Bid   Low Bid 
Fourth Quarter 10-1-21 to 12-31-21  $0.0490   $0.0011 
Third Quarter 7-1-21 to 9-30-21  $0.0350   $0.0001 
Second Quarter 4-1-21 to 6-30-21  $0.1800   $0.0010 
First Quarter 1-1-21 to 3-31-21  $0.2650   $0.0350 

 

 

Fiscal Year
2020		  High Bid   Low Bid 
Fourth Quarter 10-1-20 to 12-31-20  $0.0750   $0.0100 
Third Quarter 7-1-20 to 9-30-20  $0.0390   $0.0070 
Second Quarter 4-1-20 to 6-30-20  $0.0250   $0.0075 
First Quarter 1-1-20 to 3-31-20  $0.0166   $0.0106 

 

Dividends

 

We have not declared any cash dividends, nor do we intend to declare cash dividends at this point. We are not subject to any legal restrictions respecting the payment of cash dividends, except that they may not be paid to render us insolvent and any payment of any dividends is subject to the limitations of the Nevada General Corporation Law. Dividend policy will be based on our cash resources and needs and it is anticipated that any cash that may be available will likely be needed for our operations and to pay our creditors in the foreseeable future.

 

A stock dividend was declared on February 11, 2008, wherein two additional common shares were issued for each one common share issued and outstanding as at February 25, 2008. We have not declared any other dividends.

 

Section 15(g) of the Securities Exchange Act of 1934

 

Our company’s shares are covered by Section 15(g) of the Securities Exchange Act of 1934, as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses). For transactions covered by the Rule, the broker/dealer must make a special suitability determination for the purchase and have received the purchaser’s written agreement to the transaction prior to the sale. Consequently, the Rule may affect the ability of broker/dealers to sell our securities and also may affect your ability to sell your shares in the secondary market.

 

Section 15(g) also imposes additional sales practice requirements on broker/dealers who sell penny securities. These rules require a one-page summary of certain essential items. The items include the risk of investing in penny stocks in both public offerings and secondary marketing; terms important to in understanding of the function of the penny stock market, such as “bid” and “offer” quotes, a dealers “spread” and broker/dealer compensation; the broker/dealer compensation, the broker/dealers duties to its customers, including the disclosures required by any other penny stock disclosure rules; the customers rights and remedies in causes of fraud in penny stock transactions; and, the FINRA’s toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker/dealers and their associated persons.

-12-

  ITEM 6. SELECTED FINANCIAL DATA.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

  ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

As used herein, the term “we,” “our,” “us,” and the “Company” refers to Kallo, Inc., a Nevada corporation unless otherwise noted.

 

This section of the report includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like, believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this report. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions. All funds are reflected in United States dollars unless otherwise indicated.

 

There is a high risk that the Company may be facing severe and prolonged financial adversity, a filing in U.S. Bankruptcy Court with the high likelihood that the Company’s stockholders will lose their entire investment.

 

WARNING: Matter of Ten Day Stop Trading Order & Related Risks. As noted above and in our prior periodic filings with the Securities and Exchange Commission (including but not limited to the Form 8-K that we filed on March 26, 2021) on March 24, 2021, the U.S. Securities and Exchange Commission issued a Ten Day Stop Trading Order to stop the trading in our Common Stock (the “Order”). The Order was issued pursuant to Section 12(k) of the Securities Exchange Act of 1934, as amended and it expired on April 7, 2021. As a result, we have expended and continue to expend significant efforts to secure at least one market-maker who may be willing, subject to a complete and satisfactory due diligence review and evaluation of our corporate, business, and financial affairs, to serve as our market-maker for our Common Stock. Currently and despite our continuing efforts, we have not been successful in securing the services of a duly licensed and registered market-maker for our Common Stock and we cannot assure you that we will be successful in these and other efforts needed that may allow the holders of our Common Stock to regain trading privileges on OTC Markets.

 

Further and as a result of the Order, we do not currently have a FINRA-registered market-maker and we have no certain prospect that we will be successful in gaining a FINRA-registered market-maker in the near future (“to make a market” in our common stock). As a result of the Order and given our state of insolvency, and the severely high risks associated with our business strategy, there is a clear and unmistakable very high risk that we will not longer have the status of being a publicly traded company. In that context and for these and other reasons, any person who acquires our Common Stock, our Preferred Stock or any debt instrument that we issued, faces a clear and unmistakable HIGH RISK that they will lose their entire investment.

 

If we are not successful in gaining a FINRA-registered market-maker, then holders of our Common Stock will surely incur the total loss on their investment since our Common Stock will lose all liquidity and all marketability of the shares of our Common Stock that they hold. In that context and unless we are successful in securing the services of such a market-maker, the Company will effectively become a “privately-held” company and the fair market value of our Common Stock will likely be $0.00. We cannot assure you that we will be successful in securing a market-maker for our Common Stock and any person who acquires our Common Stock should be prepared to lose all of their investment since there can be no guarantee that any market-maker will be willing to provide us with market-making services for our Common Stock at any time in the future.

 

Status as Insolvent Company with Continuing Losses, No Revenues and Negative Equity

 

We agree with our independent auditors in that there is substantial doubt about our ability to continue as a going concern since:

 

(a) our Total Current Liabilities exceed our Total Current Assets which are currently $6,495,562 and thus we are insolvent;

 

(b) we have no cash assets and our Total Liabilities are in excess of $6.5 million;

 

(c) as of December 31, 2021 we have incurred over $89 million in accumulated losses and there is no certain prospect that we will ever achieve and sustain any positive cash flow, profitability or either of them;

-13-

(d) we incurred losses of over $8 million during our most recent fiscal year ending December 31, 2021; and

 

(e) we have over $6.5 million in Liabilities as of December 31, 2021.

 

In every respect, we are insolvent and anyone who acquires our Common Stock should be prepared to lose their entire investment. Our Common Stock, our Preferred Stock, and any other instrument that we have or will issue, should be considered a “HIGH RISK” investment suitable only for those persons who can afford the TOTAL LOSS of their investment.

 

Overall, we are a small company with minimal financial and managerial resources, and our business model and all of our plans have not been reviewed or evaluated by any independent third party. We incurred over $8 million in losses in our most recent fiscal year ending December 31, 2021 and we are insolvent. MAKE NO MISTAKE: there is substantial doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital to pay our bills and meet our operating expenses. This is because we have generated insignificant revenues from our operations during the last ten years and we have no clear prospect that we will generate any revenues at any time in the future. We have been able to remain in business primarily as a result of management’s determination and the efforts by certain other parties but we cannot assure you that we will have the necessary resources that will allow us to continue our corporate existence. We expect to incur significant operating losses in the foreseeable future and our ability to continue as a going concern is dependent upon our ability to raise additional money through investments by others and achieve profitable operations.

 

There is no assurance and there can be no assurance that we will ever be able to raise additional money or that additional money or that additional financing will be available to us on satisfactory terms or that we will be able to achieve profitable operations with positive cash flow. Moreover, we cannot assure you that we will be successful in securing a FINRA-registered market-maker that may be willing to serve as a market-maker for our Common Stock. In that event, we will lose our status as a public company. Our consolidated financial statements were prepared under the assumption that we will continue as a going concern, however, there can be no assurance that we can raise any additional funds or otherwise obtain the necessary financial support to allow us to remain as a corporate entity. There can be no guarantee that we have any ability to raise funds or otherwise maintain our corporate existence as a Nevada corporation. In every respect, our financial circumstances raise substantial doubt about our ability to continue as a going concern and, for that matter, our very existence as a corporation. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

For the last eleven fiscal years, starting January 2010, our management and board of directors raised funds through a personal and professional network of investors. This allowed us to undertake a limited amount of business development, maintain minimal operations, and generate limited amount of potential customer interest. We had losses of over $8 million for the fiscal year ending December 31, 2021 and we have no basis to believe that we will avoid further losses at or around that magnitude in the future. In order to continue operations, we need to raise significant additional capital and sustain operations. We cannot assure you that we will achieve any success in either raising additional capital and in sustaining our operations. We know that other companies raise capital from one or more existing shareholders or via debt and equity offers to independent investment professionals and through various other financing alternatives. We do not have many viable options and we know that if we are to avoid bankruptcy and the decimation of the Company, we would need significant amounts of additional capital on a timely basis, in sufficient amounts and on reasonable terms. Unless this is achieved without undue delay and without any significant legal complications, we may, if circumstances and market conditions allow, continue our existing limited operations. However, we are insolvent, we have almost no cash assets, and we have no basis to believe that we will raise any additional capital on a timely basis and on reasonable terms that may allow is to continue to remain in business. Currently we have not received any commitment from any third party to provide the additional capital that we believe we will require if we are to sustain our Company as a corporate entity or otherwise allow us to meet our financial obligations.

 

We have no recent history of generating any revenues or positive cash flow and there can be no assurance that we will be successful in generating any revenues or, if we are successful in generating revenues, that we can sustain any such revenues at a level that will allow us to become solvent or otherwise operate with a positive cash flow at any time in the future. Make no mistake: there is a high risk that the Company may be facing severe and prolonged financial adversity with the high likelihood that the Company’s stockholders will lose their entire investment.

 

We are a small company with very limited managerial resources and we are insolvent. There is substantial doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital to pay our bills and meet our operating expenses. This is because we have generated only insignificant revenues from our operations during the last eleven years. We have been able to remain in business as a result of investments, in debt or equity securities, by our officers and directors and by certain other related parties. We expect to incur operating losses in the foreseeable future and our ability to continue as a going concern is dependent upon our ability to raise additional money through investments by others and achieve profitable operations. There is no assurance that we will be able to raise additional money or that additional money or that additional financing will be available to us on satisfactory terms or that we will be able to achieve profitable operations. The consolidated statements were prepared under the assumption that we will continue as a going concern, however, there can be no assurance that such financial support shall be ongoing or available on terms or conditions acceptable to the Company. This raises substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-14-

On April 8, 2017, the Company entered into an agreement with FE Pharmacy, Inc. (the “Prior FE Pharmacy Agreement”) whereby in consideration for the issuance of 475,000,000 shares of common stock of Kallo, FE Pharmacy, Inc. assumed and agreed to pay all of the Company’s outstanding indebtedness as of April 7, 2017. We currently do not have any additional or similar commitment from FE Pharmacy, Inc. which would assure us that FE Pharmacy, Inc. will provide any additional funds to us at any time in the future. While this agreement has, in the past, allowed us to pursue our business strategy, there can be no assurance that any such agreement or similar arrangement with FE Pharmacy, Inc. will be obtained.

 

Every person who is considering the purchase of our Common Stock, our Preferred Stock or any other instrument that we may issue should fully appreciate that if an agreement with FE Pharmacy, Inc. similar to the Prior FE Pharmacy Agreement is not obtained on a timely basis and on similar terms, we will likely need to cease operations and pursue the liquidation of the Company and otherwise likely terminate the very existence of the Company. Thus, our Common Stock, our Preferred Stock and any other instrument that we have issued must be considered a HIGH-RISK investment that is suitable only for persons who can afford to LOSE THEIR ENTIRE INVESTMENT.

 

Highly Risky & Uncertain Agreements with Countries in Africa & Agreements with Project Funding Source

 

The following summarizes certain agreements that we currently have with five (5) countries in Africa. In each case, the agreements provide for us to provide certain healthcare services to the named country located in Africa and in each instance, we also entered into a financing arrangement with the same provider of funding that is lending funds to the country that is our counterparty in each agreement. While the agreements between us and each country vary and the funding provisions in the financing agreements with the financing source follow a general pattern, we recognize that the agreements and arrangements are subject to significant risks and uncertainties that include, but are not limited to the following:

 

  ● There are implicit and very significant political risks in that each country does not have an established rule of law and as a result, the rights and the obligations of each of the parties to these agreements do not offer the level of certainty or enforceability that is found in comparable agreements entered into between parties in the United States, Canada, or the United Kingdom.

 

  ● There are political processes in each country that are not predictable but can result in not just a sudden change of government but the wholesale abrogation of existing agreements and contracts and thereby the destruction of our property rights and contractual rights that otherwise, in another context, may be assumed to be inviolate.

 

  ● There are many unforeseeable political forces and institutional challenges that may arise which can directly or indirectly result in an adverse economic and political environment that can effectively inhibit our ability to conduct our planned business operations for months if not years.

 

  ● The vagaries and circumstances relating or involving the conduct of each of the governments that is a counterparty to our agreements are not at all predictable and the political systems and legal systems present in each of the countries do not readily conform or allow any predictable legal outcomes which, as a result, create risks that fundamentally undermine our investment of our resources in each of the governmental agreements that we reached with each of these governments and all of the collateral and related agreements that we entered into which assumed the validity of the governmental agreements.

 

  ● In the event of any later dispute or controversy arising out of any one or more of the governmental agreements that we have, we are likely to experience significant challenges in enforcing our rights and ensuring that each governmental entity that is the counterparty to our agreement, fulfills its contractual obligations to us. As a result, we are exposed and likely will remain exposed to many uncontrollable and very significant risks and uncertainties in all of our dealings with each country and these very significant risks far exceed the contractual risks associated with contracts in the United States, Canada, and the United Kingdom.

-15-

It is in that context that we have entered into the following agreements in the following countries and, as we have learned by our experiences, that we face continuing significant risks and uncertainties which we inherently cannot mitigate or avoid in any significant way. We caution you that these risks and uncertainties are likely to remain at all times and any person who acquires our Common Stock, our Preferred Stock or any other instrument that we have issued will face the clear and unmistakable risk of a Total Loss of their investment. That is, we have not had any experience where we have been successful in operating or managing any health care program in any country. Thus, any person who reads this Form 10-K should understand that we have no experience, no track record, and no obvious ability to manage and maintain any health care services in any country at any time in the history of Kallo, Inc.

 

The six (6) governmental agreements are as follows:

 

A.       Ghana. In 2017 the Government of Ghana initiated several discussions with us, to revisit how the Ministry of Defense – Military Hospital requirements, the Ministry of Health healthcare infrastructure requirements and the Ministry of Education Teaching Hospital infrastructure requirements can be met using the Kallo Integrated Delivery Model. The success of these discussions confirmed Ghana’s continued belief that the Kallo Integrated Delivery System may be a viable solution for the nation’s healthcare infrastructure development, which is very encouraging given the significant risks and uncertainties involved.

 

On June 20, 2017, our branch office was legally registered in Ghana. A valid tax identification number was issued and this number is to be used by us in all of our anticipated business that we hope to conduct within Ghana. We have incorporated four SPVs (Special Purpose Vehicles/Companies) to oversee the various projects we seek to undertake in Ghana. The SPVs are all incorporated under the laws of Ghana as private companies. Based on our internal management assessments conducted without the benefit of any independent third-party review or evaluation, we believe that our business plans involving Ghana are sound and may offer us significant business opportunities. However, we cannot assure you that we will be able to obtain sufficient financing on reasonable terms and on a timely basis that will allow us to pursue these opportunities. If we are not successful in obtaining sufficient financing on a timely basis and on reasonable terms, we may be unable to pursue any of our plans involving Ghana or any of the other countries.

 

We have entered into four major concession agreements with four key governmental institutions in Ghana. We have also, through our SPVs entered into the following concession arrangements for the construction and operation of various hospital facilities in Ghana:

 

  Project Description Kallo SPV
1 Tamale Military Hospital project K-TMH Ghana Limited
2 Cape Coast Teaching Hospital project K-UCC Cape Coast Limited
3 Sunyani Teaching Hospital project K-UENR Sunyani Limited
4 Ho Teaching Hospital project K-UHAS Ho Limited

 

These agreements are effective upon execution and the concession period will start from the date on which financial close is achieved with the Lenders and all conditions precedent are satisfied or waived. The financing that is required that would allow us to pursue and implement our plans in Ghana (and each of the other countries) has not been received and we cannot guarantee that we will ever receive any financing that would allow us to implement any of our plans in Ghana or otherwise. In every way, we cannot assure you that we will be able to obtain sufficient financing on reasonable terms and on a timely basis that will allow us to pursue any of these opportunities. If we are not successful in obtaining sufficient financing on a timely basis and on reasonable terms, we may be unable to pursue any of our plans involving Ghana or any of the other countries.

 

Notwithstanding the many uncertainties and risks that we face, we continue to believe that the global need for standardized healthcare service delivery to all geographies and to all people is fundamental. And we believe that we can offer an innovative approach via our Kallo Integrated Delivery System – “KIDS”.

 

And while we have not conducted any extensive market research or otherwise received any assessment from an independent consultant, we continue to believe that our approach is a unique and comprehensive concept which we developed based on our own internal firsthand discovery and a detailed study of ground realities and causal analysis over 15 years. The business issues in the current healthcare systems are addressed by intricate orchestration of technologies both proprietary and off the shelf to create a standardized healthcare delivery model across the continuum of care.

-16-

We have adopted what we believe is a “strategic market approach” in that our strategy is to ensure that our potential customers (the counterparties to our health services agreements) undertake a well-informed decision that we hope will allow them to work with us to embrace a national strategy for healthcare infrastructure and a standardized healthcare services delivery model across the country. This led us to develop what we believe may be a structured business development process and management of the services that we seek to offer and the benefits that we seek to provide to each national health care agency in each country. However, we have no record of achieving any of our goals and we have not been successful in entering into any agreement with any country that has allowed us to demonstrate that our business strategy is viable. As a result, there can be no assurance that our contemplated strategy and contemplated business is financially viable.

 

After many years of hard work in developing countries we believe that there is a dynamic shift in the thought process within the developing countries to consider innovative solutions leveraging technology for strengthening and advancing their healthcare infrastructure and services delivery for all citizens alike. Our assessments and our evaluations in all of these matters are based solely upon the determinations made internally by our management and we have not had the benefit of any independent and professional third-party evaluation in any of these matters. We may later discover that our assumptions, our analysis, and our assessments are fatally inaccurate and otherwise not commercially viable. In that event, investors in our Company should be prepared to lose all of their investment. As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

 

B.        Kenya. On June 26, 2020, the Cabinet Secretary of the Department of Health and the Cabinet Secretary of the National Treasury and Planning of the Republic of Kenya entered into a Project Contract (the “Kenya Contract”) with Kallo Inc. and a Loan Contract with Techno-Investment Module SL. now with its registered office in Spain (the “Financing Source”) for implementing Kallo Integrated Delivery Systems (KIDS) in the Republic of Kenya to strengthen their National Healthcare Infrastructure and build a robust, sustainable healthcare ecosystem. On March 23, 2021, we received a letter from the Cabinet Secretary for the National Treasury & Planning, the Republic of Kenya, informing us that the project and agreements previously entered into have been put on hold. We can not assure you that the Kenya Contract will later be implemented and if it is later implemented whether the terms and conditions will resemble or adhere to the terms and conditions that were set forth in the Kenya Contract. Overall, we do not know and we cannot predict whether the Kenya Contract will later be abrogated or if other events and political considerations in the Republic of Kenya will prevent or preclude us from achieving our original objectives that we sought to achieve when we originally entered into the Kenya Contract and the agreement with the Financing Source. While we did not fully appreciate the extent of the risks and uncertainties that we face in entering into the Kenya Contract and completing what we thought were appropriate steps to securing the financing with the Financing Source, we now appreciate the apparently significantly greater risks and uncertainties that are inherent in all transactions similar to the Kenya Contract. For these and other reasons, we are acutely aware that we face significant “political risks” in Kenya and, for that matter, in each country where we seek to implement our contemplated business. These risks are inherent and we are not able to mitigate or reduce our exposure to the unpredictable and dramatic political risks that we face in Kenya or, for that matter, in any foreign country. In that light, our contemplated business strategy will likely remain a HIGH RISK strategy for the foreseeable future. As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

 

C.       Eswatini. On November 10, 2020, the Minister of Health and the Minister of Finance of the Kingdom of Eswatini entered into a Project Contract with Kallo Inc. and a Loan Contract (the “Eswatini Contract”) with Techno-Investment Module SL., now with its registered office in Spain (the “Financing Source”) for implementing Kallo Integrated Delivery Systems (KIDS) in the Kingdom of Eswatini to strengthen their National Healthcare Infrastructure and build a robust, sustainable healthcare ecosystem. Given our recent experience with the Kenya Contract, we can not assure you that the Eswatini Contract will later be implemented and if it is later implemented whether the terms and conditions will resemble or adhere to the terms and conditions that were set forth in the Eswatini Contract. Overall, we do not know and we cannot predict whether the Eswatini Contract will later be abrogated or if other events and political considerations in the Kingdom of Eswatini will prevent or preclude us from achieving our original objectives that we sought to achieve when we originally entered into the Eswatini Contract and the agreement with the Financing Source. While we did not fully appreciate the extent of the risks and uncertainties that we face in entering the Eswatini Contract and completing what we thought were appropriate steps to securing the financing with the Financing Source, we now appreciate the apparently significantly greater risks and uncertainties that are inherent in all transactions similar to risks that we encountered in the Kenya Contract. (See discussion regarding Kenya above.) As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

-17-

D.       Ethiopia. On November 30, 2020, the Minister of Health and the Minister of Finance of the Federal Democratic Republic of Ethiopia entered into a Project Contract with Kallo Inc. (the “Ethiopia Contract”) and a Loan Contract with Techno-Investment Module SL., now with its registered office in Spain (the “Financing Source”) for implementing Kallo Integrated Delivery Systems (KIDS) in the Federal Democratic Republic of Ethiopia to strengthen their National Healthcare Infrastructure and build a robust, sustainable healthcare ecosystem. Included in the contract is a Medical Tourism project with a Medical Center of Excellence. Again and given our recent experience with the Kenya Contract, we can not assure you that the Ethiopia Contract will later be implemented and if it is later implemented whether the terms and conditions will resemble or adhere to the terms and conditions that were set forth in Ethiopia Contract. Overall, we do not know and we cannot predict whether the Ethiopia Contract will later be abrogated or if other events and political considerations in the Federal Democratic Republic of Ethiopia will prevent or preclude us from achieving our original objectives that we sought to achieve when we originally entered into the Ethiopia Contract and the agreement with the Financing Source. While we did not fully appreciate the extent of the risks and uncertainties that we face in entering into the Ethiopia Contract and completing what we thought were appropriate steps to securing the financing with the Financing Source, we now appreciate the apparently significantly greater risks and uncertainties that are inherent in all transactions similar to the risks that we have encountered in the Kenya Contract. (See discussion regarding Kenya above.) As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

 

E.       Mozambique. On December 10, 2020, the Minister of Health and the Minister of Finance of the Republic of Mozambique entered into a Project Contract (Phase-1) with Kallo Inc. (the “Mozambique Contract”) and a Loan Contract (Phase-1) with Techno-Investment Module SL., now with its registered office in Spain (the “Financing Source”) for implementing Kallo Integrated Delivery Systems (KIDS) in the Republic of Mozambique to strengthen their National Healthcare Infrastructure and build a robust, sustainable healthcare ecosystem. Given our recent experience with the Kenya Contract, we can not assure you that the Mozambique Contract will later be implemented and if it is later implemented whether the terms and conditions will resemble or adhere to the terms and conditions that were set forth in the Mozambique Contract. Overall, we do not know and we cannot predict whether the Mozambique Contract will later be abrogated or if other events and political considerations in the Republic of Mozambique will prevent or preclude us from achieving our original objectives that we sought to achieve when we originally entered into the Mozambique Contract and the agreement with the Financing Source. While we did not fully appreciate the extent of the risks and uncertainties that we face in entering into the Mozambique Contract and completing what we thought were appropriate steps to securing the financing with the Financing Source, we now appreciate the apparently significantly greater risks and uncertainties that are inherent in all transactions similar to the Kenya Contract. (See discussion above regarding the Kenya contract.) As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

 

F.        Eritrea. On December 11, 2020, the Minister of Health and the Minister of Finance of the State of Eritrea entered into a Project Contract with Kallo Inc. (the “Eritrea Contract”) and a Loan Contract with Techno-Investment Module SL., now with its registered office in Spain (the “Financing Source”) for implementing Kallo Integrated Delivery Systems (KIDS) in the State of Eritrea to strengthen their National Healthcare Infrastructure and build a robust, sustainable healthcare ecosystem. Given our recent experience with the Kenya Contract, we can not assure you that the Eritrea Contract will later be implemented and if it is later implemented whether the terms and conditions will resemble or adhere to the terms and conditions that were set forth in the Eritrea Contract. Overall, we do not know and we cannot predict whether the Eritrea Contract will later be abrogated or if other events and political considerations in the State of Eritrea will prevent or preclude us from achieving our original objectives that we sought to achieve when we originally entered into the Eritrea Contract and the agreement with the Financing Source. While we did not fully appreciate the extent of the risks and uncertainties that we face in entering into the Eritrea Contract and completing what we thought were appropriate steps to securing the financing with the Financing Source, we now appreciate the apparently significantly greater risks and uncertainties that are inherent in all transactions similar to the Kenya Contract. (See the discussion above regarding the Kenya Contract.) As of the date of the filing of this 2021 Annual Report on Form 10-K for the fiscal year ending December 31, 2021, we have not received any indication that the project as envisioned by the agreements that we entered into will be implemented or undertaken at any time.

 

Status Update on contracts signed with Kenya, Eswatini, Mozambique, Ethiopia and Eritrea

 

We have been working diligently for the past several years to introduce our Kallo Integrated Delivery System (KIDS), a comprehensive healthcare delivery solution, to developing countries in Africa.

 

In 2019 we began working with a local representative in Africa, Global Interest Services (GIS). Working through GIS, Kallo entered into detailed discussions and negotiations with a number of African countries including Kenya, Eswatini, Mozambique, Ethiopia and Eritrea. These efforts culminated in signing project and loan contracts with each of these countries through the second half of 2020.

-18-

Normally, during the final stages of negotiations and signing of such contracts, the President and CEO of Kallo would have travelled to the countries in question and would have concluded the negotiations and signing of the contracts in person. However, with the advent of Covid-19 and the imposition of lockdowns and travel restrictions in early 2020, in-person meetings were not possible.

 

In each case, all parties involved agreed to sign contracts remotely with all signatures being legally notarized. As required by regulation, in each instance, we reported the signing of these contracts as material events by filing the required Form 8-K with the U.S. Securities and Exchange Commission and in each instance, we believe that we provided and fulfilled our disclosure obligations in accordance with U.S. securities laws and accepted good practices.

 

With the signing of each contract, work proceeded with arranging financing for the projects. These are all major projects and arranging financing is a major undertaking. Techno Investment Module SL (TIM), a financier based in Spain, was willing to provide financing for the projects. In order to provide the financing, it was established that collateral for the required loans would need to be provided in the form of a cash-backed standby letter of credit to be issued by the central bank of each country and confirmed by a corresponding major bank in the United Kingdom.

 

Beginning in late 2020, TIM and Kallo have been working through GIS to establish the required collateral with the governments of each country. This part of the process has proven to be much more challenging and time consuming than anticipated. Although efforts have been continuous and persistent, with regular communications through our local representative, none of these governments has yet to provide this essential requirement before financing can be finalized.

 

A number of factors may have contributed to the delays in completing this process in each country. During this period there have been multiple elections in Ethiopia which have disrupted the normal process of government. Further deliberations with the government of Kenya have been put on hold as the government prepares for major elections later this summer. Political unrest and regional conflicts in Mozambique, Eswatini and Ethiopia have had economic impacts and have also disrupted the process of government in these countries. We do not know why the governments and the governmental agencies in each of these countries did not and have not completed the additional steps needed that would allow us to proceed with the implementation of the agreements that we entered into with each such government and each such agency. More than that, we do not understand what would provoke any such delays or hesitation by any of our counterparties in these instances.

 

As we have previously disclosed, we have spent a considerable amount of time and energy negotiating these significant contracts while also incurring significant expenses. We want to provide every opportunity to allow these efforts to be concluded successfully. However, we cannot continue to expend time and energy on these engagements indefinitely. As well, TIM is growing increasingly impatient with the prolonged timeframe to conclude this part of arranging the financing.

 

Accordingly, we will formally request video conference calls with the appropriate government officials of each of these countries to confirm their willingness and ability to provide the required collateral instruments for the financing of these projects within reasonable timeframes. If these video conference calls are not forthcoming, or if the governments cannot commit to providing their collateral instrument in a reasonable timeframe, we will have to consider cancelling these contracts in order to focus on more promising business opportunities.

 

Throughout this period Kallo has continued with its business development efforts in Africa. Kallo has been in discussions with several other African countries that have expressed keen interest in the unique and comprehensive healthcare delivery solution that Kallo offers. In some instances, discussions have progressed to an advanced stage with the potential of leading to contractual commitments that may be promising. However, and given the circumstances, Kallo is also considering alternative financing options to provide more flexibility to its client countries.

 

If circumstances and market conditions allow, we may also seek business development opportunities in other parts of the globe including Southeast Asia, the Caribbean and North America as its unique healthcare delivery solution is relevant to many countries and circumstances.

 

In general, and as we have become more fully aware of the business landscape and the risks and uncertainties associated with efforts to conduct any business in countries where the rule of law can easily become subject to ever unpredictable and changing political pressures, we cannot approach our business plans and strategies without deep concern that we face risks that we cannot realistically mitigate or otherwise contain. In that respect and when any business enterprise commits its limited financial and managerial resources to a business strategy where there is no certainty that the rule of law will be upheld and fully observed, the risks facing the enterprise are existential. For that reason, we face the clear and unmistakable risk that our business and our assets may be entirely lost and we may have little or no recourse to protect the Company, its planned business and assets and the stockholders’ investment. In that respect, any person who acquires our Common Stock, our Preferred Stock, or any debt instrument that we may issue, should be prepared to lose their entire investment.

-19-

Plan of Operation

 

The following plan of operation contains forward-looking statements, which involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth elsewhere in this document. Because of the speculative nature of our operations and the nature of the African countries we are attempting to do business with, there is no assurance that any of our planned operations will occur and there can be no assurance that we will achieve anything that is commercially viable given the significant risks and uncertainties inherent in our business and given that we are insolvent with no history of generating and sustaining any sales revenues, profits and positive cash flow during anytime in the past eleven (11) years.

 

However, any person who reads this Report on Form 10-K should know that we are acutely aware that we face significant “political risks” in each and every country where we seek to implement our contemplated business. These risks are inherent and we are not able to mitigate or reduce our exposure to the unpredictable and dramatic political risks that we face in Kenya or, for that matter, in any foreign country. In that light, our contemplated business strategy will likely remain a HIGH-RISK strategy for the foreseeable future.

 

In that context and subject to the serious risks that we face, including but not limited to: (a) our current state of insolvency; (b) the effect that the Ten Day Stop Trading Order has had on our Common Stockholders; (c) the lack of any market-maker for our Common Stock and the likelihood that, as a result of the amendment to Rule 15c2-11 that will directly and adversely impact us and our Common Stockholders likely in September 2021; and (d) other risks and issues that we are likely to face in the near future assuming that we survive as a corporate entity, then and subject to the Risk Factors set forth here and those set forth in Item 1A of our 2020 Annual Report filed on Form 10-K for the fiscal year ending December 31, 2020, then and if to the extent that we are financially able and if circumstances allow, we plan to continue to develop components of Kallo Integrated Delivery System:

 

Kallo Integrated Delivery System (KIDS)

 

The following are “Forward-Looking Statements” that are subject to the qualifications set forth at the beginning of this Form 10-K and subject to the Risk Factors set forth herein.

 

MobileCareTM – as currently planned and subject to our ability to successfully implement our business plan, we plan to establish a mobile trailer that opens into a state of the art clinical setup in a vehicle equipped with the latest technology in healthcare.  As currently envisioned, MobileCare TM may be able to instantly connect the onboard physician with specialists for on-demand consultation via satellite through its Telehealth system. In that respect and if we are successful, we believe that this would provide a truly a holistic approach to delivering healthcare to the remotely located. For many rural communities, the nearest hospital, doctor or nurse may be hundreds of kilometers away. In many cases, this gap can be bridged using Telehealth technology that allows patients, nurses and doctors to talk as if they were in the same room.

 

RuralCareTM – if we are successful, we currently plan to establish prefabricated modular healthcare units focused in rural areas where no roads infrastructure is available. As currently planned and subject to our ability to successfully implement our business plan, these units are to be equipped to provide primary healthcare including X-Ray, ultrasound, surgery, pharmacy and lab services.  Ranging from 1,200 to 3,800 square feet, these clinics can be up and running in disaster zones or rural areas in as little as one week.  Similar to the MobileCare TM product, RuralCare TM also utilizes satellite communications to access the Telehealth system.

 

Our overall healthcare mission is to “reach the unreached”.  Based on our own internal assessments conducted by our officers and without the benefit of any independent third-party evaluation, we believe that may be able to offer end-to-end solution that may include the following:

 

Global command center – as currently planned and subject to our ability to successfully implement our business plan, this center is to be located in the Kallo headquarters in Canada and serve as a hoped-for escalation point for the coordination of our planned delivery of Telehealth and eHealth support. It consists of both the Clinical Command Center and the Administrative Command Center.

-20-

Regional command centers, Clinical and Administrative – as currently planned and subject to our ability to successfully implement our business plan, we intend to establish centers which, if we are able to secure one or more contracts with a host country, we currently plan to locate centers in the urban area hospitals and connected with satellite communications, these centers coordinate all aspects of the healthcare delivery solution with the Mobile clinics and Rural clinics including clinical services, Telehealth services, pharmacy and medical consumable coordination as well as escalations to our planned global response center.

 

Kallo University – as currently planned and subject to our ability to successfully implement our business plan, we seek to establish a focal point that we hope may provide education, training and development of local resources for all aspects of the healthcare delivery which includes clinical, engineering and administration.

 

Emergency Medical Services – as currently planned and subject to our ability to successfully implement our business plan, we seek to establish an ancillary organization that we hope will provide ground and air ambulance vehicles for emergency patient transport. We have now incorporated Medical Drone Services.

 

All of the foregoing is based solely on our internal management assessments conducted without the benefit of any independent third-party review or evaluation, we believe that our end-to-end delivery solution is equipped with necessary medical equipment as per regional healthcare requirements. We also plan to install our copyrighted software and third-party software as required along with a five (5) year support agreement renewable after the five (5) year initial term that includes the medical equipment, software licenses, installation implementation and training.  If we are successful in implementing our business plan and if we have sufficient financial resources, then we anticipate that may, if circumstances are favorable, allow us to generate an ongoing revenue stream for service, maintenance, spare-parts, and consumables. However, we cannot assure you that even if we are able to achieve these goals that we can do so at levels that may allow us to achieve and sustain positive cash flow and profitability. We have incurred significant and protracted losses and we have no record of achieving and sustaining positive cash flow and profitability and we cannot be certain that we will achieve either or both of these goals at any time in the future. We are currently insolvent; we have no cash assets and we have liabilities in excess of $50.5 million.

 

Business Overview

 

Our plans and strategies were developed internally without the benefit of any independent professional consultants, but we believe that the global need for standardized healthcare service delivery to all geographies and to all people may be the fundamental business driver for the innovation of the Kallo Integrated Delivery System – “KIDS”.

 

We developed what we believe may be a unique and comprehensive concept as a result of our internal assessments over the past 15 years. We believe that if we can implement our business plan and raise a sufficient amount of additional capital on reasonable terms and on a timely basis, we may be able to address what we believe may be the core business issues in the current healthcare systems with intricate orchestration of technologies both proprietary and off the shelf to create a standardized healthcare delivery model across the continuum of care.

 

If market conditions allow and if we are successful in raising additional capital on reasonable terms, on a timely basis and in sufficient amounts and avoid bankruptcy as well as the other very significant risks set forth in the Risk Factors set forth herein, we believe that we may be able to implement a strategic market approach that may allow our potential customers to take a well-informed decision and to work with Kallo on a national strategy for healthcare infrastructure and a standardized healthcare services delivery model across the country. This led to the development of a structured business development process and management for what we hope may provide us with an opportunity to demonstrate that our business strategy can be successfully implemented. However, we cannot assure any holder of our Common Stock, our Preferred Stock or our debt instruments that we will have the managerial and financial resources that will allow us to undertake the steps needed to implement our business plan.

 

We believe that our business development model, unique to KIDS, is planned to include in-country stakeholder workshops and white-board sessions on the KIDS concept and its application in their context of healthcare infrastructure and healthcare services delivery model. However, we have not received and we do not anticipate receiving any independent or third party evaluation of our plans, strategies, or business model and for this reason we may be exposed to significant additional existential problems that could result in the total destruction of the Company and, for our common stockholders, the total loss of their investment. Our Common Stock is suitable only for those investors who are able to suffer the TOTAL LOSS of their investment.

 

We previously developed the concept of conducting detailed Clinical, Engineering and Technology studies led by Kallo to establish detailed requirements for preparation of a customized proposal for the country and a phased roll out plan that we would seek to implement if we were able to obtain sufficient managerial and financial resources that would be required to undertake these efforts.

-21-

In addition, and if we are successful in avoiding bankruptcy and the liquidation of the Company as well as avoiding the effects of the other very significant existential risks that we face, then we may proceed to implement our business plan (with such revisions as we deem necessary in light of then existing circumstances) that may allow us to raise additional capital on a timely basis and in sufficient amounts while avoiding bankruptcy or insolvency, we may be able to develop a network of financial institutions and banks across the globe that we hope may be focused on humanitarian and healthcare projects. However, given our recent adverse experience with the Kenya Contract, we remain far more skeptical and entirely concerned that we may be facing unanticipated but significantly greater risks and uncertainties that may well prevent us from undertaking any of our plans as provided in each of the agreements with each of the six countries, namely, Ghana, Kenya, Ethiopia, Eswatini, Mozambique, and Eritrea. However, in the event that we are not successful in mitigating and limiting our exposure to these and other risks and uncertainties and if we raise a sufficient amount of additional capital on reasonable terms and on a timely basis, we may not be able to implement some of our business plans and strategies as described herein. In that event we may revise or alter or plans based on then-existing market conditions and assessments that we make as we reassess our ability to conduct our business and meet our obligations to creditors and others.

 

Go-To-Market Strategy

 

If we are successful in implementing our business plan, avoid bankruptcy and avoid other very significant existential risks that we face (as set forth herein) and provided that we are able to raise a sufficient amount of additional capital on reasonable terms, in sufficient amounts and on a timely basis, then we currently intend to implement what we call our “Our Sales Go-To-Market Strategy” – a strategy that is segmented based on the varying needs of our customers in the following three categories:

 

  1. Full solution with Kallo Integrated Delivery System (KIDS) – typically longer sales cycle and includes the end-to-end solution of Mobile Clinics, Rural Poly Clinics, Global and Regional response centers, Clinical and Administrative command centers, telehealth support, Kallo University training, pharmacy and medical consumable support and Emergency services with ground and air ambulance vehicles. This solution is focused on the end-to-end healthcare needs of developing countries.

 

  2. Medical Tourism

 

  3. COVID-19 Rapid Response Program

 

Kallo’s Value Proposition

 

All of the above and the following is based on our internal assessments made by our three (3) corporate officers/directors without the benefit of any independent third-party professional consultants:

 

  ● Laying the foundational elements in building the primary care infrastructure for an entire country
     
  ● Providing Technologies for current and future adoption of advancements in clinical services such as Telemedicine, remote maintenance and management etc.
     
  ● Creating operational policies and procedures to set higher standards of care
     
  ● Provide Education and training to build resource capacity within the country
     
  ● KIDS provide a modular and flexible Point-of-Care facility to enable healthcare services from cities to the most rural areas in a given country and helps overcome inequalities in healthcare services across all geographies.

 

Kallo’s Key Market Differentiators

 

Notwithstanding the clear and unmistakable existential risks that we face, we know that we face ever-changing technology and competition from many others who possess greater managerial and financial resources, if we can avoid bankruptcy and insolvency and provided that we can raise additional capital in sufficient amounts and on a timely basis, we believe that we may be able to offer and differentiate our services in our current market segment by currently offering a far more comprehensive and holistic healthcare delivery solution compared to that currently offered by others.

-22-

However, we are well-aware that other competitors have significantly greater financial and managerial resources and we know that our competitors are familiar with our business plans and strategies which they can freely adopt in competing with us. However, we have invested considerable time and energy studying and understanding the healthcare needs of our target market segments.

 

Unequivocal Differentiators

 

Subject to our ability to avoid bankruptcy and the existential risks that we face, we may be able to offer what we describe as the following “Unequivocal Differentiators” – attributes that we may be able to offer and provide that we believe (based on our own internal assessments without the benefit of any independent third party professional consulting advice) may provide us with opportunities that may allow us to implement one or more parts of our business plan assuming that we have and can obtain sufficient amounts of additional financing on reasonable terms, in sufficient amounts and on a timely basis:

 

  1. Care platforms (Point-of-care facilities - Mobile Clinics, Rural clinics & Modular Hospitals) to be manufactured to North American and internationally accepted standards.

 

  2. Programs, facilities and services to be set-up to proactively detect and treat infectious diseases.

 

  3. On-going Tele-health service support, leveraging to be established with both local and international expertise.

 

  4. On-going education, training, & certification programs to be offered through Kallo University.

 

  5. On-going service & maintenance programs to be provided for all facilities and equipment.

 

  6. Leverages local skillsets to be offered so as to provide employment opportunities.

 

Competitive Landscape

 

Based solely upon our own internal assessments without the benefit of any third party professional consulting advice, we believe that the healthcare landscape is the most complex industry at large. It has developed in each area of its function in an isolated fashion and hence today we have disparate functions, technologies and infrastructure. Globally healthcare industry leaders are working hard to bring a synchronized approach in patient encounter, diagnosis and treatment including preventive care. Kallo has leaped into the future with the KIDS concept and have successfully brought together technologies including global telemedicine, infrastructure and functional expertise leading the industry and have created the Kallo business ecosystem.

 

We also believe that the Kallo Integrated Delivery System (KIDS) may, if we can avoid bankruptcy and the existential risks that we face and if circumstances allow, provide us with an ability to offer health care services in the under-developed, countries which may allow us, if we able to successfully implement our business plan, to provide developing and developed countries with the flexibility of deploying components of KIDS.

 

Need for additional capital

 

We have incurred significant and protracted operating losses since inception: (a) we have an accumulated deficit of over $89 million; (b) we incurred losses of over $8 million in the fiscal year ending December 31, 2021; and (c) we have limited cash assets and over $6.5 million in liabilities. We have both a working capital deficit and we are insolvent. We expect to incur additional significant losses as we execute our current business plan and strategy as well. These losses and our state of insolvency both raise substantial doubt about our ability to continue as a going concern. In that respect, our Common Stock should be considered a HIGH RISK investment suitable only to those persons who can afford the total loss of their investment.

-23-

As stated below, we may be in the “Zone of Insolvency.” Under the corporate common law of many jurisdictions, a Board of Directors of a corporation that is in the “Zone of Insolvency” generally owe a duty of care to the holders of its debt instruments and other creditors to take steps to avoid or minimize the losses that such persons would otherwise incur. While we believe that we have acted with due regard to our duty of care to our stockholders and to our creditors, we cannot assure you that we have always acted with the requisite level to discharge our duties to each of the foregoing. In that event, holders of our Common Stock and holders of our Preferred Stock will likely suffer the total loss of their investment.

 

We cannot guarantee we will be successful in our business operations or in implementing our business plan. Our business is subject to significant risks and uncertainties inherent in the establishment of a business enterprise, including those risks set forth herein.

 

To become profitable and competitive, we anticipate that we will have to sell our products and services in sufficient volumes and with margins that may allow us to achieve profitability. We cannot assure you or anyone that we will be successful in these efforts and that we will avoid any of the severe financial and nonfinancial consequences that commonly result when a corporation is insolvent and has had a history of losses with a large accumulated deficit.

 

There is no guarantee that we will obtain sufficient additional financing on a timely basis and on reasonable terms. If financing is not available on satisfactory terms, we may be unable to continue, develop, or expand our operations. Any equity financing will likely result in immediate and substantial dilution of existing stockholders.

 

Results of operations

 

December 31, 2021 compared to December 31, 2020

 

Revenues

 

We did not generate any revenues during the year ended December 31, 2021 or at any time during 2020. However, we are pursuing what we hope may be suitable business opportunities that, based on our own internal management assessments conducted without the benefit of any independent third-party review or evaluation, may offer us commercially feasible and appropriate opportunities. However, we cannot assure you that we will be successful in any of these matters or, if we achieve any success, that it will allow us to achieve and sustain positive cash flow and profitability for any period of time.

 

We are insolvent, we incurred over $8 million in losses in the 2021 fiscal year that ended December 31, 2021 and we will continue to incur losses with no assurance that we will ever generate any revenues or if we do generate any revenues, that we can sustain such revenues at any level in excess of our costs. We have no history of generating and sustaining revenues, positive cash flow or profitability and we cannot assure you that we will ever generate and sustain any revenues, positive cash and profitability at any time in the future. Our Common Stock and our Preferred Stock should be viewed as HIGH-RISK securities that are suitable only for persons who can accept the TOTAL LOSS of their investment.

 

We believe that we may be in the “Zone of Insolvency.” Under the corporate common law of many jurisdictions, a Board of Directors of a corporation that is in the “Zone of Insolvency” generally owe a duty of care to the holders of its debt instruments and other creditors to take steps to avoid or minimize the losses that such persons would otherwise incur. While we believe that we have acted with due regard to our duty of care to our stockholders and to our creditors, we can not assure you that we have always acted with the requisite level to discharge our duties to each of the foregoing. In that event, holders of our Common Stock and holders of our Preferred Stock and holders of our debt instruments will very likely suffer the total loss of their investment.

 

Expenses

 

During the year ended December 31, 2021 we incurred total expenses of $8,093,468, including $7,713,041 in salaries and compensation, $218,119 in professional fees, $27,784 in selling and marketing, $111,403 in interest and financing costs, $15,476 in foreign exchange loss and $11,835 as other general and administrative expenses offset by $4,190 in debt forgiveness. Our professional fees consist of legal, consulting, accounting and auditing fees. Many of our costs are primarily fixed costs and, as a result, we cannot effectively reduce these costs as aggressively as we would like.

-24-

During the year ended December 31, 2020 we incurred total expenses of $36,055,668, including $35,789,315 in salaries and compensation, $79,406 in professional fees, $18,563 in selling and marketing, $111,596 in interest and financing costs, $95,108 in foreign exchange loss and $11,565 as other general and administrative expenses offset by $49,885 in debt forgiveness. Our professional fees consist of legal, consulting, accounting and auditing fees. Many of our costs are primarily fixed costs and, as a result, we cannot effectively reduce these costs as aggressively as we would like.

 

The decrease in our expenses for the year ended December 31, 2021 was primarily due to a decrease in salaries and compensation of $28,076,274 as a result of lower non-cash stock-based compensation in 2021 compared to in 2020 issued to management and employees. There is however an increase in professional fees of $138,713 as the Company was catching up on all its previously late filings in 2021, an increase in selling and marketing of $9,221 and a decrease in debt forgiveness of $45,695, offset by a decrease in foreign exchange loss of $79,632. The decrease in foreign exchange loss is due to the depreciation of the Canadian dollar versus the US dollar.

 

The Company is operating with a minimal number of full-time employees and office space until such time as we may be able to secure new contracts, if any. As stated above, we face significant risks and uncertainties that we cannot control.

 

Net Loss

 

During the year ended December 31, 2021 we did not generate any revenues and incurred a net loss of $8,093,468 compared to a net loss of $36,055,668 in 2020. The main reason for the decrease in the loss is the decrease in salaries and compensation as discussed above. In that respect, we cannot assure you that we will be successful in reducing our losses at any time in the future and we may face significant and protracted financial losses and we cannot guarantee that we will achieve any of our business goals. We are insolvent and our Total Liabilities exceed our Total Assets and we may become more insolvent unless and until we can generate sufficient revenues and positive cash flow that may allow us to meet our financial and legal obligations to our creditors. We are in the “zone of insolvency” and holders of our Common Stock and our Preferred Stock face the total loss of their investment.

 

Liquidity and capital resources

 

As at December 31, 2021, we had current assets of $13,535, current liabilities of $6,509,097 and a working capital deficiency of $6,495,562. As of December 31, 2021, we had no assets and our total liabilities were $6,509,097 comprised of $4,802,752 in accounts payable and accrued liabilities, loans payable of $311,109 and convertible loans payable of $1,395,236.

 

Cash used in operating activities amounted to $236,032 during fiscal 2021, primarily and as a result of the net loss adjusted for non-cash items and various changes in operating assets and liabilities.

 

Cash provided by financing activities amounted to $236,828 from proceeds from short term loans payable.

 

There was no cash movement in investing activities during the year ended December 31, 2021.

 

We have insignificant cash, our liabilities are in excess of $6.5 million and we are insolvent. In this context we are considered to be in the “zone of insolvency.”

 

As of December 31, 2021, our Total Liabilities exceeded our Total Assets and we were insolvent. In that respect we face all the risks and uncertainties of any insolvent corporation that could easily result in stockholders losing all or substantially all of their investment. Our common stock and our preferred stock are securities that should only be acquired by persons who can accept the HIGH RISK of such an investment and the total loss of their investment.

 

As stated above, we believe that we may be in the “Zone of Insolvency.” Under the corporate common law of many jurisdictions, a Board of Directors of a corporation that is in the “Zone of Insolvency” generally owe a duty of care to the holders of its debt instruments and other creditors to take steps to avoid or minimize the losses that such persons would otherwise incur. While we believe that we have acted with due regard to our duty of care to our stockholders and to our creditors, we cannot assure you that we have always acted with the requisite level to discharge our duties to each of the foregoing. In that event, our creditors may assert additional claims against us which would further destroy any value that may be otherwise recoverable by holders of our Common Stock, our Preferred Stock, our debt instruments and all of them.

-25-

Summary of critical accounting policies

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.

 

Stock-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).

 

Stock Issued in Exchange for Services

 

The valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).

 

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

-26-

  ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

INDEX

 

  PAGE
   
Report of Independent Registered Public Accounting Firm for December 31, 2021 and 2020 28
   
Consolidated Balance Sheets 29
   
Consolidated Statements of Operations 30
   
Consolidated Statements of Changes in Stockholders’ Deficiency 31
   
Consolidated Statements of Cash Flows 32
   
Notes to Consolidated Financial Statements 33 - 44

-27-

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

Kallo Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Kallo Inc. and its subsidiary (collectively, the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations, stockholders’ deficiency, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern Matter

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ BF Borgers CPA PC

  

We have served as the Company’s auditor since 2020.

Lakewood, Colorado

PCAOB ID # 5041 

  
June 3, 2022  

-28-

KALLO INC.

Consolidated Balance Sheets

As at December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

   2021   2020 
ASSETS          
           
Current Assets:          
           
Cash  $796   $— 
Prepaid expenses   12,739    — 
Total Current Assets   13,535    — 
           
TOTAL ASSETS  $13,535   $— 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY          
Current Liabilities:          
Accounts payable and accrued liabilities  $4,802,752   $4,359,752 
Convertible loans payable – third parties   314,981    290,133 
Short term loans payable   311,109    78,397 
Convertible loans payable – related parties   1,080,255    993,812 
Liability for issuable shares   —    37,149,790 
Total Current Liabilities   6,509,097    42,871,884 
TOTAL LIABILITIES   6,509,097    42,871,884 
           
Commitments and Contingencies          
           
Stockholders’ Deficiency:          
Preferred stock, $0.00001 par value, 120,000,000 shares authorized, 95,000,000 Series A preferred shares and 5,000,000 Series B preferred shares issued and outstanding   1,000    950 
Common stock, $0.00001 par value, 8,000,000,000 shares authorized, 6,356,429,204 and 1,147,698,199 shares issued and outstanding respectively   63,564    11,478 
Additional paid-in capital   86,337,770    41,920,116 
Assignment of liabilities   (3,455,111)   (3,455,111)
Accumulated deficit   (89,442,785)   (81,349,317)
           
Total Stockholders’ Deficiency   (6,495,562)   (42,871,884)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY  $13,535   $— 

 

The accompanying notes are an integral part of these consolidated financial statements

-29-

KALLO INC.

Consolidated Statements of Operations

(Amounts expressed in US dollars)

 

   For the Year Ended December 31, 
   2021   2020 
Operating Expenses          
General and administration  $7,942,995   $35,880,286 
Selling and marketing   27,784    18,563 
Operating loss   (7,970,779)   (35,898,849)
           
Interest and financing costs   (111,403)   (111,596)
Foreign exchange loss   (15,476)   (95,108)
Debt forgiveness   4,190    49,885 
           
Net loss  $(8,093,468)  $(36,055,668)
           
Net loss per share - Basic and diluted  $(0.004)  $(0.03)
           
Weighted average number of shares outstanding - Basic and diluted   2,289,746,749    1,147,698,199 

 

The accompanying notes are an integral part of these consolidated financial statements

-30-

KALLO INC.

Consolidated Statements of Changes in Stockholders’ Deficiency

(Amounts expressed in US dollars)

 

                                       Deficit     
                   Accumulated   Total 
   Preferred Stock   Common Stock   Additional   Assignment   During the   Stockholders’ 
   $.00001 par value   $.00001 par value   Paid-In   Of   Development   Equity 
   Shares   Amount   Shares   Amount   Capital   Liabilities   Stage   (Deficit) 
Balance December 31, 2019   95,000,000   $950    1,147,698,199   $11,478   $41,920,116   $(3,462,554)  $(45,293,649)  $(6,823,659)
Cash settlement of liabilities   —    —    —    —    —    7,443    —    7,443 
Net Loss   —    —    —    —    —    —    (36,055,668)   (36,055,668)
Balance December 31, 2020   95,000,000    950    1,147,698,199    11,478    41,920,116    (3,455,111)   (81,349,317)   (42,871,884)
Shares issued to director   5,000,000    50    —    —    201,300    —    —    201,350 
Shares issued as compensation   —    —    5,208,731,005    52,086    44,216,354    —    —    44,268,440 
Net loss   —    —    —    —    —    —    (8,093,468)   (8,093,468)
Balance December 31, 2021   100,000,000   $1,000    6,356,429,204   $63,564   $86,337,770   $(3,455,111)  $(89,442,785)  $(6,495,562)

 

The accompanying notes are an integral part of these consolidated financial statements

-31-

KALLO INC.

Consolidated Statements of Cash Flows

(Amounts expressed in US dollars)

 

   For the Year Ended December 31, 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(8,093,468)  $(36,055,668)
Adjustments to reconcile net loss to net cash used in operating activities          
Stock-based compensation   7,295,600    35,398,420 
Interest and penalties   111,291    111,596 
Unrealized foreign exchange gains   14,738    96,136 
Debt forgiveness   (4,190)   (49,885)
Changes in operating assets and liabilities:          
Increase in accounts payable and accrued liabilities   452,736    433,787 
Increase in prepaid expenses   (12,739)   — 
NET CASH USED IN OPERATING ACTIVITIES   (236,032)   (65,614)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from short term loans payable   236,828    65,614 
NET CASH PROVIDED BY FINANCING ACTIVITIES   236,828    65,614 
           
NET DECREASE IN CASH   796    — 
CASH          
Beginning of year   —    — 
End of year  $796   $— 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Income tax paid  $—   $— 
Interest paid   —    — 
           
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Settlement of accounts payable by FE Pharmacy Inc.   —    7,443 
Issuance of common stock previously accrued   44,268,440    — 
Issuance of preferred stock previously accrued   201,350    — 
Unissued shares for services reclassified to liability   —    35,425,500 

 

The accompanying notes are an integral part of these consolidated financial statements

-32-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 1 - BUSINESS AND GOING CONCERN

 

Organization

 

Kallo Inc. (“Kallo” or the “Company”) develops customized health care solutions designed to improve or enhance the delivery of care in the countries and regions we serve.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The amounts of assets and liabilities in the consolidated financial statements do not purport to represent realizable or settlement values. The Company has incurred operating losses since inception and has an accumulated deficit and a working capital deficit at December 31, 2021. The Company is expected to incur additional losses as it executes its go to market strategy. This raises substantial doubt about the Company’s ability to continue as a going concern.

 

The Company has met its historical working capital requirements from the sale of common shares and related party loans. In order to not burden the Company, certain officers/stockholders have agreed to provide funding to the Company to pay its annual audit fees, filing costs and legal fees as long as the board of directors deems it necessary. However, there can be no assurance that such financial support shall be ongoing or available on terms or conditions acceptable to the Company. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

COVID-19

 

The Company’s results of operations are affected by economic conditions, including macroeconomic conditions and levels of business confidence. There continues to be significant volatility and economic uncertainty in many markets and the ongoing COVID-19 pandemic contributes to that level of volatility and uncertainty and has created economic disruption. The Company is actively managing its business to respond to the impact. There were no adjustments recorded in the financial statements that might result from the outcome of these uncertainties.

 

The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on the Company’s business, financial condition and results of operations. Management continues to monitor the business environment for any significant changes that could impact the Company’s operations.

 

NOTE 2 - ACCOUNTING POLICIES AND OPERATIONS

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.

 

Basis of Consolidation

 

The consolidated financial statements include the accounts of Kallo and its wholly-owned subsidiary, Rophe Medical Technologies Inc. Significant inter-company transactions and balances have been eliminated on consolidation.

-33-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 - ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Earnings Per Share

 

The Company computes basic net loss per share in accordance with ASC 260, Earnings Per Share, by dividing the net loss for the period by the weighted average number of common shares outstanding during the year. Diluted loss per share reflects the potential dilution of securities that could share in earnings of an entity.  In a loss year, dilutive common equivalent shares are excluded from the loss per share calculation as the effect would be anti-dilutive.  For the years ended December 31, 2021 and 2020, basic and diluted losses per share are the same for both years.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key estimates include the fair value of common stock issued for services received by the Company, valuation of financial instruments, measurement of non-monetary transactions and provision for penalties and interest on estimated payroll tax liabilities.

 

Software Development Costs

 

Software development costs are accounted for in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed. Software development costs incurred internally in creating computer software products are expensed until technological feasibility has been established upon completion of a detailed program design. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. The determination of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including anticipated future gross product revenues, estimated economic life and changes in hardware and software technology.

 

Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently reported at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution. No costs have been capitalized to date as the Company has not completed a working model as of yet.

 

Related party transactions

 

FASB ASC 850, “Related Party Disclosures” requires companies to include in their financial statements disclosures of material related party transactions.  The Company discloses all material related party transactions.  Related parties are defined to include any principal owner, director or executive officer of the Company and any immediate family members of a principal owner, director or executive officer.

-34-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 – ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Research and Development

 

The Company accounts for research and development costs in accordance with ASC 730-10, Research and Development. Accordingly, all research and development costs are charged to expense as incurred as software development costs.

 

Foreign Currency Translation

 

The Company’s functional and reporting currency is the United States dollar. Transaction may occur in Canadian dollars which are accounted for under ASC 830, Foreign Currency Matters. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statements of Operations. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized.  Changes in recognition or measurement are reflected in the period in which a change in judgement occurs, as a result of information that arises or when a tax position is effectively settled.  Interest and penalties related to income tax matters are recognized in general and administrative expense.

 

In accordance with the statute of limitations for federal tax returns, the Company’s federal tax returns for the years 2011 through 2021 are subject to examination. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of FASB ASC 740.

-35-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 – ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Fair Value of Financial Instruments

 

The Company used a three-level hierarchy that prioritizes the inputs used in valuation techniques for determining fair value of investments and liabilities. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:

 

Level 1 – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives and most United States Government and agency securities).

 

Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following:

 

  ● Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);
     
  ● Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and
     
  ● Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).

 

Level 3 – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

There are no financial instruments that are accounted for at fair value at December 31, 2021 and 2020.

-36-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 – ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Stock-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).

 

Contingencies

 

The Company accrues estimates for resolution of any legal and other contingencies when losses are probable and estimable, in accordance with ASC 450, Contingencies. Legal defense costs are accrued as incurred.

 

Stock Issued in Exchange for Services

 

In accordance with ASC 505, the valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).

 

Convertible promissory note

 

The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments if they do not meet the criteria for classification in stockholders’ equity.

 

The Company has evaluated the terms and conditions of its convertible notes under the guidance of ASC 815. The conversion feature did not meet the definition of “indexed to a company’s own stock” provided for in ASC 815. Therefore, the conversion features require bifurcation and liability classification. The Company recorded the conversion feature as a derivative liability and debt discount and is amortized over the life of the convertible note. The debt discount is recorded against the related convertible note outstanding. The amortization is recorded as interest expense. The derivative liabilities are re-valued at the end of each reporting period using the lattice Model, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur.

-37-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 - ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Revenue recognition

 

Revenue will be recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.

 

Professional service revenue will primarily consist of the fees the Company earns related to installation and consulting services. The Company will recognize revenue from professional services upon delivery or completion of performance.

 

Training services will be recognized upon delivery of the training.

 

There were no revenues during 2021 and 2020.

 

Lease accounting

 

The Company follows ASU 2016-02 (Topic 842), “Leases”. ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors may use the effective date method and elected certain practical expedients allowing the Company not to reassess:

 

  ● whether expired or existing contracts contain leases under the new definition of a lease;
     
  ● lease classification for expired or existing leases; and
     
  ● whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.

 

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 

Advertising costs

 

The Company expenses advertising costs as incurred. The total costs the Company recognized related to advertising were $Nil during the years ended December 31, 2021 and 2020.

 

Recent Accounting Pronouncements

 

Accounting Standards Adopted

 

On December 18, 2019 the FASB issued the ASU 2019-12 “Income taxes (Topic 740)—Simplifying the accounting for income taxes”. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles and also improve consistent application by clarifying and amending existing guidance, such as franchise taxes and interim recognition of enactment of tax laws or rate changes. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of 2021 and it did not have any impact on its financial statements and related disclosures.

-38-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 2 - ACCOUNTING POLICIES AND OPERATIONS (continued)

 

Recent Accounting Pronouncements

 

Recently Issued Accounting Standards Not Yet Adopted

 

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies the accounting for certain convertible instruments such that the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, or that do not result in substantial premiums accounted for as paid-in-capital. As a result, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost. In addition, the ASU requires the use of the if-converted method to be applied to convertible instruments when calculating earnings per share. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using either a modified retrospective or a full retrospective approach. Early adoption is permitted for fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is does not believe adoption of this ASU will have a material impact on its consolidated financial statements.

-39-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 3 – CAPITAL STOCK

 

Common Stock

 

During the year ended December 31, 2021, the Company issued 5,208,731,005 common shares for compensation valued at $44,268,440, which were approved and accrued for between 2018 and 2021.

 

During the years ended December 31, 2020, there were no movements in share capital issued and outstanding.

 

On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 common stock of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The 475,000,000 shares issuable to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $4,135,037. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $ Nil (2020 - $7,443) cash settlement of accounts payable.

 

Preferred Stock

 

The Company has designated 95,000,000 of its preferred stock as Series A Preferred Stock, each of which has 100 votes. The Company, will not, without the affirmative vote or written consent of the holders of at least a majority of the outstanding Series A Preferred Stock (i) authorize or create any additional series of stock ranking prior to or on a parity with the Series A Preferred Stock as to dividends, voting rights, or the distribution of assets upon liquidation; or (ii) change any of the rights, privileges or preferences of the Series A Preferred Stock.

 

The Company’s Board of Directors approved the issuance of an aggregate of 95,000,000 shares of the Company’s Series A Preferred Stock to several directors as compensation for services rendered during 2014. The shares of Series A Preferred stock are not convertible, carry voting rights of 100 votes per Preferred share and the fair value of the Preferred shares were deemed to be $288,780 based on the voting rights of the Preferred shares relative to the fair value of the Company at the date of the issuance.

 

During the year ended December 31, 2021, the Company issued 5,000,000 Series B Preferred shares to a director. The shares of Series B Preferred stock which are not convertible and carry voting rights of 1,000 votes per Preferred share were approved for issuance on February 19, 2019. The fair value of the Series B Preferred shares were deemed to be $201,350 based on their voting rights relative to the fair value of the Company at the date of approval and were accrued for in 2019.

 

During 2020, the Company did not issue any Preferred Class shares.

-40-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 4 – RELATED PARTY TRANSACTIONS

 

During the quarter ended December 31, 2020, the Board of Directors approved the issuance of 1,619,000,000 shares to directors and shareholders of the Company for par value of $16,190, resulting in stock-based compensation valued at $26,697,310. These shares were issued during 2021.

 

During the quarter ended September 30, 2020, the Board of Directors approved the issuance of 1,089,000,000 shares to directors and shareholders of the Company for par value of $10,890, resulting in stock-based compensation valued at $8,701,110. These shares were issued during 2021.

 

During 2019, the Board of Directors approved the issuance of 57,000,000 shares to directors and shareholders of the Company for par value of $570, resulting in as stock-based compensation valued at $1,373,130. These shares were issued during 2021.

 

During 2019, the Company designated 5,000,000 of is preferred stock as Series B preferred stock, each of which has 1,000 votes and are not convertible. The Company, will not, without the approval or express written consent of the all the holders of the Series B preferred stock (i) establish, create, authorize or approve the issuance of any series or class of preferred stock (ii) change any of the rights, privileges or preferences of the Series B preferred stock or (iii) redeem the Series B preferred stock..

 

During 2019, the Board of Directors approved the issuance of 5,000,000 Series B preferred shares to a director as compensation for services rendered and their fair value were deemed to be $201,350 based on the voting rights of the preferred shares relative to the fair value of the Company at the date of the approved issuance. These shares were issued during 2021.

 

During 2018, 3,031,900 valued at $121,276 were issued to the family of the controlling shareholder of FE Pharmacy Inc. and a related party as compensation for services rendered and for nominal cash. A further 3,731,005 valued at $149,240 was approved for issuance to the same family of the controlling shareholder of FE Pharmacy Inc, as compensation for services rendered and were issued during 2021.

 

On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 shares of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The 475,000,000 shares issued to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $4,135,037. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $Nil (2020 - $7,443) cash settlement of accounts payable.

 

Included in convertible loans payable to related parties is an amount of $1,080,255 (2020 - $993,812), including accrued interest, owing to a director and a shareholder of the Company.

 

Included in accounts payable and accrued liabilities is an amount of $1,988,921 (2020 - $1,675,108) due to directors and officers of the Company as at December 31, 2021.

 

Included in short term loans payable is an amount of $2,206 (2020 - $Nil) due to the controlling shareholder of FE Pharmacy Inc. and a related party as at December 31, 2021.

 

Included in short term loans payable is an amount of $291,729 (2020 - $61,297) due to a director and officer of the Company as at December 31, 2021.

-41-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 5 – CONVERTIBLE LOANS PAYABLE

 

   2021   2020 
Convertible promissory note bearing interest at 15% per annum – third parties  $314,981   $290,133 
Convertible promissory note bearing interest at 15% per annum – related parties   1,080,255    993,812 
Convertible loans payable  $1,395,236   $1,283,945 

 

The Convertible loans payable bear 15% interest per annum and are convertible at a fixed price at any time during the 1 year term.  The Company has the option to pay the note at any time.  The Company analyzed the conversion option for derivative accounting consideration under ASC Topic 815-40, Derivatives and Hedging – Contract in Entity’s Own Stock and concluded that the embedded conversion was a derivative but the fair value of the feature was zero. The total outstanding notes is $1,395,236, including accrued interest, of which $1,080,255 is to from related parties. Interest of $111,291 (2020 - $111,596) on the convertible loans payable are included in net finance charge for the year ended December 31, 2021 included in the consolidated statement of operations. All of the above convertible loans payable were in default as at December 31, 2021.

 

NOTE 6 – SHORT TERM LOANS PAYABLE

 

   2021   2020 
Non-interest bearing short term funding from third party  $17,174   $17,100 
Non-interest bearing short term funding from related party   2,206    — 
Non-interest bearing short term funding from director   291,729    61,297 
Short term loans payable  $311,109   $78,397 

 

As at December 31, 2021, the balance of $311,109 (2020 - $78,397) represented short term funding provided by a third party and related parties which are non-interest bearing, unsecured and have no fixed repayment date.  The portion of the loan from third party in Canadian dollars is $21,772 which is subject to revaluation at the end of each period end.

-42-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 7 – INCOME TAXES

 

The Company had no income taxes payable at December 31, 2021 and 2020.

 

The reconciliation of income tax provision computed at statutory rates to the reported income tax provision is as follows:

 

   2021   2020 
Net loss for the year  $(8,093,468)  $(36,055,668)
Effective statutory rate   21%   21%
Expected tax recovery  $(1,699,628)  $(7,571,690)
Net effects of non deductible and allowable items   1,532,076    7,433,668 
Change in valuation allowance   167,552    138,022 
Income Tax Expense  $—   $— 

 

Deferred income taxes reflect the net income tax effect of temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and amounts used for income taxes.

The Company’s deferred income tax assets and liabilities consist of the following:

 

   2021   2020 
Net operating loss carry forward  $4,230,233   $4,058,167 
Equipment   7,261    15,660 
Valuation allowance   (4,237,494)   (4,073,827)
Deferred tax assets, net of valuation allowance  $—   $— 

 

Net operating loss carry forwards totaled approximately $20,144,000 at December 31, 2021. The net operating loss carry forwards will begin to expire in the year 2022 if not utilized. After consideration of all the evidence, management has recorded a valuation allowance at December 31, 2021 due to uncertainty of realizing the deferred tax assets. Utilization of the Company’s net operating loss carry forwards may be limited based on changes in ownership as defined in Internal Revenue Code Section 382. Tax years 2011 through 2021 remain open to examination by tax authorities.

-43-

KALLO INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(Amounts expressed in US dollars)

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

On April 21, 2017, an ex-employee of Kallo obtained a judgement ordering Kallo to pay Canadian $ 135,959 for unpaid wages and expenses relating to services performed in 2016. The full amount has been accrued for in the financial statements of Kallo.

 

On October 24, 2016, a consultant obtained a judgement ordering Kallo to pay Canadian $34,924 for unpaid fees. The full amount has been accrued for in the financial statements of Kallo.

 

On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. An amount of Canadian $134,960 has been accrued for in the financial statements of Kallo.

 

There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. An amount of Canadian $24,016 has been accrued for in the financial statements of Kallo. Negotiations are in process for the settlement of this debt for a lump sum.

 

Canada Revenue Agency has assessed the Company for unpaid Canadian $84,643 representing unremitted employee source deductions and related penalties and interest, the full amount of which has been accrued in the financial statements of Kallo.

 

Responsibility for payments of the above claims has been assumed by FE Pharmacy Inc. under the terms of the agreement mentioned in Note 3.

-44-

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None

 

  ITEM 9A CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation (the “Evaluation”), under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of our disclosure controls and procedures (“Disclosure Controls”) as of the end of the period covered by this report pursuant to Rule 13a-15 of the Exchange Act. Based on this Evaluation, our CEO and CFO concluded that our Disclosure Controls were not effective as of the end of the period covered by this report due to lack of segregation of duties in financial reporting and presence of adjusting journal entries during the audit.

 

 Management’s Report on Internal Control Over Financial Reporting.

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Exchange Act Rule 13a-15(f). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

Because of the inherent limitations due to, for example, the potential for human error or circumvention of controls, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

 

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

Based on this evaluation, management concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2021. Material weakness identified included:

 

* Lack of segregation of duties
   
* Insufficient controls over the financial close process and preparation of the financial statements identified by the auditors during the audit of the company’s financial statements for the year ended December 31, 2021.

 

We will begin to take steps to remedy the foregoing material weaknesses, including hiring a VP of Finance to oversee the accounting and financial reporting process, after the Company secures new contracts.

 

Changes in Internal Controls

 

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

  ITEM 9B. OTHER INFORMATION.

 

None.

-45-

PART III

 

  ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.

 

Officers and Directors

 

Each of our directors serves until his or her successor is elected and qualified. Each of our officers is elected by the board of directors to a term of one (1) year and serves until his or her successor is duly elected and qualified, or until he or she is removed from office. The board of directors has no nominating, auditing or compensation committees.  It does have an audit committee comprised of the board of directors.

 

The names, addresses, ages and positions of our present officers and directors are set forth below:

 

Name and Address Age Position(s)

John Cecil
255 Duncan Mill Road,

Suite 504

Toronto, Ontario

Canada M3B 3H9

 59 President, Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer
     
Lloyd A. Chiotti 74 Chief Operating Officer and Director

255 Duncan Mill Road,

Suite 504

Toronto, Ontario

Canada M3B 3H9

    
     
Samuel R Baker 87 Secretary and a Director

255 Duncan Mill Road,

Suite 504

Toronto, Ontario

Canada M3B 3H9

    

-46-

Background of officers and directors

 

John Cecil – President, Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer

 

On October 20, 2010, John Cecil was appointed Chairman of the Board of Directors, Chief Executive Officer and a Director and on February 29, 2016, Mr Cecil was appointed President. And as of March 25, 2011, John Cecil was appointed the treasurer, principal financial officer and principal accounting officer of Kallo Inc. Since December 31, 2009, John Cecil was on our board of directors.  Since December 2003 John Cecil has been the president of Rophe Medical Technologies Inc., in Toronto, Canada.  He was responsible for its research and development and the design and copyright of the company’s technology.  From May 2008 to April 2009 Mr. Cecil was the Senior Healthcare Solutions Architect at SUN Microsystems Canada Inc., in Toronto, Canada, a publicly traded company listed on the NASDAQ under the symbol JAVA.  He was responsible for Innovative product positioning by workshops / white board sessions with stakeholders of the customer to increase business value and support sales in revenue growth and design innovative technology solutions.  From April 2007 to May 2008, Mr. Cecil was the Healthcare Director at Satyam Computer Service Ltd., in Toronto, Canada, a publicly traded company listed on the NYSE under the symbol “SAY”.  He managed healthcare consulting practices and services. On February 29, 2016, Mr Cecil was appointed to the position of President of Kallo Inc.

 

Samuel Baker - Secretary and a Director

 

On November 17, 2010, Samuel Baker was appointed Secretary and a member of our Board of Directors.  Since October 1997 Mr. Baker has been the Senior Lawyer at Baker Law Firm in Toronto, Canada. Since September 2008, Mr. Baker has been the director of Arehada Mining Limited.  Arehada Mining Limited operates a lead/zinc mine in Inner Mongolia, China.  It is a public company traded on the Toronto Stock Exchange, ticker symbol AHD.

 

Lloyd Chiotti – Chief Operating Officer and Director

 

On September 22, 2011, Lloyd Chiotti was appointed to our board of directors and on February 29, 2016, Mr Chiotti was appointed Chief Operating Officer. In February 2015, Mr. Chiotti began full time with Kallo Inc. as the Executive Vice President. He holds an Engineering degree and an MBA, both from the University of Toronto. He worked with Enbridge Gas Distribution (formerly The Consumers Gas Company) for over 34 years. Over the course of his career he held a number of senior management positions including Director of Information Services and a number of Regional General Manager roles within Operations. In 2006 he joined the Engineering department to lead the Asset Management initiative as Director, Asset Management Strategy. In this capacity, he led a team which implemented an Asset Management system for gas distribution consistent with the international standard called PAS 55 (now ISO 55001). In 2010 he was appointed to the position of Director, Distribution Asset Management. In this capacity, he was responsible for all distribution system planning and records management and led the development of a comprehensive methodology to develop risk based, long range asset management plans. He was actively involved in the natural gas industry. He served as Chair of the Asset Management Task Force of the Canadian Gas Association from 2006 to 2013 and served as a member of the Distribution Working Committee of the International Gas Union from 2007 to 2012. Throughout his career he has also served on the Boards of a number of not-for-profit organizations including: President, Alternative Computer Training for the Disabled; Chair, United Way of Peel Campaign 1992; Chair of the Board, West Park Healthcare Centre Foundation; Vice-Chair of the Board, Junior Achievement of Toronto and Chair of the Board, Toronto Mendelssohn Choir. He retired from Enbridge on October 1, 2013.

 

 Conflicts of Interest

 

There is no conflict that we foresee as our officers and directors devote full time to the business and the operations of the company except for Samuel R. Baker who is not full time in the organization.

-47-

Involvement in Certain Legal Proceedings

 

During the past ten years, Messrs. Cecil, Baker, and Chiotti have not been the subject of the following events:

 

  1. A petition under the Federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

  2. Convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

  3. The subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities;

 

  i) Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

  ii) Engaging in any type of business practice; or

 

  iii) Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

 

  4. The subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph 3.i in the preceding paragraph or to be associated with persons engaged in any such activity;

 

  5. Was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

  6. Was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

 

  7. Was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

  i) Any Federal or State securities or commodities law or regulation; or

 

  ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or

 

  iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

  8. Was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

-48-

Audit Committee and Charter

 

We have a separately designated audit committee of the board. Our board of directors performs the audit committee functions. None of our directors are deemed independent. Two of our directors also hold positions as our officers. Our audit committee is responsible for: (1) selection and oversight of our independent accountant; (2) establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls and auditing matters; (3) establishing procedures for the confidential, anonymous submission by our employees of concerns regarding accounting and auditing matters; (4) engaging outside advisors; and, (5) funding for the outside auditory and any outside advisors engagement by the audit committee. A copy of our audit committee charter is filed as an exhibit to our 2007 Form 10-K.

 

Audit Committee Financial Expert

 

We do not have an audit committee financial expert.

 

Code of Ethics

 

We have adopted a corporate code of ethics. We believe our code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of code violations; and provide accountability for adherence to the code. A copy of the code of ethics is filed as Exhibit 14.1 to our S-1 filed with the Securities and Exchange Commission on August 25, 2014.

 

Disclosure Committee and Committee Charter

 

We have a disclosure committee and disclosure committee charter. Our disclosure committee is comprised of all of our officers and directors. The purpose of the committee is to provide assistance to the Chief Executive Officer and the Chief Financial Officer in fulfilling their responsibilities regarding the identification and disclosure of material information about us, and the accuracy, completeness and timeliness of our financial reports. A copy of the disclosure committee charter is filed as Exhibit 99.2 to our 2007 Form 10-K.

 

Section 16(a) of the Securities Exchange Act of 1934

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors, officers and persons who beneficially owned more than ten percent of our common stock to file reports of ownership and changes in ownership of common stock. Based solely upon a review of Forms 3, 4 and 5 furnished to us during the fiscal year 2020, all officers, directors, and persons who beneficially own more than ten percent of our common stock filed all reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended.

-49-

  ITEM 11. EXECUTIVE COMPENSATION.

 

The following table sets forth the compensation payable by us during the last two fiscal years for our officers. This information includes the dollar value of base salaries, bonus awards and number of stock options granted, and certain other compensation, if any. The compensation discussed addresses all compensation awarded to, earned by, or paid to our named executive officers.

 

Summary Compensation Table

 

(a)  (b)   (c)   (d)   (e)   (f)   (g)   (h)   (i)   (j) 
                           Change in         
                           Pension Value &         
                           Nonqualified         
                       Non-Equity   Deferred         
               Stock   Option   Incentive Plan   Compensation   All Other     
Name and Principal      Salary   Bonus   Awards   Awards   Compensation   Earnings   Compensation   Totals 
Position [1]  Year   ($)   ($)   ($)[1]   ($)   (S)   ($)   ($)   ($) 
John Cecil   2021    172,594    0    3,000,000    0    0    0    0    3,172,594 
Chairman & CEO   2020    161,618    0    19,278,000    0    0    0    0    19,439,618 
                                              
Samuel Baker   2021    0    0    165,000    0    0    0    0    165,000 
Secretary   2020    0    0    1,006,500    0    0    0    0    1,006,500 
                                              
Lloyd Chiotti   2021    138,937    0    690,000    0    0    0    0    828,937 
Director & EVP   2020    130,102    0    4,660,000    0    0    0    0    4,790,102 

 

  [1] During the year ended December 31, 2021, 1,285,000,000 common shares were approved for issuance to directors and officers for a total amount of $3,855,000 of which $12,850 was contributed as cash by them and $3,842,150 was to be granted to them as stock-based compensation.

 

The number of shares approved for issuance as compensation to each named executive officer for the year ended December 31, 2021 was as follows:

 

  ● John Cecil – 1,000,000,000 common shares issuable as compensation valued at $3,000,000

 

  ● Samuel Baker – 55,000,000 common shares issuable as compensation valued at $165,000

 

  ● Lloyd Chiotti – 230,000,000 common shares issuable as compensation valued at $690,000

 

The values reported represent the issue date fair value of the shares multiplied by the number of shares issuable.

 

All compensation received by our officers and directors has been disclosed.

 

Option/SAR Grants

 

There are no stock option, retirement, pension, or profit sharing plans for the benefit of our officers and directors other than our 2012 Non-Qualified Incentive Stock Option Plans. No options have been granted to our officers and directors thereunder.

-50-

Long-Term Incentive Plan Awards

 

We do not have any long-term incentive plans that provide compensation intended to serve as incentive for performance.

 

Compensation of Directors

 

The members of our board of directors are not compensated for their services as directors. We no longer have employment contracts with our officers or directors.

 

Indemnification

 

Under our Bylaws, we may indemnify an officer or director who is made a party to any proceeding, including a lawsuit, because of his position, if he/she acted in good faith and in a manner he/she reasonably believed to be in our best interest. We may advance expenses incurred in defending a proceeding. To the extent that the officer or director is successful on the merits in a proceeding as to which he/she is to be indemnified, we must indemnify him/her against all expenses incurred, including attorney’s fees. With respect to a derivative action, indemnity may be made only for expenses actually and reasonably incurred in defending the proceeding, and if the officer or director is judged liable, only by a court order. The indemnification is intended to be to the fullest extent permitted by the laws of the State of Nevada.

 

Regarding indemnification for liabilities arising under the Securities Act of 1933, which may be permitted to directors or officers under Nevada law, we are informed that, in the opinion of the Securities and Exchange Commission, indemnification is against public policy, as expressed in the Act and is, therefore, unenforceable.

-51-

  ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

 

The following table sets forth, as of the date of this report, the total number of shares owned beneficially by each of our directors, officers and key employees, individually and as a group, and the present owners of 5% or more of our total outstanding shares. The stockholder listed below has direct ownership of his/her shares and possesses sole voting and dispositive power with respect to the shares.

 

Name and Address

Beneficial Owner [1]

 

Number of Common

Shares Owned

 

Percentage of

Ownership

 

Number of Preferred

Shares Owned

 

Percentage of

Ownership

John Cecil [2]  3,039,756,028  47.82%  75,000,000  75.00%
255 Duncan Mill Road, Suite 504
Toronto, ON M3B 3H9		            
             
Lloyd Chiotti  701,370,917  11.03%  5,000,000  5.00%
255 Duncan Mill Road, Suite 504
Toronto, ON M3B 3H9		            
             
Samuel Baker [3]  166,546,508  2.62%  —  0.00%
255 Duncan Mill Road, Unit 504
Toronto, ON, M3B 3H9		            
             
All Officers and Directors as a Group (3 persons)  3,907,673,453  61.47%  80,000,000  80.00%

 


[1]		 The persons named above may be deemed to be a “parent” and “promoter” of our company, within the meaning of such terms under the Securities Act of 1933, as amended, by virtue of his/its direct and indirect stock holdings.
   
[2] Includes 32,670 shares of common stock owned by family members of John Cecil.
   
[3] Includes 667 shares of common stock owned by family members of Samuel Baker.
   
[4]    Each preferred share is entitled to 100 votes.

-52-

  ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

 

As at December 31, 2021, we owe our officers and directors $1,988,921 in accounts payable and accrued liabilities.

 

  ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 

(1)        Audit Fees

 

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for our audit of annual financial statements and review of financial statements included in our Form 10-Ks or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years was:

 

2021  $60,000   BF Borgers
2020  $60,000   BF Borgers

 

(2)        Audit-Related Fees

 

The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountants that are reasonably related to the performance of the audit or review of our financial statements and are not reported in the preceding paragraph:

 

2021  $0   BF Borgers
2020  $0   BF Borgers

 

(3)        Tax Fees

 

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning was:

 

2021  $0   BF Borgers
2020  $0   BF Borgers

 

(4)        All Other Fees

 

The aggregate fees billed in each of the last two fiscal years for the products and services provided by the principal accountant, other than the services reported in paragraphs (1), (2), and (3) was:

 

2021  $0   BF Borgers
2020  $0   BF Borgers

 

(5)        Our audit committee’s pre-approval policies and procedures described in paragraph (c)(7)(i) of Rule 2-01 of Regulation S-X were that the audit committee pre-approve all accounting related activities prior to the performance of any services by any accountant or auditor.

 

(6)        The percentage of hours expended on the principal accountant’s engagement to audit our financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full time, permanent employees was 0%.

-53-

PART IV

 

  ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

    Incorporated by reference Filed
Exhibit Document Description Form Date Number herewith
           
2.1 Articles of Merger. 8-K 1/21/11 2.1  
           
3.1 Articles of Incorporation. SB-2 3/05/07 3.1  
           
3.2 Bylaws. SB-2 3/05/07 3.2  
           
3.3 Amended Articles of Incorporation (11/23/2015). 8-K 12/02/15 3.1  
           
4.1 Specimen Stock Certificate. SB-2 3/05/07 4.1  
           
10.1 Option Agreement. SB-2 3/05/07 10.1  
           
10.2 Lease Agreement SB-2 3/05/07 10.1  
           
10.3

Agreement with Rophe Medical Technologies Inc. dated December 11, 2009.

 10-K 3/31/10 10.2  
           
10.4

Amended Agreement with Rophe Medical Technologies Inc. dated December 18, 2009.

 10-K 3/31/10 10.3  
           
10.5

Amended Agreement with Rophe Medical Technologies Inc. dated March 16, 2010.

 10-K 3/31/10 10.4  
           
10.6 Investment Agreement with Kodiak Capital Group, LLC. S-1 10/29/14 10.6  
           
10.7 Consulting Agreement with Ten Associate LLC. S-1 5/24/10 10.7  
           
10.8 Employment Agreement with Samuel Baker. S-1 5/24/10 10.9  
           
10.9 Employment Agreement with John Cecil. S-1 5/24/10 10.10  
           
10.10

Amended Consulting Agreement with Ten Associate LLC dated October 5, 2010.

 8-K 10/14/10 10.13  
           
10.11 Agreement with Jarr Capital Corp. 8-K 11/17/10 10.1  
           
10.12 Agreement with Mary Kricfalusi. 8-K 11/19/10 10.1  
           
10.13 Agreement with Herb Adams. 8-K 11/19/10 10.2  
           
10.14

North American Authorized Agency Agreement with Advanced Software Technologies, Inc.

 8-K 12/16/10 10.1  

-54-

  ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES. (CONTINUED)

 

10.15 Amended Agreement with Jarr Capital Corp. 8-K 2/22/11 10.1  
           
10.16 Termination of Employment Agreement with John Cecil. 8-K 2/22/11 10.2  
           
10.17 Termination of Employment Agreement with Samuel Baker. 8-K 2/22/11 10.4  
           
10.18

Services Agreement with Buchanan Associates Computer Consulting Ltd.

 10-K 5/18/11 10.1  
           
10.19

Equipment Lease Agreement with Buchanan Associates Computer Consulting Ltd.

 10-K 5/18/11 10.2  
           
10.20 Agreement with Mansfield Communications Inc. 10-K 5/18/11 10.3  
           
10.21 Agreement with Watt International Inc. 10-K 5/18/11 10.4  
           
10.22 Pilot EMR Agreement with Nexus Health Management Inc. 10-K 5/18/11 10.5  
           
10.23 2011 Non-Qualified Stock Option Plan. S-8 6/27/11 10.1  
           
10.24 Multimedia Contractual Agreement with David Miller. 8-K 10/28/11 10.1  
           
10.25

Strategic Alliance Agreement with Petro Data Management Services Limited and Gateway Global Fabrication Ltd.

 8-K 11/02/11 10.1  
           
10.26 Independent Contractor Agreement with Savers Drug Mart. 8-K 1/26/12 10.1  
           
10.27 2012 Non-Qualified Stock Option Plan. S-8 9/06/12 10.1  
           
10.28

Memorandum of Offering with Ministry of Health of Republic of Ghana.

 S-1/A-3 6/26/13 10.32  

-55-

  ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES. (CONTINUED)

 

14.1 Code of Ethics. 10-K 4/15/08 14.1  
           
16.1 Letter from Kempisty & Company 8-K 10/27/09 16.1  
           
16.2 Letter from MaloneBailey, LLP 8-K 3/02/11 16.1  
           
16.3 Letter from Schwartz Levitsky Feldman LLP 8-K 6/11/14 16.1  
           
21.1 List of Subsidiary Companies. 10-K 3/31/10 21.1  
           
23.1 Consent of MaloneBailey LLP. 10-K 4/14/16 23.1  
           
31.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.       X
           
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.       X
           
99.1 Audit Committee Charter. 10-K 4/15/08 99.1  
           
99.2 Disclosure Committee Charter. 10-K 4/15/08 99.2  
           
101.INS XBRL Instance Document.       X
           
101.SCH XBRL Taxonomy Extension – Schema.       X
           
101.CAL XBRL Taxonomy Extension – Calculations.       X
           
101.DEF XBRL Taxonomy Extension – Definitions.       X
           
101.LAB XBRL Taxonomy Extension – Labels.       X
           
101.PRE XBRL Taxonomy Extension – Presentation.       X

-56-

 SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 3rd of June 2022.

 

  KALLO INC.
   
  BY: JOHN CECIL
    John Cecil
    President, Principal Executive Officer, Principal Financial Officer and Chairman of Board of Directors
     

Pursuant to the requirements of the Securities Act of 1934, this amended report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

Signature Title Date
     
JOHN CECIL President, Principal Executive Officer, June 3, 2022
John Cecil Principal Financial Officer and the Chairman of Board of Directors  
     
SAMUEL BAKER Corporate Secretary and member of the Board of Directors June 3, 2022
Samuel Baker    
     

LLOYD A. CHIOTTI

Lloyd A. Chiotti

 Chief Operating Officer and member of the Board of Directors June 3, 2022

-57-

 EX-31.1 2 kalo-20211231_10kex31z1.htm EX-31.1

Exhibit 31.1

 

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

 

I, John Cecil, certify that:

 

1. I have reviewed this Form 10-K for the year ending December 31, 2021 of Kallo Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
     
Date: June 3, 2022 JOHN CECIL
    John Cecil
    Principal Executive Officer and Principal Financial Officer

 

 EX-32.1 3 kalo-20211231_10kex32z1.htm EX-32.1

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. Section 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Amended Annual Report of Kallo Inc. (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date here of (the “report”), I, John Cecil, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 3rd day of June, 2022.

 

  JOHN CECIL
  John Cecil
  Chief Executive Officer and Chief Financial Officer

 

 EX-101.SCH 4 kalo-20211231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficiency (Equity) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BUSINESS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CONVERTIBLE LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - SHORT TERM LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - CONVERTIBLE LOANS PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SHORT TERM LOANS PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - CAPITAL STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SHORT TERM LOANS PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - INCOME TAXES (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 kalo-20211231_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 kalo-20211231_def.xml XBRL DEFINITION FILE EX-101.LAB 7 kalo-20211231_lab.xml XBRL LABEL FILE Equity Components [Axis] Preferred Stock [Member] Class of Stock [Axis] Preferred Class A [Member] Preferred Class B [Member] Common Stock [Member] Additional Paid-in Capital [Member] Assignment Of Liabilities [Member] Retained Earnings [Member] Series A Preferred Stock [Member] Title of Individual [Axis] Director [Member] Series B Preferred Stock [Member] Related Party [Axis] F E Pharmacy [Member] Debt Instrument [Axis] Convertible promissory notes bearing interest at 15% per annum - third parties Convertible promissory notes bearing interest at 15% per annum - related parties Non-interest bearing short term funding from third parties Non-interest bearing short term funding from related parties Non-interest bearing short term funding from director Litigation Status [Axis] Judicial Ruling [Member] Pending Litigation [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Prepaid expenses Total Current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ DEFICIENCY Current Liabilities: Accounts payable and accrued liabilities Convertible loans payable – third parties Short term loans payable Convertible loans payable – related parties Liability for issuable shares Total Current Liabilities TOTAL LIABILITIES Commitments and Contingencies Stockholders’ Deficiency: Preferred stock, $0.00001 par value, 120,000,000 shares authorized, 95,000,000 Series A preferred shares and 5,000,000 Series B preferred shares issued and outstanding Common stock, $0.00001 par value, 8,000,000,000 shares authorized, 6,356,429,204 and 1,147,698,199 shares issued and outstanding respectively Additional paid-in capital Assignment of liabilities Accumulated deficit Total Stockholders’ Deficiency TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY Statement [Table] Statement [Line Items] Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Operating Expenses General and administration Selling and marketing Operating loss Interest and financing costs Foreign exchange loss Debt forgiveness Net loss Net loss per share - Basic and diluted Weighted average number of shares outstanding - Basic and diluted Beginning balance, value Shares, Outstanding, Beginning Balance Cash settlement of liabilities Net loss Shares issued to director [custom:StockIssuedDuringPeriodToDirectorInShares] Shares issued as compensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities Stock-based compensation Interest and penalties Unrealized foreign exchange gains Debt forgiveness Changes in operating assets and liabilities: Increase in accounts payable and accrued liabilities Increase in prepaid expenses NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from short term loans payable NET CASH PROVIDED BY FINANCING ACTIVITIES NET DECREASE IN CASH Beginning of year End of year SUPPLEMENTAL CASH FLOW INFORMATION: Income tax paid Interest paid SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Settlement of accounts payable by FE Pharmacy Inc. Issuance of common stock previously accrued Issuance of preferred stock previously accrued Unissued shares for services reclassified to liability Accounting Policies [Abstract] BUSINESS AND GOING CONCERN ACCOUNTING POLICIES AND OPERATIONS Equity [Abstract] CAPITAL STOCK Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Debt Disclosure [Abstract] CONVERTIBLE LOANS PAYABLE SHORT TERM LOANS PAYABLE Income Tax Disclosure [Abstract] INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Basis of Presentation Basis of Consolidation Earnings Per Share Use of Estimates Software Development Costs Related party transactions Research and Development Foreign Currency Translation Income Taxes Fair Value of Financial Instruments Stock-Based Compensation Contingencies Stock Issued in Exchange for Services Convertible promissory note Revenue recognition Lease accounting Advertising costs Recent Accounting Pronouncements Schedule of Convertible Loans Payable CONVERTIBLE LOANS PAYABLE Schedule of Short Term Loans payable SHORT TERM LOANS PAYABLE reconciliation of income tax provision computed at statutory rates to the reported income tax provision INCOME TAXES Company’s deferred income tax assets and liabilities INCOME TAXES (Details 2) Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Common Shares to be Issued, Shares Assignment of Liabilities Stock Issued During the Period to Director, Value Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Common Stock to be issued, Shares Common Stock to be issued Share-based Payment Arrangement, Noncash Expense Accounts Payable, Related Parties, Current Accounts Payable and Accrued Liabilities, Current Loans Payable, Current Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Convertible loans payable Interest Expense Net loss for the year Effective statutory rate Expected tax recovery Net effects of non deductible and allowable items Change in valuation allowance Income Tax Expense Net operating loss carry forward Equipment Valuation allowance Deferred tax assets, net of valuation allowance Operating Loss Carryforwards Operating Loss Carryforwards, Expiration Date Loss Contingencies [Table] Loss Contingencies [Line Items] Salary and Wage, Officer, Excluding Cost of Good and Service Sold Unpaid Fees Loss Contingency, Allegations Loss Contingency, Damages Sought Debt Forgiveness Issuance of common stock previously accrued Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Interest and Debt Expense Shares, Outstanding Foreign Currency Transaction Gain (Loss), Unrealized Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect DisclosureConvertibleLoansPayableDetailsAbstract DisclosureShortTermLoansPayableDetailsAbstract DisclosureINCOMETAXESDetailsAbstract Deferred Tax Assets, Valuation Allowance EX-101.PRE 8 kalo-20211231_pre.xml XBRL PRESENTATION FILE GRAPHIC 9 kl001_v1.jpg GRAPHIC begin 644 kl001_v1.jpg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end GRAPHIC 10 kl002_v1.jpg GRAPHIC begin 644 kl002_v1.jpg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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Apr. 21, 2022
Jan. 31, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 000-53183    
Entity Registrant Name KALLO INC.    
Entity Central Index Key 0001389034    
Entity Tax Identification Number 98-0542529    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 255 Duncan Mill Road    
Entity Address, Address Line Two Suite 504    
Entity Address, City or Town Toronto    
Entity Address, State or Province ON    
Entity Address, Country CA    
Entity Address, Postal Zip Code M3B 3H9    
City Area Code (416)    
Local Phone Number 246-9997    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers Yes    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company true    
Entity Public Float     $ 10,226,975
Entity Common Stock, Shares Outstanding   6,356,429,586  
Auditor Name BF Borgers CPA PC    
Auditor Location Lakewood, Colorado    
Auditor Firm ID 5041    

XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 796
Prepaid expenses 12,739
Total Current Assets 13,535
TOTAL ASSETS 13,535 0
Current Liabilities:    
Accounts payable and accrued liabilities 4,802,752 4,359,752
Convertible loans payable – third parties 314,981 290,133
Short term loans payable 311,109 78,397
Convertible loans payable – related parties 1,080,255 993,812
Liability for issuable shares 37,149,790
Total Current Liabilities 6,509,097 42,871,884
TOTAL LIABILITIES 6,509,097 42,871,884
Stockholders’ Deficiency:    
Preferred stock, $0.00001 par value, 120,000,000 shares authorized, 95,000,000 Series A preferred shares and 5,000,000 Series B preferred shares issued and outstanding 1,000 950
Common stock, $0.00001 par value, 8,000,000,000 shares authorized, 6,356,429,204 and 1,147,698,199 shares issued and outstanding respectively 63,564 11,478
Additional paid-in capital 86,337,770 41,920,116
Assignment of liabilities (3,455,111) (3,455,111)
Accumulated deficit (89,442,785) (81,349,317)
Total Stockholders’ Deficiency (6,495,562) (42,871,884)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY $ 13,535 $ 0
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Preferred Stock, Par or Stated Value Per Share $ 0.00001 $ 0.00001
Preferred Stock, Shares Authorized 120,000,000 120,000,000
Common Stock, Par or Stated Value Per Share $ 0.00001 $ 0.00001
Common Stock, Shares Authorized 8,000,000,000 8,000,000,000
Common Stock, Shares, Issued 6,356,429,204 1,147,698,199
Common Stock, Shares, Outstanding 6,356,429,204 1,147,698,199
Preferred Stock [Member] | Preferred Class A [Member]    
Preferred Stock, Shares Issued 95,000,000 95,000,000
Preferred Stock, Shares Outstanding 95,000,000 95,000,000
Preferred Stock [Member] | Preferred Class B [Member]    
Preferred Stock, Shares Issued 5,000,000 5,000,000
Preferred Stock, Shares Outstanding 5,000,000 5,000,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating Expenses    
General and administration $ 7,942,995 $ 35,880,286
Selling and marketing 27,784 18,563
Operating loss (7,970,779) (35,898,849)
Interest and financing costs (111,403) (111,596)
Foreign exchange loss (15,476) (95,108)
Debt forgiveness 4,190 49,885
Net loss $ (8,093,468) $ (36,055,668)
Net loss per share - Basic and diluted $ (0.004) $ (0.03)
Weighted average number of shares outstanding - Basic and diluted 2,289,746,749 1,147,698,199
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Deficiency (Equity) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Assignment Of Liabilities [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 950 $ 11,478 $ 41,920,116 $ (3,462,554) $ (45,293,649) $ (6,823,659)
Shares, Outstanding, Beginning Balance at Dec. 31, 2019 95,000,000 1,147,698,199        
Cash settlement of liabilities 7,443 7,443
Net loss (36,055,668) (36,055,668)
Ending balance, value at Dec. 31, 2020 $ 950 $ 11,478 41,920,116 (3,455,111) (81,349,317) (42,871,884)
Shares, Outstanding, Ending Balance at Dec. 31, 2020 95,000,000 1,147,698,199        
Net loss (8,093,468) (8,093,468)
Shares issued to director $ 50 201,300 201,350
[custom:StockIssuedDuringPeriodToDirectorInShares] 5,000,000          
Shares issued as compensation $ 52,086 44,216,354 44,268,440
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture   5,208,731,005        
Ending balance, value at Dec. 31, 2021 $ 1,000 $ 63,564 $ 86,337,770 $ (3,455,111) $ (89,442,785) $ (6,495,562)
Shares, Outstanding, Ending Balance at Dec. 31, 2021 100,000,000 6,356,429,204        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (8,093,468) $ (36,055,668)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 7,295,600 35,398,420
Interest and penalties 111,291 111,596
Unrealized foreign exchange gains 14,738 96,136
Debt forgiveness (4,190) (49,885)
Changes in operating assets and liabilities:    
Increase in accounts payable and accrued liabilities 452,736 433,787
Increase in prepaid expenses (12,739)
NET CASH USED IN OPERATING ACTIVITIES (236,032) (65,614)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from short term loans payable 236,828 65,614
NET CASH PROVIDED BY FINANCING ACTIVITIES 236,828 65,614
NET DECREASE IN CASH 796
Beginning of year
End of year 796
SUPPLEMENTAL CASH FLOW INFORMATION:    
Income tax paid
Interest paid
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Settlement of accounts payable by FE Pharmacy Inc. 7,443
Issuance of common stock previously accrued 44,268,440
Issuance of preferred stock previously accrued 201,350
Unissued shares for services reclassified to liability $ 35,425,500
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS AND GOING CONCERN
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
BUSINESS AND GOING CONCERN

NOTE 1 - BUSINESS AND GOING CONCERN

 

Organization

 

Kallo Inc. (“Kallo” or the “Company”) develops customized health care solutions designed to improve or enhance the delivery of care in the countries and regions we serve.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The amounts of assets and liabilities in the consolidated financial statements do not purport to represent realizable or settlement values. The Company has incurred operating losses since inception and has an accumulated deficit and a working capital deficit at December 31, 2021. The Company is expected to incur additional losses as it executes its go to market strategy. This raises substantial doubt about the Company’s ability to continue as a going concern.

 

The Company has met its historical working capital requirements from the sale of common shares and related party loans. In order to not burden the Company, certain officers/stockholders have agreed to provide funding to the Company to pay its annual audit fees, filing costs and legal fees as long as the board of directors deems it necessary. However, there can be no assurance that such financial support shall be ongoing or available on terms or conditions acceptable to the Company. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

COVID-19

 

The Company’s results of operations are affected by economic conditions, including macroeconomic conditions and levels of business confidence. There continues to be significant volatility and economic uncertainty in many markets and the ongoing COVID-19 pandemic contributes to that level of volatility and uncertainty and has created economic disruption. The Company is actively managing its business to respond to the impact. There were no adjustments recorded in the financial statements that might result from the outcome of these uncertainties.

 

The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on the Company’s business, financial condition and results of operations. Management continues to monitor the business environment for any significant changes that could impact the Company’s operations.

 
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND OPERATIONS
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
ACCOUNTING POLICIES AND OPERATIONS

NOTE 2 - ACCOUNTING POLICIES AND OPERATIONS

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.

 

Basis of Consolidation

 

The consolidated financial statements include the accounts of Kallo and its wholly-owned subsidiary, Rophe Medical Technologies Inc. Significant inter-company transactions and balances have been eliminated on consolidation.

 

Earnings Per Share

 

The Company computes basic net loss per share in accordance with ASC 260, Earnings Per Share, by dividing the net loss for the period by the weighted average number of common shares outstanding during the year. Diluted loss per share reflects the potential dilution of securities that could share in earnings of an entity.  In a loss year, dilutive common equivalent shares are excluded from the loss per share calculation as the effect would be anti-dilutive.  For the years ended December 31, 2021 and 2020, basic and diluted losses per share are the same for both years.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key estimates include the fair value of common stock issued for services received by the Company, valuation of financial instruments, measurement of non-monetary transactions and provision for penalties and interest on estimated payroll tax liabilities.

 

Software Development Costs

 

Software development costs are accounted for in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed. Software development costs incurred internally in creating computer software products are expensed until technological feasibility has been established upon completion of a detailed program design. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. The determination of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including anticipated future gross product revenues, estimated economic life and changes in hardware and software technology.

 

Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently reported at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution. No costs have been capitalized to date as the Company has not completed a working model as of yet.

 

Related party transactions

 

FASB ASC 850, “Related Party Disclosures” requires companies to include in their financial statements disclosures of material related party transactions.  The Company discloses all material related party transactions.  Related parties are defined to include any principal owner, director or executive officer of the Company and any immediate family members of a principal owner, director or executive officer.

 

Research and Development

 

The Company accounts for research and development costs in accordance with ASC 730-10, Research and Development. Accordingly, all research and development costs are charged to expense as incurred as software development costs.

 

Foreign Currency Translation

 

The Company’s functional and reporting currency is the United States dollar. Transaction may occur in Canadian dollars which are accounted for under ASC 830, Foreign Currency Matters. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statements of Operations. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized.  Changes in recognition or measurement are reflected in the period in which a change in judgement occurs, as a result of information that arises or when a tax position is effectively settled.  Interest and penalties related to income tax matters are recognized in general and administrative expense.

 

In accordance with the statute of limitations for federal tax returns, the Company’s federal tax returns for the years 2011 through 2021 are subject to examination. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of FASB ASC 740.

 

Fair Value of Financial Instruments

 

The Company used a three-level hierarchy that prioritizes the inputs used in valuation techniques for determining fair value of investments and liabilities. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:

 

Level 1 – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives and most United States Government and agency securities).

 

Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following:

 

  ● Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);
     
  ● Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and
     
  ● Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).

 

Level 3 – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

There are no financial instruments that are accounted for at fair value at December 31, 2021 and 2020.

 

Stock-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).

 

Contingencies

 

The Company accrues estimates for resolution of any legal and other contingencies when losses are probable and estimable, in accordance with ASC 450, Contingencies. Legal defense costs are accrued as incurred.

 

Stock Issued in Exchange for Services

 

In accordance with ASC 505, the valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).

 

Convertible promissory note

 

The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments if they do not meet the criteria for classification in stockholders’ equity.

 

The Company has evaluated the terms and conditions of its convertible notes under the guidance of ASC 815. The conversion feature did not meet the definition of “indexed to a company’s own stock” provided for in ASC 815. Therefore, the conversion features require bifurcation and liability classification. The Company recorded the conversion feature as a derivative liability and debt discount and is amortized over the life of the convertible note. The debt discount is recorded against the related convertible note outstanding. The amortization is recorded as interest expense. The derivative liabilities are re-valued at the end of each reporting period using the lattice Model, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur.

 

Revenue recognition

 

Revenue will be recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.

 

Professional service revenue will primarily consist of the fees the Company earns related to installation and consulting services. The Company will recognize revenue from professional services upon delivery or completion of performance.

 

Training services will be recognized upon delivery of the training.

 

There were no revenues during 2021 and 2020.

 

Lease accounting

 

The Company follows ASU 2016-02 (Topic 842), “Leases”. ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors may use the effective date method and elected certain practical expedients allowing the Company not to reassess:

 

  ● whether expired or existing contracts contain leases under the new definition of a lease;
     
  ● lease classification for expired or existing leases; and
     
  ● whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.

 

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 

Advertising costs

 

The Company expenses advertising costs as incurred. The total costs the Company recognized related to advertising were $Nil during the years ended December 31, 2021 and 2020.

 

Recent Accounting Pronouncements

 

Accounting Standards Adopted

 

On December 18, 2019 the FASB issued the ASU 2019-12 “Income taxes (Topic 740)—Simplifying the accounting for income taxes”. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles and also improve consistent application by clarifying and amending existing guidance, such as franchise taxes and interim recognition of enactment of tax laws or rate changes. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of 2021 and it did not have any impact on its financial statements and related disclosures.

 

Recently Issued Accounting Standards Not Yet Adopted

 

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies the accounting for certain convertible instruments such that the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, or that do not result in substantial premiums accounted for as paid-in-capital. As a result, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost. In addition, the ASU requires the use of the if-converted method to be applied to convertible instruments when calculating earnings per share. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using either a modified retrospective or a full retrospective approach. Early adoption is permitted for fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is does not believe adoption of this ASU will have a material impact on its consolidated financial statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
CAPITAL STOCK
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
CAPITAL STOCK

NOTE 3 – CAPITAL STOCK

 

Common Stock

 

During the year ended December 31, 2021, the Company issued 5,208,731,005 common shares for compensation valued at $44,268,440, which were approved and accrued for between 2018 and 2021.

 

During the years ended December 31, 2020, there were no movements in share capital issued and outstanding.

 

On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 common stock of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The 475,000,000 shares issuable to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $4,135,037. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $ Nil (2020 - $7,443) cash settlement of accounts payable.

 

Preferred Stock

 

The Company has designated 95,000,000 of its preferred stock as Series A Preferred Stock, each of which has 100 votes. The Company, will not, without the affirmative vote or written consent of the holders of at least a majority of the outstanding Series A Preferred Stock (i) authorize or create any additional series of stock ranking prior to or on a parity with the Series A Preferred Stock as to dividends, voting rights, or the distribution of assets upon liquidation; or (ii) change any of the rights, privileges or preferences of the Series A Preferred Stock.

 

The Company’s Board of Directors approved the issuance of an aggregate of 95,000,000 shares of the Company’s Series A Preferred Stock to several directors as compensation for services rendered during 2014. The shares of Series A Preferred stock are not convertible, carry voting rights of 100 votes per Preferred share and the fair value of the Preferred shares were deemed to be $288,780 based on the voting rights of the Preferred shares relative to the fair value of the Company at the date of the issuance.

 

During the year ended December 31, 2021, the Company issued 5,000,000 Series B Preferred shares to a director. The shares of Series B Preferred stock which are not convertible and carry voting rights of 1,000 votes per Preferred share were approved for issuance on February 19, 2019. The fair value of the Series B Preferred shares were deemed to be $201,350 based on their voting rights relative to the fair value of the Company at the date of approval and were accrued for in 2019.

 

During 2020, the Company did not issue any Preferred Class shares.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 4 – RELATED PARTY TRANSACTIONS

 

During the quarter ended December 31, 2020, the Board of Directors approved the issuance of 1,619,000,000 shares to directors and shareholders of the Company for par value of $16,190, resulting in stock-based compensation valued at $26,697,310. These shares were issued during 2021.

 

During the quarter ended September 30, 2020, the Board of Directors approved the issuance of 1,089,000,000 shares to directors and shareholders of the Company for par value of $10,890, resulting in stock-based compensation valued at $8,701,110. These shares were issued during 2021.

 

During 2019, the Board of Directors approved the issuance of 57,000,000 shares to directors and shareholders of the Company for par value of $570, resulting in as stock-based compensation valued at $1,373,130. These shares were issued during 2021.

 

During 2019, the Company designated 5,000,000 of is preferred stock as Series B preferred stock, each of which has 1,000 votes and are not convertible. The Company, will not, without the approval or express written consent of the all the holders of the Series B preferred stock (i) establish, create, authorize or approve the issuance of any series or class of preferred stock (ii) change any of the rights, privileges or preferences of the Series B preferred stock or (iii) redeem the Series B preferred stock..

 

During 2019, the Board of Directors approved the issuance of 5,000,000 Series B preferred shares to a director as compensation for services rendered and their fair value were deemed to be $201,350 based on the voting rights of the preferred shares relative to the fair value of the Company at the date of the approved issuance. These shares were issued during 2021.

 

During 2018, 3,031,900 valued at $121,276 were issued to the family of the controlling shareholder of FE Pharmacy Inc. and a related party as compensation for services rendered and for nominal cash. A further 3,731,005 valued at $149,240 was approved for issuance to the same family of the controlling shareholder of FE Pharmacy Inc, as compensation for services rendered and were issued during 2021.

 

On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 shares of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The 475,000,000 shares issued to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $4,135,037. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $Nil (2020 - $7,443) cash settlement of accounts payable.

 

Included in convertible loans payable to related parties is an amount of $1,080,255 (2020 - $993,812), including accrued interest, owing to a director and a shareholder of the Company.

 

Included in accounts payable and accrued liabilities is an amount of $1,988,921 (2020 - $1,675,108) due to directors and officers of the Company as at December 31, 2021.

 

Included in short term loans payable is an amount of $2,206 (2020 - $Nil) due to the controlling shareholder of FE Pharmacy Inc. and a related party as at December 31, 2021.

 

Included in short term loans payable is an amount of $291,729 (2020 - $61,297) due to a director and officer of the Company as at December 31, 2021.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE LOANS PAYABLE
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
CONVERTIBLE LOANS PAYABLE

NOTE 5 – CONVERTIBLE LOANS PAYABLE

 

   2021   2020 
Convertible promissory note bearing interest at 15% per annum – third parties  $314,981   $290,133 
Convertible promissory note bearing interest at 15% per annum – related parties   1,080,255    993,812 
Convertible loans payable  $1,395,236   $1,283,945 

 

The Convertible loans payable bear 15% interest per annum and are convertible at a fixed price at any time during the 1 year term.  The Company has the option to pay the note at any time.  The Company analyzed the conversion option for derivative accounting consideration under ASC Topic 815-40, Derivatives and Hedging – Contract in Entity’s Own Stock and concluded that the embedded conversion was a derivative but the fair value of the feature was zero. The total outstanding notes is $1,395,236, including accrued interest, of which $1,080,255 is to from related parties. Interest of $111,291 (2020 - $111,596) on the convertible loans payable are included in net finance charge for the year ended December 31, 2021 included in the consolidated statement of operations. All of the above convertible loans payable were in default as at December 31, 2021.

 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
SHORT TERM LOANS PAYABLE
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
SHORT TERM LOANS PAYABLE

NOTE 6 – SHORT TERM LOANS PAYABLE

 

   2021   2020 
Non-interest bearing short term funding from third party  $17,174   $17,100 
Non-interest bearing short term funding from related party   2,206    — 
Non-interest bearing short term funding from director   291,729    61,297 
Short term loans payable  $311,109   $78,397 

 

As at December 31, 2021, the balance of $311,109 (2020 - $78,397) represented short term funding provided by a third party and related parties which are non-interest bearing, unsecured and have no fixed repayment date.  The portion of the loan from third party in Canadian dollars is $21,772 which is subject to revaluation at the end of each period end.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 7 – INCOME TAXES

 

The Company had no income taxes payable at December 31, 2021 and 2020.

 

The reconciliation of income tax provision computed at statutory rates to the reported income tax provision is as follows:

 

   2021   2020 
Net loss for the year  $(8,093,468)  $(36,055,668)
Effective statutory rate   21%   21%
Expected tax recovery  $(1,699,628)  $(7,571,690)
Net effects of non deductible and allowable items   1,532,076    7,433,668 
Change in valuation allowance   167,552    138,022 
Income Tax Expense  $—   $— 

 

Deferred income taxes reflect the net income tax effect of temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and amounts used for income taxes.

The Company’s deferred income tax assets and liabilities consist of the following:

 

   2021   2020 
Net operating loss carry forward  $4,230,233   $4,058,167 
Equipment   7,261    15,660 
Valuation allowance   (4,237,494)   (4,073,827)
Deferred tax assets, net of valuation allowance  $—   $— 

 

Net operating loss carry forwards totaled approximately $20,144,000 at December 31, 2021. The net operating loss carry forwards will begin to expire in the year 2022 if not utilized. After consideration of all the evidence, management has recorded a valuation allowance at December 31, 2021 due to uncertainty of realizing the deferred tax assets. Utilization of the Company’s net operating loss carry forwards may be limited based on changes in ownership as defined in Internal Revenue Code Section 382. Tax years 2011 through 2021 remain open to examination by tax authorities.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

On April 21, 2017, an ex-employee of Kallo obtained a judgement ordering Kallo to pay Canadian $ 135,959 for unpaid wages and expenses relating to services performed in 2016. The full amount has been accrued for in the financial statements of Kallo.

 

On October 24, 2016, a consultant obtained a judgement ordering Kallo to pay Canadian $34,924 for unpaid fees. The full amount has been accrued for in the financial statements of Kallo.

 

On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. An amount of Canadian $134,960 has been accrued for in the financial statements of Kallo.

 

There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. An amount of Canadian $24,016 has been accrued for in the financial statements of Kallo. Negotiations are in process for the settlement of this debt for a lump sum.

 

Canada Revenue Agency has assessed the Company for unpaid Canadian $84,643 representing unremitted employee source deductions and related penalties and interest, the full amount of which has been accrued in the financial statements of Kallo.

 

Responsibility for payments of the above claims has been assumed by FE Pharmacy Inc. under the terms of the agreement mentioned in Note 3.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND OPERATIONS (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.

 
Basis of Consolidation

Basis of Consolidation

 

The consolidated financial statements include the accounts of Kallo and its wholly-owned subsidiary, Rophe Medical Technologies Inc. Significant inter-company transactions and balances have been eliminated on consolidation.

 
Earnings Per Share

Earnings Per Share

 

The Company computes basic net loss per share in accordance with ASC 260, Earnings Per Share, by dividing the net loss for the period by the weighted average number of common shares outstanding during the year. Diluted loss per share reflects the potential dilution of securities that could share in earnings of an entity.  In a loss year, dilutive common equivalent shares are excluded from the loss per share calculation as the effect would be anti-dilutive.  For the years ended December 31, 2021 and 2020, basic and diluted losses per share are the same for both years.

 
Use of Estimates

Use of Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key estimates include the fair value of common stock issued for services received by the Company, valuation of financial instruments, measurement of non-monetary transactions and provision for penalties and interest on estimated payroll tax liabilities.

 
Software Development Costs

Software Development Costs

 

Software development costs are accounted for in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed. Software development costs incurred internally in creating computer software products are expensed until technological feasibility has been established upon completion of a detailed program design. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. The determination of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including anticipated future gross product revenues, estimated economic life and changes in hardware and software technology.

 

Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently reported at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution. No costs have been capitalized to date as the Company has not completed a working model as of yet.

 
Related party transactions

Related party transactions

 

FASB ASC 850, “Related Party Disclosures” requires companies to include in their financial statements disclosures of material related party transactions.  The Company discloses all material related party transactions.  Related parties are defined to include any principal owner, director or executive officer of the Company and any immediate family members of a principal owner, director or executive officer.

 
Research and Development

Research and Development

 

The Company accounts for research and development costs in accordance with ASC 730-10, Research and Development. Accordingly, all research and development costs are charged to expense as incurred as software development costs.

 
Foreign Currency Translation

Foreign Currency Translation

 

The Company’s functional and reporting currency is the United States dollar. Transaction may occur in Canadian dollars which are accounted for under ASC 830, Foreign Currency Matters. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statements of Operations. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

 
Income Taxes

Income Taxes

 

The Company accounts for income taxes under FASB ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized.  Changes in recognition or measurement are reflected in the period in which a change in judgement occurs, as a result of information that arises or when a tax position is effectively settled.  Interest and penalties related to income tax matters are recognized in general and administrative expense.

 

In accordance with the statute of limitations for federal tax returns, the Company’s federal tax returns for the years 2011 through 2021 are subject to examination. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of FASB ASC 740.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company used a three-level hierarchy that prioritizes the inputs used in valuation techniques for determining fair value of investments and liabilities. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:

 

Level 1 – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives and most United States Government and agency securities).

 

Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following:

 

  ● Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);
     
  ● Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and
     
  ● Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).

 

Level 3 – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

There are no financial instruments that are accounted for at fair value at December 31, 2021 and 2020.

 
Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).

 
Contingencies

Contingencies

 

The Company accrues estimates for resolution of any legal and other contingencies when losses are probable and estimable, in accordance with ASC 450, Contingencies. Legal defense costs are accrued as incurred.

 
Stock Issued in Exchange for Services

Stock Issued in Exchange for Services

 

In accordance with ASC 505, the valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).

 
Convertible promissory note

Convertible promissory note

 

The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments if they do not meet the criteria for classification in stockholders’ equity.

 

The Company has evaluated the terms and conditions of its convertible notes under the guidance of ASC 815. The conversion feature did not meet the definition of “indexed to a company’s own stock” provided for in ASC 815. Therefore, the conversion features require bifurcation and liability classification. The Company recorded the conversion feature as a derivative liability and debt discount and is amortized over the life of the convertible note. The debt discount is recorded against the related convertible note outstanding. The amortization is recorded as interest expense. The derivative liabilities are re-valued at the end of each reporting period using the lattice Model, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur.

 
Revenue recognition

Revenue recognition

 

Revenue will be recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.

 

Professional service revenue will primarily consist of the fees the Company earns related to installation and consulting services. The Company will recognize revenue from professional services upon delivery or completion of performance.

 

Training services will be recognized upon delivery of the training.

 

There were no revenues during 2021 and 2020.

 
Lease accounting

Lease accounting

 

The Company follows ASU 2016-02 (Topic 842), “Leases”. ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors may use the effective date method and elected certain practical expedients allowing the Company not to reassess:

 

  ● whether expired or existing contracts contain leases under the new definition of a lease;
     
  ● lease classification for expired or existing leases; and
     
  ● whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.

 

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 
Advertising costs

Advertising costs

 

The Company expenses advertising costs as incurred. The total costs the Company recognized related to advertising were $Nil during the years ended December 31, 2021 and 2020.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Accounting Standards Adopted

 

On December 18, 2019 the FASB issued the ASU 2019-12 “Income taxes (Topic 740)—Simplifying the accounting for income taxes”. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles and also improve consistent application by clarifying and amending existing guidance, such as franchise taxes and interim recognition of enactment of tax laws or rate changes. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of 2021 and it did not have any impact on its financial statements and related disclosures.

 

Recently Issued Accounting Standards Not Yet Adopted

 

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies the accounting for certain convertible instruments such that the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, or that do not result in substantial premiums accounted for as paid-in-capital. As a result, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost. In addition, the ASU requires the use of the if-converted method to be applied to convertible instruments when calculating earnings per share. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using either a modified retrospective or a full retrospective approach. Early adoption is permitted for fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is does not believe adoption of this ASU will have a material impact on its consolidated financial statements.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE LOANS PAYABLE (Tables)
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Schedule of Convertible Loans Payable

CONVERTIBLE LOANS PAYABLE
   2021   2020 
Convertible promissory note bearing interest at 15% per annum – third parties  $314,981   $290,133 
Convertible promissory note bearing interest at 15% per annum – related parties   1,080,255    993,812 
Convertible loans payable  $1,395,236   $1,283,945 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
SHORT TERM LOANS PAYABLE (Tables)
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Schedule of Short Term Loans payable

SHORT TERM LOANS PAYABLE
   2021   2020 
Non-interest bearing short term funding from third party  $17,174   $17,100 
Non-interest bearing short term funding from related party   2,206    — 
Non-interest bearing short term funding from director   291,729    61,297 
Short term loans payable  $311,109   $78,397 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
reconciliation of income tax provision computed at statutory rates to the reported income tax provision

The reconciliation of income tax provision computed at statutory rates to the reported income tax provision is as follows:

 
INCOME TAXES
   2021   2020 
Net loss for the year  $(8,093,468)  $(36,055,668)
Effective statutory rate   21%   21%
Expected tax recovery  $(1,699,628)  $(7,571,690)
Net effects of non deductible and allowable items   1,532,076    7,433,668 
Change in valuation allowance   167,552    138,022 
Income Tax Expense  $—   $— 
Company’s deferred income tax assets and liabilities

The Company’s deferred income tax assets and liabilities consist of the following:

 
INCOME TAXES (Details 2)
   2021   2020 
Net operating loss carry forward  $4,230,233   $4,058,167 
Equipment   7,261    15,660 
Valuation allowance   (4,237,494)   (4,073,827)
Deferred tax assets, net of valuation allowance  $—   $— 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
CAPITAL STOCK (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Apr. 07, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture $ 44,268,440    
Common Shares to be Issued, Shares     475,000,000
Assignment of Liabilities (3,455,111) $ (3,455,111) $ 4,135,037
Stock Issued During the Period to Director, Value $ 201,350    
Common Stock [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 5,208,731,005    
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture $ 52,086    
Stock Issued During the Period to Director, Value    
Preferred Stock [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture    
Stock Issued During the Period to Director, Value $ 50    
Preferred Stock [Member] | Series A Preferred Stock [Member] | Director [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Preferred Stock, Shares Issued 95,000,000    
Stock Issued During the Period to Director, Value $ 288,780    
Preferred Stock [Member] | Series B Preferred Stock [Member] | Director [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Preferred Stock, Shares Issued 5,000,000    
Stock Issued During the Period to Director, Value $ 201,350    
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Related Party Transaction [Line Items]          
Share-based Payment Arrangement, Noncash Expense     $ 7,295,600 $ 35,398,420  
Accounts Payable, Related Parties, Current $ 993,812   1,080,255 993,812  
Accounts Payable and Accrued Liabilities, Current 4,359,752   4,802,752 4,359,752  
Loans Payable, Current $ 78,397   311,109 78,397  
Director [Member]          
Related Party Transaction [Line Items]          
Common Stock to be issued, Shares 1,619,000,000 1,089,000,000     57,000,000
Common Stock to be issued $ 16,190 $ 10,890     $ 570
Share-based Payment Arrangement, Noncash Expense 26,697,310 $ 8,701,110     $ 1,373,130
Accounts Payable, Related Parties, Current 993,812   1,080,255 993,812  
Accounts Payable and Accrued Liabilities, Current 1,675,108   1,988,921 1,675,108  
Loans Payable, Current $ 61,297   291,729 $ 61,297  
F E Pharmacy [Member]          
Related Party Transaction [Line Items]          
Loans Payable, Current     $ 2,206    
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE LOANS PAYABLE (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Short-term Debt [Line Items]    
Convertible loans payable $ 1,395,236 $ 1,283,945
Convertible promissory notes bearing interest at 15% per annum - third parties    
Short-term Debt [Line Items]    
Convertible loans payable 314,981 290,133
Convertible promissory notes bearing interest at 15% per annum - related parties    
Short-term Debt [Line Items]    
Convertible loans payable $ 1,080,255 $ 993,812
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
SHORT TERM LOANS PAYABLE (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Short-term Debt [Line Items]    
Short term loans payable $ 311,109 $ 78,397
Non-interest bearing short term funding from third parties    
Short-term Debt [Line Items]    
Short term loans payable 17,174 17,100
Non-interest bearing short term funding from related parties    
Short-term Debt [Line Items]    
Short term loans payable 2,206
Non-interest bearing short term funding from director    
Short-term Debt [Line Items]    
Short term loans payable $ 291,729 $ 61,297
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE LOANS PAYABLE (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Debt Disclosure [Abstract]    
Interest Expense $ 111,291 $ 111,596
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Net loss for the year $ (8,093,468) $ (36,055,668)
Effective statutory rate 2100.00% 2100.00%
Expected tax recovery $ (1,699,628) $ (7,571,690)
Net effects of non deductible and allowable items 1,532,076 7,433,668
Change in valuation allowance 167,552 138,022
Income Tax Expense
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details 2) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Net operating loss carry forward $ 4,230,233 $ 4,058,167
Equipment 7,261 15,660
Valuation allowance (4,237,494) (4,073,827)
Deferred tax assets, net of valuation allowance
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details Narrative)
 12 Months Ended
Dec. 31, 2021
USD ($)
Income Tax Disclosure [Abstract]  
Operating Loss Carryforwards $ 20,144,000
Operating Loss Carryforwards, Expiration Date Dec. 31, 2022
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - CAD ($)
 12 Months Ended
Oct. 06, 2017
Apr. 21, 2017
Oct. 24, 2016
Dec. 31, 2021
Judicial Ruling [Member]        
Loss Contingencies [Line Items]        
Salary and Wage, Officer, Excluding Cost of Good and Service Sold   $ 135,959    
Unpaid Fees     $ 34,924  
Pending Litigation [Member]        
Loss Contingencies [Line Items]        
Loss Contingency, Allegations On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services.      
Loss Contingency, Damages Sought Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action.     There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000.
XML 38 kalo-20211231_10k_htm.xml IDEA: XBRL DOCUMENT 0001389034 2021-01-01 2021-12-31 0001389034 2022-01-31 0001389034 2022-04-21 0001389034 2021-12-31 0001389034 2020-12-31 0001389034 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2021-12-31 0001389034 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2020-12-31 0001389034 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2021-12-31 0001389034 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2020-12-31 0001389034 2020-01-01 2020-12-31 0001389034 us-gaap:PreferredStockMember 2019-12-31 0001389034 us-gaap:CommonStockMember 2019-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2019-12-31 0001389034 us-gaap:RetainedEarningsMember 2019-12-31 0001389034 2019-12-31 0001389034 us-gaap:PreferredStockMember 2020-12-31 0001389034 us-gaap:CommonStockMember 2020-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2020-12-31 0001389034 us-gaap:RetainedEarningsMember 2020-12-31 0001389034 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001389034 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2020-01-01 2020-12-31 0001389034 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001389034 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001389034 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2021-01-01 2021-12-31 0001389034 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001389034 us-gaap:PreferredStockMember 2021-12-31 0001389034 us-gaap:CommonStockMember 2021-12-31 0001389034 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001389034 kalo:AssignmentOfLiabilitiesMember 2021-12-31 0001389034 us-gaap:RetainedEarningsMember 2021-12-31 0001389034 2017-04-07 0001389034 srt:DirectorMember us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001389034 srt:DirectorMember us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001389034 srt:DirectorMember us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001389034 srt:DirectorMember us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001389034 srt:DirectorMember 2020-10-01 2020-12-31 0001389034 srt:DirectorMember 2020-07-01 2020-09-30 0001389034 srt:DirectorMember 2019-01-01 2019-12-31 0001389034 srt:DirectorMember 2021-12-31 0001389034 srt:DirectorMember 2020-12-31 0001389034 kalo:FEPharmacyMember 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities1Member 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities1Member 2020-12-31 0001389034 kalo:ConvertibleDebtSecurities2Member 2021-12-31 0001389034 kalo:ConvertibleDebtSecurities2Member 2020-12-31 0001389034 kalo:ShortTermDebt1Member 2021-12-31 0001389034 kalo:ShortTermDebt1Member 2020-12-31 0001389034 kalo:ShortTermDebt3Member 2021-12-31 0001389034 kalo:ShortTermDebt3Member 2020-12-31 0001389034 kalo:ShortTermDebt2Member 2021-12-31 0001389034 kalo:ShortTermDebt2Member 2020-12-31 0001389034 us-gaap:JudicialRulingMember 2017-04-20 2017-04-21 0001389034 us-gaap:JudicialRulingMember 2016-10-23 2016-10-24 0001389034 us-gaap:PendingLitigationMember 2017-10-05 2017-10-06 0001389034 us-gaap:PendingLitigationMember 2021-01-01 2021-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:CAD 0001389034 false FY --12-31 2021 false 2022-12-31 10-K true 2021-12-31 000-53183 KALLO INC. NV 98-0542529 255 Duncan Mill Road Suite 504 Toronto ON CA M3B 3H9 (416) 246-9997 No Yes Yes Yes Non-accelerated Filer true false true 10226975 6356429586 BF Borgers CPA PC Lakewood, Colorado 5041 796 12739 13535 13535 0 4802752 4359752 314981 290133 311109 78397 1080255 993812 37149790 6509097 42871884 6509097 42871884 0.00001 0.00001 120000000 120000000 95000000 95000000 95000000 95000000 5000000 5000000 5000000 5000000 1000 950 0.00001 0.00001 8000000000 8000000000 6356429204 6356429204 1147698199 1147698199 63564 11478 86337770 41920116 -3455111 -3455111 -89442785 -81349317 -6495562 -42871884 13535 0 7942995 35880286 27784 18563 -7970779 -35898849 111403 111596 -15476 -95108 4190 49885 -8093468 -36055668 -0.004 -0.03 2289746749 1147698199 95000000 950 1147698199 11478 41920116 -3462554 -45293649 -6823659 7443 7443 -36055668 -36055668 95000000 950 1147698199 11478 41920116 -3455111 -81349317 -42871884 5000000 50 201300 201350 5208731005 52086 44216354 44268440 -8093468 -8093468 100000000 1000 6356429204 63564 86337770 -3455111 -89442785 -6495562 -8093468 -36055668 7295600 35398420 111291 111596 -14738 -96136 4190 49885 452736 433787 -12739 -236032 -65614 236828 65614 236828 65614 796 796 7443 44268440 201350 35425500 <p id="xdx_80A_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zqx45fx5cjFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_826_z8uP7gSUjIce">BUSINESS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Organization</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kallo Inc. (“Kallo” or the “Company”) develops customized health care solutions designed to improve or enhance the delivery of care in the countries and regions we serve.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Going Concern</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The amounts of assets and liabilities in the consolidated financial statements do not purport to represent realizable or settlement values. The Company has incurred operating losses since inception and has an accumulated deficit and a working capital deficit at December 31, 2021. The Company is expected to incur additional losses as it executes its go to market strategy. This raises substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has met its historical working capital requirements from the sale of common shares and related party loans. In order to not burden the Company, certain officers/stockholders have agreed to provide funding to the Company to pay its annual audit fees, filing costs and legal fees as long as the board of directors deems it necessary. However, there can be no assurance that such financial support shall be ongoing or available on terms or conditions acceptable to the Company. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">COVID-19</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s results of operations are affected by economic conditions, including macroeconomic conditions and levels of business confidence. There continues to be significant volatility and economic uncertainty in many markets and the ongoing COVID-19 pandemic contributes to that level of volatility and uncertainty and has created economic disruption. The Company is actively managing its business to respond to the impact. There were no adjustments recorded in the financial statements that might result from the outcome of these uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on the Company’s business, financial condition and results of operations. Management continues to monitor the business environment for any significant changes that could impact the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_z5bHWOTtQFsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_82C_zwiSwXR9lXT6">ACCOUNTING POLICIES AND OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zpD0Z3XKpF1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zV0eDCIZKsNf">Basis of Presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_ziT5FLTjKNE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zq6tJVyrms7a">Basis of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Kallo and its wholly-owned subsidiary, Rophe Medical Technologies Inc. Significant inter-company transactions and balances have been eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zsw3a7Avaao1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_ze41AD87wUo9">Earnings Per Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company computes basic net loss per share in accordance with ASC 260, <i>Earnings Per Share</i>, by dividing the net loss for the period by the weighted average number of common shares outstanding during the year. Diluted loss per share reflects the potential dilution of securities that could share in earnings of an entity.  In a loss year, dilutive common equivalent shares are excluded from the loss per share calculation as the effect would be anti-dilutive.  For the years ended December 31, 2021 and 2020, basic and diluted losses per share are the same for both years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--UseOfEstimates_zNh6z2YHavUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_z4aQQaF0MAea">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key estimates include the fair value of common stock issued for services received by the Company, valuation of financial instruments, measurement of non-monetary transactions and provision for penalties and interest on estimated payroll tax liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zUrYqdLXAyk6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z2osUF5qrHj8">Software Development Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software development costs are accounted for in accordance with ASC 985-20, <i>Costs of Software to be Sold, Leased or Marketed</i>. Software development costs incurred internally in creating computer software products are expensed until technological feasibility has been established upon completion of a detailed program design. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. The determination of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including anticipated future gross product revenues, estimated economic life and changes in hardware and software technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently reported at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution. No costs have been capitalized to date as the Company has not completed a working model as of yet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--RelatedPartyTransactionsPolicyTextBlock_zlpj8bcg7MJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zOaqnPcZ6Rnh">Related party transactions</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB ASC 850, “Related Party Disclosures” requires companies to include in their financial statements disclosures of material related party transactions.  The Company discloses all material related party transactions.  Related parties are defined to include any principal owner, director or executive officer of the Company and any immediate family members of a principal owner, director or executive officer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1fwkBLaPbDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zzGcnuKXG6oj">Research and Development</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for research and development costs in accordance with ASC 730-10, Research and Development. Accordingly, all research and development costs are charged to expense as incurred as software development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zb2ns5nrxLwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zaeIixliu5Y">Foreign Currency Translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s functional and reporting currency is the United States dollar. Transaction may occur in Canadian dollars which are accounted for under ASC 830, <i>Foreign Currency Matters</i>. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statements of Operations. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zzJZwH2ojid9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_z5EhDsim7IJ8">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under FASB ASC 740, <i>Income Taxes</i>. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized.  Changes in recognition or measurement are reflected in the period in which a change in judgement occurs, as a result of information that arises or when a tax position is effectively settled.  Interest and penalties related to income tax matters are recognized in general and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the statute of limitations for federal tax returns, the Company’s federal tax returns for the years 2011 through 2021 are subject to examination. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of FASB ASC 740.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUgO4l3JCikd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zyNaWACqwQM4">Fair Value of Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used a three-level hierarchy that prioritizes the inputs used in valuation techniques for determining fair value of investments and liabilities. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 1</b> – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives and most United States Government and agency securities).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 2</b> – Financial assets and liabilities whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 3</b> – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no financial instruments that are accounted for at fair value at December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zTrsv9VVBrQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zaGaA3rqIlq4">Stock-Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for share-based compensation in accordance with ASC 718, <i>Stock Compensation</i>. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zYsbiE5qrxL2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zT7tW4wKFwM2">Contingencies</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accrues estimates for resolution of any legal and other contingencies when losses are probable and estimable, in accordance with ASC 450, <i>Contingencies.</i> Legal defense costs are accrued as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--StockIssuedInExchangeForServicesPolicyTextBlock_zaeJAvCKzEG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_z1YR6rsJpOYc">Stock Issued in Exchange for Services</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 505, the valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ConvertiblePromissoryNotePolicyTextBlock_zs07to9duqwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zJ5BZLtYBrId">Convertible promissory note</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments if they do not meet the criteria for classification in stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated the terms and conditions of its convertible notes under the guidance of ASC 815. The conversion feature did not meet the definition of “indexed to a company’s own stock” provided for in ASC 815. Therefore, the conversion features require bifurcation and liability classification. The Company recorded the conversion feature as a derivative liability and debt discount and is amortized over the life of the convertible note. The debt discount is recorded against the related convertible note outstanding. The amortization is recorded as interest expense. The derivative liabilities are re-valued at the end of each reporting period using the lattice Model, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zxSxcia7ZEV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z54oPyTNOey2">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue will be recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional service revenue will primarily consist of the fees the Company earns related to installation and consulting services. The Company will recognize revenue from professional services upon delivery or completion of performance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Training services will be recognized upon delivery of the training.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no revenues during 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zM28z2bUlBce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zY8YdIl5GwJi">Lease accounting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASU 2016-02 (Topic 842), “Leases”. ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors may use the effective date method and elected certain practical expedients allowing the Company not to reassess:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether expired or existing contracts contain leases under the new definition of a lease;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease classification for expired or existing leases; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zL1nBTUPPP44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zpYfiFWcK7Ci">Advertising costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses advertising costs as incurred. The total costs the Company recognized related to advertising were $Nil during the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvtPULY7JfCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zJwzqlOPBTY5">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Accounting Standards Adopted</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529; background-color: white">On December 18, 2019 the FASB issued the ASU 2019-12 “Income taxes (Topic 740)—Simplifying the accounting for income taxes”. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles and also improve consistent application by clarifying and amending existing guidance, such as franchise taxes and interim recognition of enactment of tax laws or rate changes. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted this standard in the first quarter of 2021 and it did not have any impact on its financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently Issued Accounting Standards Not Yet Adopted</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, “<i>Debt - Debt with Conversion Options (Subtopic 470-20) and Derivatives and Hedging - Contracts</i> <i>in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”</i>. This ASU simplifies the<i> </i>accounting for certain convertible instruments such that the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, or that do not result in substantial premiums accounted for as paid-in-capital. As a result, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost. In addition, the ASU requires the use of the if-converted method to be applied to convertible instruments when calculating earnings per share. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using either a modified retrospective or a full retrospective approach. Early adoption is permitted for fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In May 2021, the FASB issued ASU 2021-04, <i>Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</i>. The ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is does not believe adoption of this ASU will have a material impact on its consolidated financial statements.</span></p> <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zpD0Z3XKpF1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zV0eDCIZKsNf">Basis of Presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in accordance with the instructions to Form 10-K related to smaller reporting companies as promulgated by the Securities and Exchange Commission.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_ziT5FLTjKNE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zq6tJVyrms7a">Basis of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Kallo and its wholly-owned subsidiary, Rophe Medical Technologies Inc. Significant inter-company transactions and balances have been eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zsw3a7Avaao1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_ze41AD87wUo9">Earnings Per Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company computes basic net loss per share in accordance with ASC 260, <i>Earnings Per Share</i>, by dividing the net loss for the period by the weighted average number of common shares outstanding during the year. Diluted loss per share reflects the potential dilution of securities that could share in earnings of an entity.  In a loss year, dilutive common equivalent shares are excluded from the loss per share calculation as the effect would be anti-dilutive.  For the years ended December 31, 2021 and 2020, basic and diluted losses per share are the same for both years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--UseOfEstimates_zNh6z2YHavUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_z4aQQaF0MAea">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key estimates include the fair value of common stock issued for services received by the Company, valuation of financial instruments, measurement of non-monetary transactions and provision for penalties and interest on estimated payroll tax liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zUrYqdLXAyk6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z2osUF5qrHj8">Software Development Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software development costs are accounted for in accordance with ASC 985-20, <i>Costs of Software to be Sold, Leased or Marketed</i>. Software development costs incurred internally in creating computer software products are expensed until technological feasibility has been established upon completion of a detailed program design. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. The determination of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including anticipated future gross product revenues, estimated economic life and changes in hardware and software technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently reported at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution. No costs have been capitalized to date as the Company has not completed a working model as of yet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--RelatedPartyTransactionsPolicyTextBlock_zlpj8bcg7MJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zOaqnPcZ6Rnh">Related party transactions</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB ASC 850, “Related Party Disclosures” requires companies to include in their financial statements disclosures of material related party transactions.  The Company discloses all material related party transactions.  Related parties are defined to include any principal owner, director or executive officer of the Company and any immediate family members of a principal owner, director or executive officer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1fwkBLaPbDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zzGcnuKXG6oj">Research and Development</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for research and development costs in accordance with ASC 730-10, Research and Development. Accordingly, all research and development costs are charged to expense as incurred as software development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zb2ns5nrxLwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zaeIixliu5Y">Foreign Currency Translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s functional and reporting currency is the United States dollar. Transaction may occur in Canadian dollars which are accounted for under ASC 830, <i>Foreign Currency Matters</i>. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statements of Operations. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zzJZwH2ojid9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_z5EhDsim7IJ8">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under FASB ASC 740, <i>Income Taxes</i>. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized.  Changes in recognition or measurement are reflected in the period in which a change in judgement occurs, as a result of information that arises or when a tax position is effectively settled.  Interest and penalties related to income tax matters are recognized in general and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the statute of limitations for federal tax returns, the Company’s federal tax returns for the years 2011 through 2021 are subject to examination. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of FASB ASC 740.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUgO4l3JCikd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zyNaWACqwQM4">Fair Value of Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used a three-level hierarchy that prioritizes the inputs used in valuation techniques for determining fair value of investments and liabilities. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 1</b> – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives and most United States Government and agency securities).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 2</b> – Financial assets and liabilities whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 3</b> – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no financial instruments that are accounted for at fair value at December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zTrsv9VVBrQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zaGaA3rqIlq4">Stock-Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for share-based compensation in accordance with ASC 718, <i>Stock Compensation</i>. Under the provisions of ASC 718, share-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense for services rendered and over the employee’s requisite service period (generally the vesting period of the equity grant).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zYsbiE5qrxL2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zT7tW4wKFwM2">Contingencies</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accrues estimates for resolution of any legal and other contingencies when losses are probable and estimable, in accordance with ASC 450, <i>Contingencies.</i> Legal defense costs are accrued as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--StockIssuedInExchangeForServicesPolicyTextBlock_zaeJAvCKzEG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_z1YR6rsJpOYc">Stock Issued in Exchange for Services</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 505, the valuation of the Company’s common stock issued to non-employees in exchange for services is valued at an estimated fair market value as determined by Management of the Company based upon trading prices of the Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the contractor’s requisite service period (generally the vesting period of the equity grant).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ConvertiblePromissoryNotePolicyTextBlock_zs07to9duqwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zJ5BZLtYBrId">Convertible promissory note</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments if they do not meet the criteria for classification in stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated the terms and conditions of its convertible notes under the guidance of ASC 815. The conversion feature did not meet the definition of “indexed to a company’s own stock” provided for in ASC 815. Therefore, the conversion features require bifurcation and liability classification. The Company recorded the conversion feature as a derivative liability and debt discount and is amortized over the life of the convertible note. The debt discount is recorded against the related convertible note outstanding. The amortization is recorded as interest expense. The derivative liabilities are re-valued at the end of each reporting period using the lattice Model, with changes in the fair value of the derivative liability recorded as charges or credits to income, in the period in which the changes occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zxSxcia7ZEV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z54oPyTNOey2">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue will be recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional service revenue will primarily consist of the fees the Company earns related to installation and consulting services. The Company will recognize revenue from professional services upon delivery or completion of performance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Training services will be recognized upon delivery of the training.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no revenues during 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zM28z2bUlBce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zY8YdIl5GwJi">Lease accounting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASU 2016-02 (Topic 842), “Leases”. ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors may use the effective date method and elected certain practical expedients allowing the Company not to reassess:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether expired or existing contracts contain leases under the new definition of a lease;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease classification for expired or existing leases; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--AdvertisingCostsPolicyTextBlock_zL1nBTUPPP44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zpYfiFWcK7Ci">Advertising costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses advertising costs as incurred. The total costs the Company recognized related to advertising were $Nil during the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvtPULY7JfCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zJwzqlOPBTY5">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Accounting Standards Adopted</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529; background-color: white">On December 18, 2019 the FASB issued the ASU 2019-12 “Income taxes (Topic 740)—Simplifying the accounting for income taxes”. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles and also improve consistent application by clarifying and amending existing guidance, such as franchise taxes and interim recognition of enactment of tax laws or rate changes. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted this standard in the first quarter of 2021 and it did not have any impact on its financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently Issued Accounting Standards Not Yet Adopted</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, “<i>Debt - Debt with Conversion Options (Subtopic 470-20) and Derivatives and Hedging - Contracts</i> <i>in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”</i>. This ASU simplifies the<i> </i>accounting for certain convertible instruments such that the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, or that do not result in substantial premiums accounted for as paid-in-capital. As a result, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost. In addition, the ASU requires the use of the if-converted method to be applied to convertible instruments when calculating earnings per share. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using either a modified retrospective or a full retrospective approach. Early adoption is permitted for fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In May 2021, the FASB issued ASU 2021-04, <i>Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</i>. The ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is does not believe adoption of this ASU will have a material impact on its consolidated financial statements.</span></p> <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi9RgrMW4GEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_822_zeSsMROMEMm">CAPITAL STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1dfbidiE5t">5,208,731,005</span> common shares for compensation valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231_zL2EFY3NjvLd"><span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231_zRI1WZKdyHxl">44,268,440</span></span>, which were approved and accrued for between 2018 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2020, there were no movements in share capital issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 common stock of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The <span id="xdx_908_ecustom--CommonSharesToBeIssued_iI_c20170407_zdoGU8mgsAD3">475,000,000</span> shares issuable to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $<span id="xdx_905_ecustom--AssignmentOfLiabilities_iI_c20170407_zYfBFmFRwvGj">4,135,037</span>. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $ Nil (2020 - $7,443) cash settlement of accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Preferred Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has designated 95,000,000 of its preferred stock as Series A Preferred Stock, each of which has 100 votes. The Company, will not, without the affirmative vote or written consent of the holders of at least a majority of the outstanding Series A Preferred Stock (i) authorize or create any additional series of stock ranking prior to or on a parity with the Series A Preferred Stock as to dividends, voting rights, or the distribution of assets upon liquidation; or (ii) change any of the rights, privileges or preferences of the Series A Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s Board of Directors approved the issuance of an aggregate of <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSkYhU6QYZfg">95,000,000</span> shares of the Company’s Series A Preferred Stock to several directors as compensation for services rendered during 2014. The shares of Series A Preferred stock are not convertible, carry voting rights of 100 votes per Preferred share and the fair value of the Preferred shares were deemed to be $<span id="xdx_90C_ecustom--StockIssuedDuringPeriodToDirectorInValue_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zHwfHFHu60za">288,780</span> based on the voting rights of the Preferred shares relative to the fair value of the Company at the date of the issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zZDmeBR3sHXf">5,000,000</span> Series B Preferred shares to a director. The shares of Series B Preferred stock which are not convertible and carry voting rights of 1,000 votes per Preferred share were approved for issuance on February 19, 2019. The fair value of the Series B Preferred shares were deemed to be $<span id="xdx_905_ecustom--StockIssuedDuringPeriodToDirectorInValue_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z3KzYhnO7PTk">201,350</span> based on their voting rights relative to the fair value of the Company at the date of approval and were accrued for in 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2020, the Company did not issue any Preferred Class shares.</span></p> 5208731005 44268440 44268440 475000000 4135037 95000000 288780 5000000 201350 <p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z1PnSGQJZqnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82D_zsDWRnmbcnz7">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the quarter ended December 31, 2020, the Board of Directors approved the issuance of <span id="xdx_901_ecustom--CommonStockToBeIssuesShares_c20201001__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zeEtICqlQxC">1,619,000,000</span> shares to directors and shareholders of the Company for par value of $<span id="xdx_907_ecustom--CommonStockToBeIssuesValue_c20201001__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zlcbJLkX9dZd">16,190</span>, resulting in stock-based compensation valued at $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20201001__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_z1ypQjquzSR6">26,697,310</span>. These shares were issued during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the quarter ended September 30, 2020, the Board of Directors approved the issuance of <span id="xdx_907_ecustom--CommonStockToBeIssuesShares_c20200701__20200930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zrD55gyK4Hoa">1,089,000,000</span> shares to directors and shareholders of the Company for par value of $<span id="xdx_90D_ecustom--CommonStockToBeIssuesValue_c20200701__20200930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zq1ACZPeZVr8">10,890</span>, resulting in stock-based compensation valued at $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zVIhNPLH5S8e">8,701,110</span>. These shares were issued during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2019, the Board of Directors approved the issuance of <span id="xdx_907_ecustom--CommonStockToBeIssuesShares_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zIVT0sWT29Eh">57,000,000</span> shares to directors and shareholders of the Company for par value of $<span id="xdx_909_ecustom--CommonStockToBeIssuesValue_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zD1KAZ7dVJ9j">570</span>, resulting in as stock-based compensation valued at $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zvq7YHAT800i">1,373,130</span>. These shares were issued during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2019, the Company designated 5,000,000 of is preferred stock as Series B preferred stock, each of which has 1,000 votes and are not convertible. The Company, will not, without the approval or express written consent of the all the holders of the Series B preferred stock (i) establish, create, authorize or approve the issuance of any series or class of preferred stock (ii) change any of the rights, privileges or preferences of the Series B preferred stock or (iii) redeem the Series B preferred stock..</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2019, the Board of Directors approved the issuance of 5,000,000 Series B preferred shares to a director as compensation for services rendered and their fair value were deemed to be $201,350 based on the voting rights of the preferred shares relative to the fair value of the Company at the date of the approved issuance. These shares were issued during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2018, 3,031,900 valued at $121,276 were issued to the family of the controlling shareholder of FE Pharmacy Inc. and a related party as compensation for services rendered and for nominal cash. A further 3,731,005 valued at $149,240 was approved for issuance to the same family of the controlling shareholder of FE Pharmacy Inc, as compensation for services rendered and were issued during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 shares of Kallo, FE Pharmacy Inc. assumed and will pay all of the Company’s outstanding indebtedness as at April 7, 2017. The 475,000,000 shares issued to FE Pharmacy Inc. has been valued at the book value of the total liabilities assigned to FE Pharmacy Inc. of $4,135,037. The assignment of the liabilities to FE Pharmacy Inc. has been recorded as a receivable in the equity section of the consolidated balance sheet and will be reduced as the liabilities are settled by FE Pharmacy Inc. During the year ended December 31, 2021, the assignment of liabilities amount has been reduced by $Nil (2020 - $7,443) cash settlement of accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in convertible loans payable to related parties is an amount of $<span id="xdx_90A_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zpekCdK7Ol21">1,080,255</span> (2020 - $<span id="xdx_90E_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zEKmd4gDOwv3">993,812</span>), including accrued interest, owing to a director and a shareholder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in accounts payable and accrued liabilities is an amount of $<span id="xdx_903_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zv6qkNbxbHUe">1,988,921</span> (2020 - $<span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zfwczjRs6kY7">1,675,108</span>) due to directors and officers of the Company as at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in short term loans payable is an amount of $<span id="xdx_90D_eus-gaap--LoansPayableCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FEPharmacyMember_zTCy5Gg3G4Pa">2,206</span> (2020 - $<span id="xdx_90E_eus-gaap--LoansPayableCurrent_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FEPharmacyMember_zcuh94hyVx83">Nil</span>) due to the controlling shareholder of FE Pharmacy Inc. and a related party as at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in short term loans payable is an amount of $<span id="xdx_90A_eus-gaap--LoansPayableCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zc3WeEo3RmLi">291,729</span> (2020 - $<span id="xdx_903_eus-gaap--LoansPayableCurrent_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zdXq6l3HISPe">61,297</span>) due to a director and officer of the Company as at December 31, 2021.</span></p> 1619000000 16190 26697310 1089000000 10890 8701110 57000000 570 1373130 1080255 993812 1988921 1675108 2206 291729 61297 <p id="xdx_805_eus-gaap--DebtDisclosureTextBlock_zk241CzMSSDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_821_zaHuI41qA1Oh">CONVERTIBLE LOANS PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ConvertibleLoansPayableTableTextBlock_zsPsWpQsyQic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BD_zPWzjXQIuq3c" style="display: none">Schedule of Convertible Loans Payable</span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureConvertibleLoansPayableDetailsAbstract_zqDDpeBKWkV6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE LOANS PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zjrimHEUIrZk" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_zEWoICg7EAO" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--ConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--ConvertibleDebtSecurities1Member_zY3Rqg0csj99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Convertible promissory note bearing interest at 15% per annum – third parties</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">314,981</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">290,133</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--ConvertibleDebtSecurities2Member_zIgB3ts67ZI5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note bearing interest at 15% per annum – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,080,255</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">993,812</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ConvertibleDebt_iI_zSCXyPF5A502" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="display: none">Convertible loans payable</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,395,236</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,283,945</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zW9YII7QG0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Convertible loans payable bear 15% interest per annum and are convertible at a fixed price at any time during the 1 year term.  The Company has the option to pay the note at any time.  The Company analyzed the conversion option for derivative accounting consideration under ASC Topic 815-40, Derivatives and Hedging – Contract in Entity’s Own Stock and concluded that the embedded conversion was a derivative but the fair value of the feature was zero. The total outstanding notes is $1,395,236, including accrued interest, of which $1,080,255 is to from related parties. Interest of $<span id="xdx_90B_eus-gaap--InterestExpense_c20210101__20211231_zIo6spta5xoc">111,291</span> (2020 - $<span id="xdx_90E_eus-gaap--InterestExpense_c20200101__20201231_zILtNsUbN0jg">111,596</span>) on the convertible loans payable are included in net finance charge for the year ended December 31, 2021 included in the consolidated statement of operations. All of the above convertible loans payable were in default as at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ConvertibleLoansPayableTableTextBlock_zsPsWpQsyQic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BD_zPWzjXQIuq3c" style="display: none">Schedule of Convertible Loans Payable</span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureConvertibleLoansPayableDetailsAbstract_zqDDpeBKWkV6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE LOANS PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zjrimHEUIrZk" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_zEWoICg7EAO" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--ConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--ConvertibleDebtSecurities1Member_zY3Rqg0csj99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Convertible promissory note bearing interest at 15% per annum – third parties</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">314,981</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">290,133</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--ConvertibleDebtSecurities2Member_zIgB3ts67ZI5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note bearing interest at 15% per annum – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,080,255</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">993,812</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ConvertibleDebt_iI_zSCXyPF5A502" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="display: none">Convertible loans payable</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,395,236</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,283,945</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> 314981 290133 1080255 993812 1395236 1283945 111291 111596 <p id="xdx_80C_eus-gaap--ShortTermDebtTextBlock_zrtteOE0iuY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_827_zCbA9jwedgWk">SHORT TERM LOANS PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfShortTermDebtTextBlock_zu5cqF6oWLS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zMBvf1ABgwDa"><span id="xdx_8B7_zDkQt179rui9" style="display: none">Schedule of Short Term Loans payable</span></span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureShortTermLoansPayableDetailsAbstract_z60MdJ89fi7a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHORT TERM LOANS PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20211231_z0LA7WH8yrXk" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_zsdagZ1ji0yi" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt1Member_ztVcohlrpw18" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Non-interest bearing short term funding from third party</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">17,174</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">17,100</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt3Member_zdZ5QH5WVdrl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-interest bearing short term funding from related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,206</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">—</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt2Member_ztc1pRb7maQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Non-interest bearing short term funding from director</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">291,729</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">61,297</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LoansPayableCurrent_iI_zfaFyCiMStT9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"><span style="display: none">Short term loans payable</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">311,109</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">78,397</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zmABcUxyZLs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the balance of $311,109 (2020 - $78,397) represented short term funding provided by a third party and related parties which are non-interest bearing, unsecured and have no fixed repayment date.  The portion of the loan from third party in Canadian dollars is $21,772 which is subject to revaluation at the end of each period end.</span></p> <p id="xdx_899_eus-gaap--ScheduleOfShortTermDebtTextBlock_zu5cqF6oWLS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zMBvf1ABgwDa"><span id="xdx_8B7_zDkQt179rui9" style="display: none">Schedule of Short Term Loans payable</span></span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureShortTermLoansPayableDetailsAbstract_z60MdJ89fi7a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHORT TERM LOANS PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20211231_z0LA7WH8yrXk" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_zsdagZ1ji0yi" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt1Member_ztVcohlrpw18" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Non-interest bearing short term funding from third party</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">17,174</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">17,100</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt3Member_zdZ5QH5WVdrl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-interest bearing short term funding from related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,206</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">—</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LoansPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--ShortTermDebt2Member_ztc1pRb7maQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Non-interest bearing short term funding from director</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">291,729</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">61,297</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LoansPayableCurrent_iI_zfaFyCiMStT9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"><span style="display: none">Short term loans payable</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">311,109</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">78,397</td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> 17174 17100 2206 291729 61297 311109 78397 <p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zfDqg9cMZqXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_825_zLUTnOvjYJT4">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no income taxes payable at December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zbKHVqNIwz6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_8B9_zob0eJ2ZpA5h">reconciliation of income tax provision computed at statutory rates to the reported income tax provision</span> is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureINCOMETAXESDetailsAbstract_zJpdczzhfPg5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zPtt4143Iz8i" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200101__20201231_zPLUKkkI03di" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zIBRSmh0rYc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Net loss for the year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(8,093,468</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(36,055,668</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_zp7nevOAli39" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effective statutory rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zEPZw9Zvf0E4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected tax recovery</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,699,628</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7,571,690</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_zAFp2Li965wk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net effects of non deductible and allowable items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,532,076</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,433,668</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zptvqGorykjc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167,552</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">138,022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_z71u8C5tQkz5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"><span style="display: none">Income Tax Expense</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zVDYGxPfcxJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net income tax effect of temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and amounts used for income taxes.</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGjbUzEjMGFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_8B4_z2cs57yeDba5">Company’s deferred income tax assets and liabilities</span> consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureIncomeTaxesDetails2Abstract_zcDcFjgqwxg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_zTU2ctXdQt17" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_z9rBtcWGW1d9" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zWJLKaZvbjId" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Net operating loss carry forward</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">4,230,233</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">4,058,167</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_zjIKANognwtf" style="vertical-align: bottom; background-color: White"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,261</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,660</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zh0mzgQ5MkH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,237,494</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,073,827</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zrZw4ZbLfCyf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt">Deferred tax assets, net of valuation allowance</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zPiD2YZck5ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carry forwards totaled approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20211231_zamERYYx4Y15">20,144,000</span> at December 31, 2021. The net operating loss carry forwards will begin to expire in the year <span id="xdx_90F_eus-gaap--OperatingLossCarryforwardsExpirationDate_dxH_c20210101__20211231_z7XvPB3B6lP" title="::XDX::2022-12-31">2022</span> if not utilized. After consideration of all the evidence, management has recorded a valuation allowance at December 31, 2021 due to uncertainty of realizing the deferred tax assets. Utilization of the Company’s net operating loss carry forwards may be limited based on changes in ownership as defined in Internal Revenue Code Section 382. <span style="background-color: white">Tax years 2011 through 2021 remain open to examination by tax authorities.</span></span></p> <p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zbKHVqNIwz6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_8B9_zob0eJ2ZpA5h">reconciliation of income tax provision computed at statutory rates to the reported income tax provision</span> is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureINCOMETAXESDetailsAbstract_zJpdczzhfPg5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zPtt4143Iz8i" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200101__20201231_zPLUKkkI03di" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zIBRSmh0rYc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Net loss for the year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(8,093,468</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(36,055,668</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_zp7nevOAli39" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effective statutory rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zEPZw9Zvf0E4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected tax recovery</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,699,628</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7,571,690</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_zAFp2Li965wk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net effects of non deductible and allowable items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,532,076</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,433,668</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zptvqGorykjc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167,552</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">138,022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_z71u8C5tQkz5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"><span style="display: none">Income Tax Expense</span></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> -8093468 -36055668 21 21 -1699628 -7571690 1532076 7433668 167552 138022 <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGjbUzEjMGFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_8B4_z2cs57yeDba5">Company’s deferred income tax assets and liabilities</span> consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureIncomeTaxesDetails2Abstract_zcDcFjgqwxg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_zTU2ctXdQt17" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_z9rBtcWGW1d9" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zWJLKaZvbjId" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Net operating loss carry forward</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">4,230,233</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">4,058,167</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_zjIKANognwtf" style="vertical-align: bottom; background-color: White"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,261</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,660</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zh0mzgQ5MkH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,237,494</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,073,827</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zrZw4ZbLfCyf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt">Deferred tax assets, net of valuation allowance</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">—</span></td><td style="white-space: nowrap; padding-bottom: 4pt; text-align: left"> </td></tr> </table> 4230233 4058167 7261 15660 4237494 4073827 20144000 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zx0DG9IjWuaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_828_zhvZBOeIbl32">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 21, 2017, an ex-employee of Kallo obtained a judgement ordering Kallo to pay Canadian $ <span id="xdx_908_eus-gaap--OfficersCompensation_uCAD_c20170420__20170421__us-gaap--LitigationStatusAxis__us-gaap--JudicialRulingMember_zq4iPyqemxec">135,959</span> for unpaid wages and expenses relating to services performed in 2016. The full amount has been accrued for in the financial statements of Kallo.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 24, 2016, a consultant obtained a judgement ordering Kallo to pay Canadian $<span id="xdx_904_eus-gaap--ProfessionalFees_uCAD_c20161023__20161024__us-gaap--LitigationStatusAxis__us-gaap--JudicialRulingMember_zYrONylioSM2" title="Unpaid Fees">34,924</span> for unpaid fees. The full amount has been accrued for in the financial statements of Kallo.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--LossContingencyAllegations_c20171005__20171006__us-gaap--LitigationStatusAxis__us-gaap--PendingLitigationMember_zPAM0DRYRoGg">On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services.</span> <span id="xdx_905_eus-gaap--LossContingencyDamagesSought_c20171005__20171006__us-gaap--LitigationStatusAxis__us-gaap--PendingLitigationMember_zsUuxvtSoHGj">Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action.</span> An amount of Canadian $134,960 has been accrued for in the financial statements of Kallo.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--LossContingencyDamagesSought_c20210101__20211231__us-gaap--LitigationStatusAxis__us-gaap--PendingLitigationMember_zMRJ5mGS08Qf">There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000.</span> An amount of Canadian $24,016 has been accrued for in the financial statements of Kallo. Negotiations are in process for the settlement of this debt for a lump sum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada Revenue Agency has assessed the Company for unpaid Canadian $84,643 representing unremitted employee source deductions and related penalties and interest, the full amount of which has been accrued in the financial statements of Kallo.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Responsibility for payments of the above claims has been assumed by FE Pharmacy Inc. under the terms of the agreement mentioned in Note 3.</span></p> 135959 34924 On October 6, 2017, Thornley Fallis Communications Inc. (“Thornley”) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 40 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 61 143 1 false 19 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://kalloinc.ca/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://kalloinc.ca/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://kalloinc.ca/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://kalloinc.ca/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficiency (Equity) Sheet http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity Consolidated Statements of Changes in Stockholders' Deficiency (Equity) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://kalloinc.ca/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - BUSINESS AND GOING CONCERN Sheet http://kalloinc.ca/role/BusinessAndGoingConcern BUSINESS AND GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS Sheet http://kalloinc.ca/role/AccountingPoliciesAndOperations ACCOUNTING POLICIES AND OPERATIONS Notes 8 false false R9.htm 00000009 - Disclosure - CAPITAL STOCK Sheet http://kalloinc.ca/role/CapitalStock CAPITAL STOCK Notes 9 false false R10.htm 00000010 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://kalloinc.ca/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 10 false false R11.htm 00000011 - Disclosure - CONVERTIBLE LOANS PAYABLE Sheet http://kalloinc.ca/role/ConvertibleLoansPayable CONVERTIBLE LOANS PAYABLE Notes 11 false false R12.htm 00000012 - Disclosure - SHORT TERM LOANS PAYABLE Sheet http://kalloinc.ca/role/ShortTermLoansPayable SHORT TERM LOANS PAYABLE Notes 12 false false R13.htm 00000013 - Disclosure - INCOME TAXES Sheet http://kalloinc.ca/role/IncomeTaxes INCOME TAXES Notes 13 false false R14.htm 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://kalloinc.ca/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 00000015 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS (Policies) Sheet http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies ACCOUNTING POLICIES AND OPERATIONS (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - CONVERTIBLE LOANS PAYABLE (Tables) Sheet http://kalloinc.ca/role/ConvertibleLoansPayableTables CONVERTIBLE LOANS PAYABLE (Tables) Tables http://kalloinc.ca/role/ConvertibleLoansPayable 16 false false R17.htm 00000017 - Disclosure - SHORT TERM LOANS PAYABLE (Tables) Sheet http://kalloinc.ca/role/ShortTermLoansPayableTables SHORT TERM LOANS PAYABLE (Tables) Tables http://kalloinc.ca/role/ShortTermLoansPayable 17 false false R18.htm 00000018 - Disclosure - INCOME TAXES (Tables) Sheet http://kalloinc.ca/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://kalloinc.ca/role/IncomeTaxes 18 false false R19.htm 00000019 - Disclosure - CAPITAL STOCK (Details Narrative) Sheet http://kalloinc.ca/role/CapitalStockDetailsNarrative CAPITAL STOCK (Details Narrative) Details http://kalloinc.ca/role/CapitalStock 19 false false R20.htm 00000020 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://kalloinc.ca/role/RelatedPartyTransactions 20 false false R21.htm 00000021 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details) Sheet http://kalloinc.ca/role/ConvertibleLoansPayableDetails CONVERTIBLE LOANS PAYABLE (Details) Details http://kalloinc.ca/role/ConvertibleLoansPayableTables 21 false false R22.htm 00000022 - Disclosure - SHORT TERM LOANS PAYABLE (Details) Sheet http://kalloinc.ca/role/ShortTermLoansPayableDetails SHORT TERM LOANS PAYABLE (Details) Details http://kalloinc.ca/role/ShortTermLoansPayableTables 22 false false R23.htm 00000023 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details Narrative) Sheet http://kalloinc.ca/role/ConvertibleLoansPayableDetailsNarrative CONVERTIBLE LOANS PAYABLE (Details Narrative) Details http://kalloinc.ca/role/ConvertibleLoansPayableTables 23 false false R24.htm 00000024 - Disclosure - INCOME TAXES (Details) Sheet http://kalloinc.ca/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://kalloinc.ca/role/IncomeTaxesTables 24 false false R25.htm 00000025 - Disclosure - INCOME TAXES (Details 2) Sheet http://kalloinc.ca/role/IncomeTaxesDetails2 INCOME TAXES (Details 2) Details http://kalloinc.ca/role/IncomeTaxesTables 25 false false R26.htm 00000026 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://kalloinc.ca/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://kalloinc.ca/role/IncomeTaxesTables 26 false false R27.htm 00000027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://kalloinc.ca/role/CommitmentsAndContingencies 27 false false All Reports Book All Reports kalo-20211231_10k.htm kalo-20211231.xsd kalo-20211231_10kex31z1.htm kalo-20211231_10kex32z1.htm kalo-20211231_cal.xml kalo-20211231_def.xml kalo-20211231_lab.xml kalo-20211231_pre.xml kl001_v1.jpg kl002_v1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 45 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kalo-20211231_10k.htm": { "axisCustom": 0, "axisStandard": 6, "contextCount": 61, "dts": { "calculationLink": { "local": [ "kalo-20211231_cal.xml" ] }, "definitionLink": { "local": [ "kalo-20211231_def.xml" ] }, "inline": { "local": [ "kalo-20211231_10k.htm" ] }, "labelLink": { "local": [ "kalo-20211231_lab.xml" ] }, "presentationLink": { "local": [ "kalo-20211231_pre.xml" ] }, "schema": { "local": [ "kalo-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 234, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 33, "http://kalloinc.ca/20211231": 8, "http://xbrl.sec.gov/dei/2021q4": 6, "total": 47 }, "keyCustom": 20, "keyStandard": 123, "memberCustom": 7, "memberStandard": 11, "nsprefix": "kalo", "nsuri": "http://kalloinc.ca/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://kalloinc.ca/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://kalloinc.ca/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CONVERTIBLE LOANS PAYABLE", "role": "http://kalloinc.ca/role/ConvertibleLoansPayable", "shortName": "CONVERTIBLE LOANS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - SHORT TERM LOANS PAYABLE", "role": "http://kalloinc.ca/role/ShortTermLoansPayable", "shortName": "SHORT TERM LOANS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INCOME TAXES", "role": "http://kalloinc.ca/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://kalloinc.ca/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS (Policies)", "role": "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies", "shortName": "ACCOUNTING POLICIES AND OPERATIONS (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "kalo:ConvertibleLoansPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - CONVERTIBLE LOANS PAYABLE (Tables)", "role": "http://kalloinc.ca/role/ConvertibleLoansPayableTables", "shortName": "CONVERTIBLE LOANS PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "kalo:ConvertibleLoansPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SHORT TERM LOANS PAYABLE (Tables)", "role": "http://kalloinc.ca/role/ShortTermLoansPayableTables", "shortName": "SHORT TERM LOANS PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - INCOME TAXES (Tables)", "role": "http://kalloinc.ca/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - CAPITAL STOCK (Details Narrative)", "role": "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "shortName": "CAPITAL STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2017-04-07", "decimals": "INF", "lang": null, "name": "kalo:CommonSharesToBeIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://kalloinc.ca/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2020-10-012020-12-31_srt_DirectorMember", "decimals": "INF", "lang": null, "name": "kalo:CommonStockToBeIssuesShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureConvertibleLoansPayableDetailsAbstract", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details)", "role": "http://kalloinc.ca/role/ConvertibleLoansPayableDetails", "shortName": "CONVERTIBLE LOANS PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureConvertibleLoansPayableDetailsAbstract", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LoansPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SHORT TERM LOANS PAYABLE (Details)", "role": "http://kalloinc.ca/role/ShortTermLoansPayableDetails", "shortName": "SHORT TERM LOANS PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureShortTermLoansPayableDetailsAbstract", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31_custom_ShortTermDebt1Member", "decimals": "0", "lang": null, "name": "us-gaap:LoansPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - CONVERTIBLE LOANS PAYABLE (Details Narrative)", "role": "http://kalloinc.ca/role/ConvertibleLoansPayableDetailsNarrative", "shortName": "CONVERTIBLE LOANS PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - INCOME TAXES (Details)", "role": "http://kalloinc.ca/role/IncomeTaxesDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureINCOMETAXESDetailsAbstract", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureIncomeTaxesDetails2Abstract", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - INCOME TAXES (Details 2)", "role": "http://kalloinc.ca/role/IncomeTaxesDetails2", "shortName": "INCOME TAXES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "kalo:DisclosureIncomeTaxesDetails2Abstract", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://kalloinc.ca/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2017-04-202017-04-21_us-gaap_JudicialRulingMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2017-04-202017-04-21_us-gaap_JudicialRulingMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://kalloinc.ca/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://kalloinc.ca/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficiency (Equity)", "role": "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Deficiency (Equity)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://kalloinc.ca/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - BUSINESS AND GOING CONCERN", "role": "http://kalloinc.ca/role/BusinessAndGoingConcern", "shortName": "BUSINESS AND GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - ACCOUNTING POLICIES AND OPERATIONS", "role": "http://kalloinc.ca/role/AccountingPoliciesAndOperations", "shortName": "ACCOUNTING POLICIES AND OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - CAPITAL STOCK", "role": "http://kalloinc.ca/role/CapitalStock", "shortName": "CAPITAL STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "kalo-20211231_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 19, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r325", "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r325", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r325", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r325", "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://kalloinc.ca/role/Cover" ], "xbrltype": "booleanItemType" }, "kalo_AssignmentOfLiabilities": { "auth_ref": [], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Assignment of liabilities", "verboseLabel": "Assignment of Liabilities" } } }, "localname": "AssignmentOfLiabilities", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kalo_AssignmentOfLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assignment Of Liabilities [Member]" } } }, "localname": "AssignmentOfLiabilitiesMember", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "kalo_CommonSharesToBeIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares to be Issued, Shares" } } }, "localname": "CommonSharesToBeIssued", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "kalo_CommonStockToBeIssuesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock to be issued, Shares" } } }, "localname": "CommonStockToBeIssuesShares", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "kalo_CommonStockToBeIssuesValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock to be issued" } } }, "localname": "CommonStockToBeIssuesValue", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kalo_ConvertibleDebtSecurities1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible promissory notes bearing interest at 15% per annum - third parties" } } }, "localname": "ConvertibleDebtSecurities1Member", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails" ], "xbrltype": "domainItemType" }, "kalo_ConvertibleDebtSecurities2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible promissory notes bearing interest at 15% per annum - related parties" } } }, "localname": "ConvertibleDebtSecurities2Member", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails" ], "xbrltype": "domainItemType" }, "kalo_ConvertibleLoansPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Convertible Loans Payable" } } }, "localname": "ConvertibleLoansPayableTableTextBlock", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableTables" ], "xbrltype": "textBlockItemType" }, "kalo_ConvertiblePromissoryNotePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible promissory note" } } }, "localname": "ConvertiblePromissoryNotePolicyTextBlock", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "kalo_DebtForgiveness": { "auth_ref": [], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Forgiveness", "label": "Debt forgiveness", "negatedLabel": "Debt forgiveness" } } }, "localname": "DebtForgiveness", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows", "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kalo_DisclosureConvertibleLoansPayableDetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureConvertibleLoansPayableDetailsAbstract", "verboseLabel": "CONVERTIBLE LOANS PAYABLE" } } }, "localname": "DisclosureConvertibleLoansPayableDetailsAbstract", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableTables" ], "xbrltype": "textBlockItemType" }, "kalo_DisclosureINCOMETAXESDetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureINCOMETAXESDetailsAbstract", "verboseLabel": "INCOME TAXES" } } }, "localname": "DisclosureINCOMETAXESDetailsAbstract", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "kalo_DisclosureIncomeTaxesDetails2Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES (Details 2)" } } }, "localname": "DisclosureIncomeTaxesDetails2Abstract", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "kalo_DisclosureShortTermLoansPayableDetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureShortTermLoansPayableDetailsAbstract", "verboseLabel": "SHORT TERM LOANS PAYABLE" } } }, "localname": "DisclosureShortTermLoansPayableDetailsAbstract", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayableTables" ], "xbrltype": "textBlockItemType" }, "kalo_FEPharmacyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "F E Pharmacy [Member]" } } }, "localname": "FEPharmacyMember", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kalo_IssuanceOfCommonStockPreviouslyAccrued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock previously accrued", "label": "Issuance of common stock previously accrued" } } }, "localname": "IssuanceOfCommonStockPreviouslyAccrued", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kalo_IssuanceOfPreferredStockPreviouslyAccrued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of preferred stock previously accrued" } } }, "localname": "IssuanceOfPreferredStockPreviouslyAccrued", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kalo_LiabilityForIssuableShares": { "auth_ref": [], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liability for issuable shares" } } }, "localname": "LiabilityForIssuableShares", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "kalo_RelatedPartyTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related party transactions" } } }, "localname": "RelatedPartyTransactionsPolicyTextBlock", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "kalo_SettlementOfAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Settlement of accounts payable by FE Pharmacy Inc." } } }, "localname": "SettlementOfAccountsPayable", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kalo_ShortTermDebt1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-interest bearing short term funding from third parties" } } }, "localname": "ShortTermDebt1Member", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "domainItemType" }, "kalo_ShortTermDebt2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-interest bearing short term funding from director" } } }, "localname": "ShortTermDebt2Member", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "domainItemType" }, "kalo_ShortTermDebt3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-interest bearing short term funding from related parties" } } }, "localname": "ShortTermDebt3Member", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "domainItemType" }, "kalo_StockIssuedDuringPeriodToDirectorInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:StockIssuedDuringPeriodToDirectorInShares]" } } }, "localname": "StockIssuedDuringPeriodToDirectorInShares", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "sharesItemType" }, "kalo_StockIssuedDuringPeriodToDirectorInValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued to director", "verboseLabel": "Stock Issued During the Period to Director, Value" } } }, "localname": "StockIssuedDuringPeriodToDirectorInValue", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "monetaryItemType" }, "kalo_StockIssuedInExchangeForServicesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued in Exchange for Services" } } }, "localname": "StockIssuedInExchangeForServicesPolicyTextBlock", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "kalo_UnissuedSharesForConsultingServicesReclassifiedToLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unissued shares for services reclassified to liability" } } }, "localname": "UnissuedSharesForConsultingServicesReclassifiedToLiability", "nsuri": "http://kalloinc.ca/20211231", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "srt_DirectorMember": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r115", "r267" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "verboseLabel": "Accounts Payable and Accrued Liabilities, Current" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r21", "r65", "r266", "r268" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Convertible loans payable \u2013 related parties", "verboseLabel": "Accounts Payable, Related Parties, Current" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r34", "r35", "r250", "r251", "r252", "r253", "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r206", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r68", "r69", "r70", "r203", "r204", "r205", "r239" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Assets": { "auth_ref": [ "r62", "r107", "r109", "r113", "r117", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r234", "r237", "r244", "r271", "r273", "r287", "r296" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r7", "r30", "r62", "r117", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r234", "r237", "r244", "r271", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r67", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "BUSINESS AND GOING CONCERN" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BusinessAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r19", "r50" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r44", "r249" ], "calculation": { "http://kalloinc.ca/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET DECREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r59", "r62", "r82", "r83", "r84", "r86", "r88", "r94", "r95", "r96", "r117", "r139", "r143", "r144", "r145", "r148", "r149", "r182", "r183", "r185", "r189", "r244", "r330" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r28", "r126", "r291", "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r123", "r124", "r125", "r135", "r311" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r138", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r68", "r69", "r239" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r13", "r195" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r13", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value, 8,000,000,000 shares authorized, 6,356,429,204 and 1,147,698,199 shares issued and outstanding respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r55", "r236" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r10", "r289", "r297" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible loans payable" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r8" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible loans payable \u2013 third parties" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash settlement of liabilities" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r58", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r167", "r174", "r175", "r176", "r181" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "CONVERTIBLE LOANS PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r8", "r9", "r10", "r61", "r66", "r150", "r151", "r152", "r153", "r154", "r155", "r157", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r173", "r177", "r178", "r179", "r180", "r260", "r288", "r289", "r295" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails", "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r27", "r61", "r66", "r150", "r151", "r152", "r153", "r154", "r155", "r157", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r173", "r177", "r178", "r179", "r180", "r260" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails", "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r217" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred tax assets, net of valuation allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r221", "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry forward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r216" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r39", "r73", "r74", "r75", "r76", "r77", "r81", "r82", "r86", "r87", "r88", "r91", "r92", "r240", "r241", "r293", "r302" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share - Basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r63", "r212", "r228" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r34", "r35", "r36", "r68", "r69", "r70", "r72", "r78", "r80", "r93", "r118", "r195", "r196", "r203", "r204", "r205", "r224", "r225", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r304", "r305", "r306", "r335" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r242", "r243" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r245", "r246", "r247", "r248" ], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign exchange loss" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r49", "r247", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedLabel": "Unrealized foreign exchange gains" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r41" ], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administration" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r63", "r213", "r214", "r219", "r226", "r229", "r231", "r232", "r233" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r64", "r79", "r80", "r106", "r211", "r227", "r230", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r33", "r209", "r210", "r214", "r215", "r218", "r223" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Expected tax recovery" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Net effects of non deductible and allowable items" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r46", "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income tax paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase in accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r258" ], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "negatedLabel": "Interest and financing costs" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r37", "r105", "r257", "r259", "r294" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest and penalties", "verboseLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetailsNarrative", "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r43", "r45", "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_JudicialRulingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.", "label": "Judicial Ruling [Member]" } } }, "localname": "JudicialRulingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lease accounting" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r24", "r62", "r110", "r117", "r139", "r140", "r141", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r235", "r237", "r238", "r244", "r271", "r272" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r62", "r117", "r244", "r273", "r290", "r299" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u0092 DEFICIENCY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u0092 DEFICIENCY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r26", "r62", "r117", "r139", "r140", "r141", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r235", "r237", "r238", "r244", "r271", "r272", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation." } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "Short term loans payable", "verboseLabel": "Loans Payable, Current" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative", "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r126", "r127", "r128", "r130", "r131", "r132", "r134", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAllegations": { "auth_ref": [ "r126", "r129", "r133" ], "lang": { "en-us": { "role": { "documentation": "Presents an assertion of a fact by a plaintiff in a pleading or complaint, which the plaintiff claims it will prove upon presentation of evidence at the proceeding.", "label": "Loss Contingency, Allegations" } } }, "localname": "LossContingencyAllegations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDamagesSought": { "auth_ref": [ "r126", "r129", "r133" ], "lang": { "en-us": { "role": { "documentation": "Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.", "label": "Loss Contingency, Damages Sought" } } }, "localname": "LossContingencyDamagesSought", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r44" ], "calculation": { "http://kalloinc.ca/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r44", "r47", "r49" ], "calculation": { "http://kalloinc.ca/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r31", "r32", "r36", "r38", "r49", "r62", "r71", "r73", "r74", "r75", "r76", "r79", "r80", "r85", "r107", "r108", "r111", "r112", "r114", "r117", "r139", "r140", "r141", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r241", "r244", "r292", "r301" ], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss for the year" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetails", "http://kalloinc.ca/role/StatementsOfCashFlows", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity", "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r107", "r108", "r111", "r112", "r114" ], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r220" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsExpirationDate": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format.", "label": "Operating Loss Carryforwards, Expiration Date" } } }, "localname": "OperatingLossCarryforwardsExpirationDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Preferred Class A [Member]" } } }, "localname": "PreferredClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Preferred Class B [Member]" } } }, "localname": "PreferredClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r12", "r182" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r12", "r182" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r12", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value, 120,000,000 shares authorized, 95,000,000 Series A preferred shares and 5,000,000 Series B preferred shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r6", "r119", "r120" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r42" ], "calculation": { "http://kalloinc.ca/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from short term loans payable" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r309", "r310" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Unpaid Fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r198", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r198", "r264", "r268", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r262", "r263", "r265", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r20", "r121", "r122", "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r196", "r206", "r273", "r298", "r307", "r308" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r68", "r69", "r70", "r72", "r78", "r80", "r118", "r203", "r204", "r205", "r224", "r225", "r239", "r304", "r306" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r56", "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "reconciliation of income tax provision computed at statutory rates to the reported income tax provision" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Company\u2019s deferred income tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r266", "r268" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails", "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short Term Loans payable" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://kalloinc.ca/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation", "verboseLabel": "Share-based Payment Arrangement, Noncash Expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/RelatedPartyTransactionsDetailsNarrative", "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ConvertibleLoansPayableDetails", "http://kalloinc.ca/role/ShortTermLoansPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "SHORT TERM LOANS PAYABLE" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/ShortTermLoansPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r54", "r67" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "ACCOUNTING POLICIES AND OPERATIONS" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r11", "r12", "r13", "r59", "r62", "r82", "r83", "r84", "r86", "r88", "r94", "r95", "r96", "r117", "r139", "r143", "r144", "r145", "r148", "r149", "r182", "r183", "r185", "r189", "r195", "r244", "r330" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r29", "r34", "r35", "r36", "r68", "r69", "r70", "r72", "r78", "r80", "r93", "r118", "r195", "r196", "r203", "r204", "r205", "r224", "r225", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r304", "r305", "r306", "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r68", "r69", "r70", "r93", "r274" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheetsParenthetical", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r12", "r13", "r195", "r196" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r12", "r13", "r196", "r199", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares issued as compensation", "verboseLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStockDetailsNarrative", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r13", "r16", "r17", "r62", "r116", "r117", "r244", "r273" ], "calculation": { "http://kalloinc.ca/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u0092 Deficiency" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets", "http://kalloinc.ca/role/StatementsOfChangesInStockholdersDeficiencyEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u0092 Deficiency:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r60", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "CAPITAL STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/CapitalStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r97", "r98", "r99", "r100", "r101", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/AccountingPoliciesAndOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r81", "r88" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of shares outstanding - Basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://kalloinc.ca/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r233": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r314": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r315": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r316": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r317": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r318": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r319": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r320": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r321": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r322": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r323": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r324": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r325": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r326": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r327": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r328": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r329": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r330": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r331": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r332": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r333": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r334": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" } }, "version": "2.1" } ZIP 46 0001520138-22-000250-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001520138-22-000250-xbrl.zip M4$L#!!0 ( /MZPU0AVNJ6Q @ *E+ 1 :V%L;RTR,#(Q,3(S,2YX M B3Q*0$..-OM?>D1M@ UQF(E M.8'^]7?D+SYL"Y/-]M)Z\Y!C2S.CF=]((XT97?V\6CCHB7!!F=LLUK=__<;=\JKUO M?[J3U>JOQO1-/QCR2EASLL (G.&*9DG9%YKWW#AG?%:I5ZNURJ?[WMBG*P6$ MERN'NH]IY+4/'SY4_-Z(-$&YFG G$MVHJ.X)%B26#+U40T]=(;%K[=#;,F;8 M)GY;"3IW2&DJZ45 2B-2F^S1"6*=S]A3!3J OE[[_"8B]41YAO$R)I]B,?'% MAAT^>;E:*S=J$8O@,DD.C>FD9;E>$I'*$'2EL-F2[['M( G=%=6M.*N*LQYS M/F*'Q4SPXC#J6N<6]@>IU=40Q"$+XLH;QA<=,L6> ]9\]K!#IY38)20QGQ&I M9JQ88HOHA46S'KLN@\4!*S1L46W+)879#PW_NE+3Y)(SAYB@-E(/L"Q31:N^ M2IM!9"DA:C=+P:,2 B)],3:94I?Z8X7+KX;*:K%YRBQX]%FN*OO$6R(\0>R! M^Y/_O.1$ )^O? \:0L:0)(/)PH[E. MLU=M3:&L\)D2* M;[=)#V,=L%,ACL0XNH(YU(86&X6"4""I\.@.,0>SYD124#8%ZMU^/>Z-_+BC MLQW!_RFB'V*HQ& Z6*J3 PP63O>,/CW^;W3X;R0B-D4;F45'OCW'[HP(PQU+ M9CW.F6/#"0WV$VI1. >NNY\]*M=)I^1CT_OK;7Y_A<,AZJ+M 7] FR'163!H MX==2&XOYC<.>4Y;2IDOOF8LC/ ,BD2^SB+A?>X*Z1(B6:]]"QPR L@AWPXTD MHU./_3MU"((,PV'"XP1>KA_&1K\['J-6OX-N!T;_%K4'_79WU"\BXBW+8IXK M _>WC$)'> ^_W/=!JMPXP_[&+=;0\-L]=#8'+1_*2*<(^*H\ KG0KDV.78% MMK9F=&:O%N9:=1_F4;?7,KL=-&R-S-^0.6KUQZUV<:$YREC3._6(UQ(3>]#_V!V9QG6OBWH#P!NP_ZT%;T4$?#QG7)J$+Y)PIW?I MP:[O@SV^&XQ,9'9']]^P-ER++8B)5R2,(=L->EP;^[@:_?;@OHO,UJ=N00/% M8D&E?^B%DP1$!G6V@*R#1MCJ"/18OTD&C/M[P[SO]LW@E $!1!T]NGUU[B@B M^ =.L MK6/2SO)(:==#GTBJ=\]/15X(22SK62#7#Z"&R6!%4EP:6P M;<[)M%E218_EJ";Q=S#M?+5P(A(E6E.0ZOM\'XUPX$@$YE9"2J)@%H2PI=K\ MB:A$RD<"))6*?;@U#%+CP#95>0V3'3PYUF1@(U6!8.L<:O+O:OI*]G7B0;7/#JM_*INPW?-\O#;X"PR%K06ZBQ%A7 M+AX4NO>8Y8O2L*BW(*'*)N0WS!Y$B_3/%210Y, MC? "A7_X4Q'[]Y80=.:JML&T1_&$.E3%SWNRF*AK#$KO9ND0$74<]:V@69+< M4Q%77:2YA$A,F6WZ&X;M!;]%EE"P@<271"YMML#4-219*$JPVYL(B-6>HK[E MS%LV2X$X"B0Z0VZZPSGF"VRM=W5/:3\%=;<^MW3(1(Z)Y7$?U-JN^CGH3MJ< M>DYSZB=E3OQM4BFYYY&,OI-3NZ%1NW&Z:M;K5S K(]@?V M.V" U M<\ !,_I$5&EZ9$BR^8A)]==:X/^NJR80L3L0+]W9,%"*=2@GEH3)Y?I7<^-% MDY_^[VSS[F([AN'H\!%0")__-8PC4@9M@VE8O;6I# W-T9*W(R-S4+[?7)I._Q%S0>DHX@)O7XL,,IVKT@TO] M918L)XBAZJZ4YZAOQV/"GZA%Q(A8#H:=0MW+-EF\#T8H?)&$4X4EJ^K#KY%< MFV0EKQW_WDB 07[R+SCLR$C,ZT9DP^VN+/]^(O@N\EB&G<>SG8B]6[G*D+,% MS%C&UWTF28:A1]"?GH6)VDB=>5KB$[%M\V.4OK*A!?(Y++WX6'@\W\E9K"NM MR;8W)]?)61O\$NS_$'S01BWMZ5F6+$_0F*8E/A';PF.>O^V;[)H$^\(FQ&3T MYD\MO\IQ?>MP&JLE=K,//TG@JXN7N^9 EI VJ$ M1#78IK_^O8:]I2T0'E+ X"CGI+%!VN,UCS__?WCXWB\[U=W*CB$\ MR[<=;_#+3ASUR^]V_K_C[:V?AQ$\!\]ZX2\[PR@:OW_SYO;V=O=V;]E9(GG)=;QO\\?';Y-' M>X'K9![%3]0D>V]FAH9O[?0%_>'#-_QEYM$H]]$#?C12CSJAOU^KOKUO'?Q$ M\L+=O&>KN&;8H?B_C^VS]/$H__GTT3=18'IAWP]&9@1WB",=E"NU-6<\(7\$:M^O>^>C00 M_;D#'[Z!;]6#<5@>F.8X>;AOACUZ4'Y!XY8K56W5\$W@NR+,?8>^R7G)CH)R M-!F+,']9\/4;_!K?K.";M>1-RX^]*)CD[UQ^21.J%\(@FET:?)BSJF^FZR?/ MPB^N[WC6KF72H]4:/$B8*DP;_C7PS\^1$[GB^. 09?%W[-S\ MLM/PO4AX4;D+^]DQ+/[MEYU(W$5O&*'?X'MOY+ __[]RV3AUA&N_-SHB^F!< MF"/QWKBS[SX8K1/ZX6NE5O]ZW?E/[>13O7X%_^#RC'+YL6_OU;_B3K]J._RJ M=OB$8?8/Z:T*_.][7C\X^2H 4F'Y\/^F!P,D;M:V=H M!@*V])68%@\2TF=/&><$UW(EQ]J;6=*_&_SHZU4;T^,,)JXXI>=/I"9]T:U,HZ,KC."I5Z(6Z/MCTROQ!^48)[ MZ1-!LYT;]9[MA&/7G+PW/-\3]*5S]QXIDPB0Y-%OCFT+CP@@_@H/7@ P!([% MM.TN:B.S.0W\D2*PE6KDT\_5&A%;#S8'4PGG?2[:[QRG>/_SF\P4_V96YKR_ M[ "W?M_S@2^9'H&KOIX,N=@YIN\7N(1THKG$9.?X],^ES#B/U.PPS MH3X[Q_CXBB]W'M5Z^)Y/ ]/"Y^5@4A9ZWS##8=VS\9\F\GK3A='#>M0P@V " M\OT?IALKEB_W4 \O^R33R'4[]B\[@-PU!\D"B+_P4>PY_"S0'!!,PO>>XX*X M$,!0QVJ-:D&/6.15(,:F8S?OQL(+A82"IRUJ?^&+JH>AB,+O6LS;A2T&9:#W M9X[9[D84>%L2,]P:]RO*\ "'T!!VYW(M_Z=BY&/1%,[Z/Z]F#M]]'P1R/? MNW<3AVN_B;IM$P4"V@_(V?(:YMB)3'?>AA8'],O:4!O4'E!T[:89>$#ZPGD[ M.5KX3BY$U/(L?R3._#!3DR M1E9.2IG6$R#H:'%HNHR-?,_EU"J+DZV6>3F/(Z3PXL+19,Z&:!,D$GTT0V$# M\* D23;,)V[M,=2V5ED\\U[:QKX/#A?/ I=^"':?>_A+?J<_"; M?T&;:]7%B^C_9L%/XNZUZN*Q^WL6_UV(6UV\% X+#P3@YHG@?UM>5EU_G+ R ML]*#=PM?*1HYI@P=;1%&@6-%PI:&D.P'VI-,CF8W:[DQ^D&;=];0] :B;4:B MV>\#\_S.?;]=O."[1 MDZP!-)W!*B4B97Z>^%C;PGZXIEO>@IN'V'*5T)79^@'45<$(S0V[N7+6OL' MRR!3DGY*V>JC\$3?^6YRM?]NB=SG$4M\$&KWCY;ADV#L@B6R"V>&J-[O)SFH M+,._\,@US3FG@W]CSQY6AT M'_<E&/E)*S E([ M/A!Z?!\-)-$$#?:^1U:2.R?<.=9">F8.YNQ_N#-0I,7SV.J9M9)A>8N?W9L)P8_"#P\*B#K98,#>8;O/8 ?!!8>"#I]V5"@'LO?_(\! 1LF;Z_VD!Z7 MP_1C(,EZ""\MH+S2N&A$)S76G!^%MI0",YK M)#@_C\FZD [70SI<8[ZGS\&+"S7H+U!@).(5BOLV"]00!5 M"-;K+EAO$# 5@O5Z"M;K!T)/2%3Y0!%-+PFDC#SWSOA3"[9L+L M,\%#(8NNH2SZS+2A$"6?791<+014WV*YDLK;S0W_E1M8*9K!7V9M_J83E MN[PX!?84V+/6V/-R+#Q3J/:Q0+4U1;7*R2<5#PJX61^X4=?S)+B93OQ?JD)50,N/H1-, M97<6U[XVU[[*2J[2-7K:O!J:PW9-K=/H 7CC63UU_@UIU1T[/%=@V MIR.L."#7#9V &W9 MP6"=J$$!!C\2-<@TU'OIC"!OLS\6UA?7_>-B]]Z/=-U[SW[=SXW=Q77_4-C] MTL6VO,W^P-A=7/?+P6[IVJ, <)Q+_I3&[_P:V[!=TVW'KN,-7L;-GX'.-: V MQ!@)$T_%W^3M^%D=>_)RGN;8>YMMH;H4A_ A1CC4]I*?]@NH61^HD9?S-*B1 M][A4J'E+<3$'R4^'::P@S(=MPY.#_A$ 9\ZFGYGBT!4]E>+0;2X3=NZ+,RU@ M9RU@9TW")6//8<"Y[IS,P,!(F&$",\? M.=Y#TSY\+M/SY@VLOL^>#*QO#C=U]8H_XPT,$SCQS_YS?.W7LX M)S\.+!'B1_3)4)@V(?7/;V#_\"_^[^?_5RX;IXYP[?<&B"*B?&4.A%$N'_\, MSQAA-'&!L(W,8.!XY<@?OS_*S6\>.AN^-:J7RGYW,VST_ M@'GY[8^N:7TS]L>1$?JN8W\P^H",Y=#Y1\";.(I\6(W,SU?5\SO'__L_U9+=#^QFH9.!,N#\;J MT,C0MQ:[3]D>F5^(.2@4'L?;4[VI91 M@;V$8]/31RGWS9'C3MX_-(Z^-Q@K73P."*L?+V:%'PPD9V73=0;PD06D&-G8 MXE;]<^_X^J+5;9YL;W6Z]6ZS\_.;WO$&;J+3;%RW6]U6L[.]5;\X,9K_U_A< MO_C4-!J7Y^>M3J=U>;&A._MBAD-@ZY'OE;:W3G:-QJY1JQSL'VWB=C8.1_;E M)9Q>ML]AI30DTO0[^^[K467_J["%4RZ?^!:9C;J3L?AJH013@?]]_8H_56L@ ME_XS]O][V+ON>9/! 8P']-KS/>*=CF5(D:4M^M.2;>2GTM".X9DHA\*$[_7Y M=HY!T/Z->$ Z9@H8+P5&(K/G"IC-=<>FC6+N+SN5'?H=GK/4[]^YLR-GG7=&/[CO*+[!/W'N8 M3RFFP;,^!9YUSXM-MRW&?A#E@VFS=>H<_G;4K/_C?C>8]OU@9$:_[#AWT?N> M[[O"]*(@%GGPJR]HY_CN,4 8>]D*I;_WBXKI^MKW5;EY=MKO&U76[ M;NP@\_.NW/\6_WL[-)H731V7\;I$RJ\^MDY;MZ95K2]A?LW_+X1)/LVS- ( MQ\)"VYUM.'!%46A80S.(T(KF'+_>M-T^)$KIHM.T:/7DG6E24J+I6[[KFN,0 M%J1^8DN()D0]?H(<<4O95321X,D+/L#U+IT 3^/\00;G6Y[E!R %);9=T?!C M$)LF#=^>0P+^C'\+O_Q]TNAT^HO@\N506&B>C<0X\&\0-[)L_A'KW#F^$#>F M;3Z:TV_FS=4S-]E2L' M^[6#VM%CY6H4O-8$.^%XUIVX B=Y12BPO072O _B? Z2."$MD-)8,!;D&ED MJ"^=Q@9LS-'QG/<7#$S/^8<^>#VUKW^+SLN_I]9N>[>SRTMLCL:N/X'+RJ*- M<>'O9C>608G%Z2/Y^U6L>D,DBQRZV,S0Q;IM!R(,Y3]GCB>J^33Q;G+[N^=8 M>R?MQ>D0.9/O'-<.#HR3V+-@T>>.Z\)&37L.92P]H!?-CE_+WUSC[^NK?\X/ M)L%?WV]/>7ASM9WC3NQ$ ACB_J-WM)>WHP;\>!ET_5LO?S^5JU][OX_KT;OQ MMT7O)YUZY[CK!S"8_^B]'.3MA6CS97 %X@R0LSE2U&]?3OXTW=O;P=_[JY.B M\A>X.)\'1?[N_-T:_CJU% VIF]IWC\[V/QM[G1\E8 MFT+;@6'*O0+K[QM7 8"G,S9=HWDGK#AR;H1QV0>^*<+7QBLX" -/8EHH6.)6 M-Y]7*K!&HE%8>JE&:;2G&->+MM"12!L8QP'88Q& MT]5ZCS11]5W4K>K]Q]IQ';CA,-SR8N^'"7O)4-G@!I&R&-&^* M3>05%2@EB8@JI2[6"K(9%\B=GK:WJ #LR[[)99A^UM\5O<@58B5?B^RCO8EA M#87U#>?Z9CA,3C6_FQ,:IG$+?+[\S?-O879AAD J;/@"Y:$2.N9LT7<\=LMA M'*BQ7SE0A#DEZDBC=_EDY/GTCO^$CW50[7UG@(VOR9;&O:,\&22G1.UJ1NG] M N?R&QY+1YX*"XGY\[[+ MR/)K"-\O# ,]/X)/_HX=%(9 !J(PD8!BL\)\:7#/\(/T-XI_2D6E72-'[\T: M'?_PW1A-7A3S$83Y$/WN8/^?LX_M\=]_+\X^/#7Q#M*(^:#\[TG'W=)(QX6_ M$%SS?TQ&KZFMC"+P.4<\V3-=-\$]'S)Z0#\"865S, MX*#&%9MWUM#T!K ,0$S\GH(0;?C:&]"SXT!8@NP*U9I!L7ZA\0H&[,/?,+:& M1HA9\+!@SKF"=\QH>O&W9CA+/^AEN8G7P,<]VWA5>[V]A;OL"0&G'/?^@CV0 MTH7/PENX##D0!A:&M I:I1E&QE'%L,U)N)OP]_N= 8TX"& 0CC&%D3EQ+I_4 MO!5[5['Y+70^+B)(^[[Y"XJS%(JS='S^,<@0(B?@Y M.F7A(D/4TBFU.73!0Y?[VV(0N^RX[Y2[QBN\F;$9PD<""N+&ZU6 M*]G&*8QA8"X8#@G$UP D]VPH/[*;A9'O0@[ *G_Y?K8"/[Z3B9--S845 M"L.T+&#B!$>,,0C0N9\"?'OEW"_"$7!_F"50@NSVEN6/Q@AG!&X& "V>QL 8 M!/YM-#3DMQEK7$<(6J9" M\+$7P14]Y^F+=6_/;=!_G0O*^WM_C[F66J=?!C MC,G\Z)P%R^F4F;%:ZY5K2J52>A39-S8.@ JGZR,6O$ MU5M_OCV]\[N_?W]^VG2<(5[+J*F3\"\9>7R!,Y@>&_]CJ>"R:L3?WN+3!*D[J%1=5814\"S MY.SDA6]N ]SG_>VM^9HMFG-8(S<>\JZC09W,Z"" X'5&OA&'K K#"7/A#WPR M))U8V9W1'HUSN1-2MV\=F!OU;0\VX", W#@AZ1*>Z6&Q6=0P,,L"EXI5H6TS ML$.T,F$YO#D!G7NOS->YVNW]]MA<06;QIJ ?#-R^P\ 3#D%15Q!IO,J)DYIK MP'B,8Z*#P]]+_?][V#GM__[7Q[BVD 2J!^0M;3DK\TX8#[H07I)W8OU1;NEV M,IG4C?AB#@: <4CB$1-%9-R8;BP4-MWX1&O1I(AV4_FK13&R!CH'HXD!$$N! M&F18[6-T XP6$L;&$<=PI&9]Z4L8 RC#W!%@OF,->2794=']Z&(T1.B[=LF0 M\1$FJ =8';/GL O5#+\AW:?18,GDD\R,0X&5\ V X*^F%YO!1)5KJKTW?KH_ M>.LJ[KF.=>KZ9O35:1%QJ%6J2!+V0M>JA2(8=M/*%*"8^$N-;%J09SJB[S86GOX+"T7SLJ';P[G =Y M!A<\1@246!GB*@T_7:#$SSK@L&O4)&HNW/.P=,A\QFK$277A1U8C3JH7/[T: M\?0>\;L/<%#HJK9P4GZ0U/K9-6>744F7K9](M99S)(=DLAUG3Y!.2D^5576A M9Z8/A/FMW!, [;#&,:U9G_(P9T9"KNAX-[;.XNEE^TN]?5(^N[S\K77Q M21;5/F]>=#>RL/:&2O!P$=W/K<[V%I9MYIB8QN5%M]ZZZ$@3YA_-L\LKFK!D MG%YWKV$-\!G]>M5LXT;KL RL1 LOGEPW\(OKBY-F^^Q/7-DKF*C=['2PT#L\ MTSJ_.FLU3UX;]<[U^15-8F#9],ONYV9;WUSW<[U+&^9OX-<+ XZV>]EN->IG MQFD=)MJ%=1N?FA?--GXR_]P:\.['IM$ZP3V>MG I'_^D>KG7G2;6QIU^]\ME M^Z1C=*X;GV&=\N;4$9]DJ>G')NP'3SGS*9_NU(?G]3^S'WQIG9U-Q9%T/E]> MGR53P('QQW58>*-U13>/'S-)_='O=WB:\YYI'%Y M?E5OUS^>R<]*=$EP.">M3N.:JM?3:P14^(($H3_Y?EH7?UR>P=SM5N*Q!O&L ;-0_T2T87UH=F!OK%S?JUU2_&)??;M9/^'J[-B\NN<=8ZQS8",'!)O_,VG$L;GZ1I:)\7?](26_!MLA\=\#4D MD@B#KS6[+3S?[:UNNWEQHD,K/-MMMC50Q>5,PRC#\,79GX >S9,6X]4N/ J0 MU;EN(^XD /H)YKG@X0CVM#<,A!7$,%Q)X[+=;F)5Y_3@C!1"3A2: MI=GW7E MJQ^Q$/1G!-6372P)?0T+9#S&8=2C *)P]:>GO+LF0,X9K+S9HOU^;,+-(<)< M(+IO;YU?PB3Z&FEY>,,P6;/=ANJ2[B6!C!\X M 4(.7-_VUEGKT^>N*H M8:O>_C-#./':S[&0-I;0QGNYA'L[:78:[=;')@YC M(-TV$K+] *1)K,0)Y6 'G@3>'YU.#ZXG.PE2*2%Y7^YP.. @6"F.J_L0L,3 MCM[L: A(S\#W9W]V6H2,IZT+ !NX&N0 )ZVN>D9.!2@,1PRTN2YAC?",#ILW MU>0M*8C5$2A]%*#S$N; +[[ ]<,$1K,.-+T,Q_HI1:C/L!=3E_" MDVDJ0H.8! "EWDAW FN_O&XC+JB+Y EX26>7,'0G!78U.^SG&BZR"9!M_ G+ M*V6_Q0UWD$!==+DY!Z)^][(+\YVUZA];9TFE]&93_Y(WPH,1@>@T4U(@"9>: M!.X?ACAM7YY+L 8J O04B=U)\A( 2 G/A<_B#$C36992\M9.6HC69Y),722_ M NAB$7>-%V=N@2@MKH41TR"\3&A]P@CX7AN(/T!""),E'5#8#X ]B_RT-8+T M+%7!]36('QH)BR\9*8M'L"8J-A^;=[>WOC196.C6?T-H!+$%T+G.IWQI7%^= MP+-,H/YHX8+QQ.>-AV^TFZ=GB'U*1&FTVHWK$Q8L.2%@X35W2QT?O[C.0<()/N2E%+;F;P9^[>2K,/0:/ MVA,,'K7"X+$N2A\ZI!S-,=C%:(G+?@--I5Z$H2,, DA?F\3E4+EB%=?9R-); M+RDR^E\%0>=VM%$+WEMZ=:8%1FO=OY>W1YN]%Z9+R7;>K:(..M*P198,7S2@ M;LSES;2)6A8)!TF_R^MNS5#FY<#CJE&J@+\7OM9-!"S@ZB#1#@(?)&OD['[P MW@@&O5>URGZIMO>N5#LX>+T$X#.-88 ^Z/\Q*Y7JUYOJ0D/3,*FVFCJ>S24! MY3+WH.+TE[F+>\%UF9NK3F]JT0#\9>A$8LE06UL*U-97"[:+WD3;";\9IZ85 M^<%Z@.ZB-_ANV:"[8MJ[MQ0H_KA:*%[T)JX];%GNW@C;Z$1FOV]@6!9:$]8" MI!>]V^J+(,?[RP#DVFKA>-%[N K\,4XJU@-P%[V]Y0/NBHGQP3)@>&^U,+SH M/9R)@>D: ,F6H#I8ZP'*B][ERZ#!A\N W_W5PN^B]W .:IS1,?LBFA@G266H M]8#B1>_U11#DS3 U;=):7XI9;"DD=*,].\_A'"B\ ^M!*@O +4CJ>I+4*2GG M[3*DTH/52J6+WL,Y)PACT8;+.# X[=!HRCS;MG"I_!3E(0Y]UQ:!<6Y&$:;V M8/8/M]0PKN+ &IHA)P7RNT9:QWTM)-Q%GUNU]@(D7/V WBT#.0Y7BQR+WD-' M53\Y38J58*'IM0#H1>^UNO<2# ]'RX#BMZN%XD7OX=STS $59U:UG='\$(*:0W?,_FPC[X3%N$L1O1(Y=CP4&XZT'9%WU$U5+V M:F4I.+%:__3"-_$[UI1R(I-*FB. PP>N^ETSSQEFSX\C0XI)Z-5>!Z!?^''4 M#E\ ]:\N)7[HW6H!?=%[2 EZ)ZW1CP#?B<=CEW[' CKK(MUT^&*^8J"\E M:.EHM=%W"]_$)=4/;:5MAM8"EA>]R\TER9OA(=FDM;X4;TX1G?&JL'E1=F M(%A*[%)UM6E-"]^$C#&:&)>W'A#JH3-&_W0#UF$ZGO%1> (H.%IU^7LBY*DW M7/JUYT8XK05B+/K(#I8>M[0*\KZ48*7J:A.D%KX)!?<$TAB> ?@09H"\B\V: MN)I_6)*>$A9\C)9GBS&V=%H7N6;1IW/PTL(ZEA+J5%UMDM7"-W$5.)[EC('D MIPX_XU0(Z?(6P0V(].M!V1>]]>4#>&%'WI2U%K:1%W:ASV%'_J,P(Q=FY!>/ M62\%"EV'J=.B(Z%!NNO 5&:$88&9GFO/2(,6O\*] MWU!I]..'ZO_OK:;^_^,/=_80L[-5\AM.KJJKP.,WDND_D(+!=*5^(W(B')@^ M)XN^^N9XYB.^YI?5PX!UL-DHGJ(MP>SL2VY+,(=._PM*J4KYU\9WZM"Q6T5: M7%>>VR)A"MM%\9*KN\;"-/H% _['ZT[KHMGI[,ZOUI\0\/7O';P!W2:?W@M6 MZ_TZW1SVR;U@2_G-8(W8 _4H-'R,_;YU0F%X?B3LU?6(+2#C^(O8WKH%B# < M3]T,P(CCT06'J,PB!^;+PV2J$V&)44\$(!E@J^_*(?;_1D\,Y596)Q M#V"&%,^P*&G+-@"JJ/TY LB)8XY\>* KK*$'$OC $0"CV??@,7S%BH, =6IZ M%=9#L,537.IKHO;CE:.2<2N,D0AP1LH(X^?UB?CE5YAN( )W8GSS_%L/]]+V MQ]@7_ES8R EFWWF-SE28-3(#QS=T:,9%HT& >J9S>$%HO$*V)"R,Q(%9&&-H M"L:7U\8MXR.NV+3^CIT U@RKA5UN;^$=.%AVQ:;!]:[K\QJS]WD#>(/BCD\= M"[XP=.Z5*I4*_DU>XE%P\)^JI1I_N?#F[07NY2_[&G!E>XMO'>^4;HX)<]^W M8KI=A/Z>; M@W)I$66T!P.2/ <(91ITT:P:6+.%U KI*/[J%^]TU6I$QA%=A M%$L 6,#Z;0 I& FGLH4+P!E,8"4 !F$\!H".<.K;H1DA6/;@ 9@1#F<"'P-Y M1P00H#9'?AG^ 89BNM'0@IE0/8II&5AC2"X3=T;NV<"1H!;$ :P:03#VJ&H0 M(RDN9N";[O86#.",QH%_0SF;@ QF. 8LH!\'EL3S6R'I11XE MZ8E<,F)DZ BR0'C5">%C8*,L=BKF'XD!2RLGD@P8G4F(KH57O[5..J]WJ<@9 M_F@ *;%C*U)B!#!BR_=")V2*PO06QKQ%LLS+S?N&LL]/)' M++BVG^KE:V=D7](:M;#V?[>^)0-P \@ K^[*-2.4;\+-MQ,4^#?7+O:CX)^Y M(?C7'8I0(B#(U&YL"^*3Q)W[ +LNAN*/%6J"8ONN5JU^,,[]GN,*1-Z?09,X M[I[#;N%?CDQ&L7_V*UN$5N#TV.HP\DFL!SG<54:(\Y/_-4?C#W5>3"@HI+F$ MU@,N9$=+PO%[@0,:,$DDH,&8()'[X=B)3"R3 2J&(#V"AA1D&_"L2:)"A3): ME$?K^2CLX$CTUPF,"*.I43$B+6M7WEM!D%X60?H1!8+:AA"D$V> N,P+3*QR MDP('7Q@.%D+!^N)@=^B$O+I$-U8*=&*CE-(",]HFFKX#WW,L0QG4V\("8 R- M5\WS]NN2<>58&*-BU -KZ-RH&FT-M@U:;--4:OU5O=&!5\29, ,/'I42 7T+ M'Z?)VHG](,/YT93:%:XH2TM#8JPD&X,T?/*Z/[E^3UHWVF+ =K] @ #@A4)Z MT4.R<09"D:0(CDZWGBK)0LD:F>+H!;%Z&<3J1Q08]C:$6#7MF.D'+Y&4",R* M=)!T%)CXPC"Q$!O6%Q/SQ(:,F" 4JK+C7^(H,=A<[Q\IZ:,TN5]9'RS7\:1' M%$>BX%'V6 M^(5)$4,U+=*CKA!?QH$?<7N>V,.R+0T@_K9C,E5&5S H?C(^PU)WRTYHL@[' MT=#'J) >$VK_UN-??O6'GM$0EN/NEF@E%$2"\2!^#V-!*/!J8H@;TXV9"TAU M%TY&*K\4GJ:FQ#@0BF8$!(\$!7XA<1AS2^Z)P0]9KNF,0EX,TA]5C0,C2IS MWMX:F_BP=*'+)<$@0,;@F;%K>D1D>(DT1AA;0WV5%)SBA*24[AIU3Q(W^-B" M6X#%EXSI8]="ZH9L)M_>DL.K"]6]?T[7P5<"FG3$&'^+:*! .0Q" ,+O. M-PRD"P2%R@&Q#NBX]4%N_>#;KM'%N#JBVCTZ/C,,XX"(LHSOX?'PKK%@"@SA MA!9%#='W]USR]I:\0-R#"HF E;_Q@V1L&>$0QKV_X&SP!.4[,!C2?F (LBY1 M& )D,#0RY "DA-AO!^Z"AX.M>?J@XF[L P."4_&-$)#3Z8- (@\/\20P"5%< M)W(&# XR>(-.#B,?*/TE4O$;L #'CT,MJD.&. 74!XB#(N P>Y,9/G5/9LW^ M!^-R3&+2>Z0)'0:1#\8? *1( EY,XDU9/P6U?] T)V/89CTP>X[UP;@P1X+/ MZ,+'G52OJ+?RF7*3P)"D\A8Z;67!E U3<=XM=8WU#5%P0+,]W&[O*.^4* M%O91G)SRC1L-TDBUAY1]6SUWPKQ,!GV[9NQA)CDRVPO@3Q3H7JM4*;MGN9HE M_;=6W=U#JE($K!4$X!D(P,?-(0#-\[:LIB-#4U'T:I*1*4,'YCK%F+JP"C,4>H,;O3JME 4LI^DR/Y"K<<%VO_H:'^R06C?^#0;=J8Q](;T M,94QN%7&CCC_F-/Y>.KQE>/XQMB:';*"PF>[M04+'UTT9Z9)/DZ("4[Q:(3M M4*5)5_/U+2O?9WG[>XC*ZE1UFNH^>6MS"6N& ,]0V?RZ03GD,]<(6-T]2,V M\TH0W6+-L#)N#E;E^;>!.9:'=2O0=(M/NG9^492+&%5K1L)T+7EFP9P!Y?FF M1C=<[;QUIM>51_F>9_^^^\$'DV'V_C-'=+OO[.>.5CV8-UQBH-OC M0A3/M<#*O.'(;VHN=UGWW>?!8>Y]GCE]H?APG9RU7 8A$"/3(7%)?@G#"L\V M V,B3'2R2G_\L$"P#J([S]\50L FP7!\K)6\EB@70RD_AC0^;UT>1Z@'A2 6@#JFI+1 M@_U'2 I+A\[JVP(\UQL\]9JQ2[&K?C D4/]/M8[_6W_#S#*"+Z]4')GC9:U@ M14&?!$ZFS$4+MA;1-:BB.)BP!OB"Q>RF8Z)#60T'4,5U!!)OC,Y)X@#UB+Z2 M+%HG416+8;D4[#A=^\?R8].RB X7+"\C .XR> M#!P1H:TN$QA*")U6)1O[D8QJZ\>44ZAVZ%-2GJHUAED%,0!?'R_BFZ"02"[N M%6YO81#D[73H'17VZR>QF&&,S6(=_"8-F4LJ'U%D)<9H4APXAV3"!V80)6T+ M9Y:3$\7(U=@PWT $.(&R)R?Q[.H65A,[OFR(++Q$1;;A1M$#A95?E)F6S%? M@!$\RN5";H%#GJJ4,>)Z;E:%EFF97AS+ N M8\25*?N!#R?A<6Y1C#'D,E+> UA[J7E?!4W^X6GR@DK&_.N@]!7@P&S$SV/_ MH(O9DZE)(BKW3,P9S-3'!4+O (E2-2\HGU46T7XHCNB)2TEI'!?%!%%Z("(I M_W(>RV<.1;X,!J8G94W90YMS65%4!:+/CY72TEI/6PG5]B G$YV BHK"[(# M=XU7C9/&:YFICW3TBQ^ KI"S-./5E\^7KXT1659P V@Q>MI2J-JPZ_>FDB_Q MJ_4'RQS2O!D+7Z^7JJWF)S I.5_ MFQ/XN#3 [:W9/$#C.=( "4:F\@"-E:G^"X$&1"\BY@+4B%[#(!7QNF7X3](Y-J3R5Q L[: W.&G%*BDP3 M*U&!PV1J&,P)'*;N%AEQB;BMLF[#>"7-FBW-QF,!F.C<"&644B9N@RS<)6DR MCTE)20W2$V117.@NZ0\R"-B3QA8L5=8N@O4[X<@8#X7G POS/6G%*@,IBAPJ MA#+PR0/G\QI@6L"L,-*:@: .(&1WG*1@'NS+$C;VK=QEH.3_?B0%"J4M.#CL MU>.P!,@Y[ G_1385$DLEL2(ROPE/V6VDX2=/O#*D?)7*2[,5$NC45>L"HV^& M45F=S2TJ*K=HKH*1T9(&3%4,1CR\=%+@6[(/$"\$>;,O>;[J/9*<3>J# $O M!+!QHM3^!Y\"C*G?J1H-C$%5B[FC"U:<,9.J14.X(#DR.55,=46RJ=K'D(A.XEW?1/-DR'UJ6%B6MN# D%@S] MA3+T_0UAZ.>--!QM"UK#(H:1F#_74PJZ76OJCM-&3J!Z" M'!^8(X'V-A ]^U@&G/!=-?8(I>]8E?Y$23N1)6],,CHE$C&;%F59*F[)H94G M THB>_ZQ9D']-H&NH+I1THIXDG08PQEH'O&L64O75577#K@97!4TOE$CF1J8G;2L 181W0K0$9-IRM([R:2 MW@RQNB\:]]GIW^&/XQ].2>AC_SQ,:E7W >I5()V?392E\WV7Z76,^3K8LP)DG3A(2J&?MIYPXEG#P/?\6%Z"_H'B5AR;1(ZNQ/:& MW$5(3;/=Q4<^ MH$=J=T8W -DXB;!0Q0S+Q7R

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ì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`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end